<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Influenza vaccines for preventing acute otitis media in infants and children - Norhayati, MN - 2017 | Cochrane Library</title> <meta content="Influenza vaccines for preventing acute otitis media in infants and children - Norhayati, MN - 2017 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010089.pub3/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Influenza vaccines for preventing acute otitis media in infants and children - Norhayati, MN - 2017 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010089.pub3/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD010089.pub3" name="dc.identifier" scheme="DOI"/> <meta content="Influenza vaccines for preventing acute otitis media in infants and children" name="citation_title"/> <meta content="Mohd N Norhayati" name="citation_author"/> <meta content="Universiti Sains Malaysia" name="citation_author_institution"/> <meta content="hayatikk@usm.my" name="citation_author_email"/> <meta content="Jacqueline J Ho" name="citation_author"/> <meta content="Penang Medical College" name="citation_author_institution"/> <meta content="Mohd Y Azman" name="citation_author"/> <meta content="Raja Perempuan Zainab II Hospital" name="citation_author_institution"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="10" name="citation_issue"/> <meta content="10.1002/14651858.CD010089.pub3" name="citation_doi"/> <meta content="2017" name="citation_date"/> <meta content="2017/10/17" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010089.pub3/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010089.pub3/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010089.pub3/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="Acute Disease; Anti‐Bacterial Agents [therapeutic use]; Influenza Vaccines [adverse effects, *therapeutic use]; Otitis Media [*prevention &amp; control]; Randomized Controlled Trials as Topic" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010089.pub3&amp;doi=10.1002/14651858.CD010089.pub3&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010089.pub3&amp;doi=10.1002/14651858.CD010089.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010089.pub3&amp;doi=10.1002/14651858.CD010089.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010089.pub3&amp;doi=10.1002/14651858.CD010089.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010089.pub3&amp;doi=10.1002/14651858.CD010089.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010089.pub3&amp;doi=10.1002/14651858.CD010089.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010089.pub3&amp;doi=10.1002/14651858.CD010089.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010089.pub3&amp;doi=10.1002/14651858.CD010089.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010089.pub3&amp;doi=10.1002/14651858.CD010089.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010089.pub3&amp;doi=10.1002/14651858.CD010089.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010089.pub3&amp;doi=10.1002/14651858.CD010089.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010089.pub3&amp;doi=10.1002/14651858.CD010089.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010089.pub3&amp;doi=10.1002/14651858.CD010089.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010089.pub3&amp;doi=10.1002/14651858.CD010089.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010089.pub3&amp;doi=10.1002/14651858.CD010089.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010089.pub3&amp;doi=10.1002/14651858.CD010089.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010089.pub3&amp;doi=10.1002/14651858.CD010089.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010089.pub3&amp;doi=10.1002/14651858.CD010089.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010089.pub3&amp;doi=10.1002/14651858.CD010089.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010089.pub3&amp;doi=10.1002/14651858.CD010089.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010089.pub3&amp;doi=10.1002/14651858.CD010089.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010089.pub3&amp;doi=10.1002/14651858.CD010089.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010089.pub3&amp;doi=10.1002/14651858.CD010089.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772874000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772901000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000"}};Liferay.authToken="sogqpCtr";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD010089\x2epub3\x26doi\x3d10\x2e1002\x2f14651858\x2eCD010089\x2epub3\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010089\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010089\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513679709000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","ru","ko","ms","ja","hr","de","zh_HANS","fa","zh_HANT"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD010089.pub3",title:"Influenza vaccines for preventing acute otitis media in infants and children",firstPublishedDate:"Oct 17, 2017 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Acute Respiratory Infections Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734064000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=sogqpCtr&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD010089.pub3&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD010089.pub3';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD010089.pub3/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD010089.pub3/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD010089.pub3%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD010089.pub3/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD010089.pub3/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD010089.pub3/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD010089.pub3/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD010089.PUB3" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;ja&quot;,&quot;title&quot;:&quot;アブストラクト&quot;},{&quot;language&quot;:&quot;ko&quot;,&quot;title&quot;:&quot;초록&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;摘要&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;de&quot;,&quot;title&quot;:&quot;Zusammenfassung in einfacher Sprache&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;hr&quot;,&quot;title&quot;:&quot;Laički sažetak&quot;},{&quot;language&quot;:&quot;ja&quot;,&quot;title&quot;:&quot;一般語訳&quot;},{&quot;language&quot;:&quot;ko&quot;,&quot;title&quot;:&quot;쉬운 말 요약&quot;},{&quot;language&quot;:&quot;ms&quot;,&quot;title&quot;:&quot;Ringkasan bahasa mudah&quot;},{&quot;language&quot;:&quot;ru&quot;,&quot;title&quot;:&quot;Резюме на простом языке&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;简语概要&quot;},{&quot;language&quot;:&quot;zh_HANT&quot;,&quot;title&quot;:&quot;淺顯易懂的口語結論&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]},{&quot;param&quot;: &quot;comments&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Comments&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD010089.pub3/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD010089.PUB3" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD010089.pub3/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD010089.pub3/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>4877 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD010089.pub3" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010089.pub3/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010089.pub3/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010089.pub3/full#CD010089-abs-0005"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010089.pub3/full#CD010089-sec-0109"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010089.pub3/full#CD010089-sec-0043"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010089.pub3/full#CD010089-sec-0044"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010089.pub3/full#CD010089-sec-0049"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010089.pub3/full#CD010089-sec-0050"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010089.pub3/full#CD010089-sec-0074"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010089.pub3/full#CD010089-sec-0103"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD010089.pub3/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010089.pub3/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010089.pub3/appendices#CD010089-sec-0114"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010089.pub3/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010089.pub3/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD010089.pub3/media/CDSR/CD010089/table_n/CD010089StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD010089.pub3/media/CDSR/CD010089/table_n/CD010089StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010089.pub3/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010089.pub3/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010089.pub3/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD010089.pub3/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD010089.pub3/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD010089.pub3/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2017 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD010089.pub3/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> <div class="inline-status-wrapper"> <ul class="cochrane-status"> <li aria-label="A new search for studies has been conducted." class="status-item up-to-date custom-tooltip" data-status="newsearch" title="A new search for studies has been conducted."> <a class="btn secondary" href="information#history">New search</a> </li> </ul> </div> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Influenza vaccines for preventing acute otitis media in infants and children</h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD010089.pub3/information#CD010089-cr-0002"><i class="icon corresponding-author fa fa-envelope"></i>Mohd N Norhayati</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD010089.pub3/information#CD010089-cr-0003">Jacqueline J Ho</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD010089.pub3/information#CD010089-cr-0004">Mohd Y Azman</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD010089.pub3/information/en#CD010089-sec-0127">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 17 October 2017 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD010089.pub3/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD010089.pub3">https://doi.org/10.1002/14651858.CD010089.pub3</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD010089-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD010089-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD010089-abs-0004">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD010089-abs-0015">فارسی</a> </li> <li class="section-language"> <a class="" href="full/ja#CD010089-abs-0003">日本語</a> </li> <li class="section-language"> <a class="" href="full/ko#CD010089-abs-0002">한국어</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD010089-abs-0013">简体中文</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD010089-abs-0001" lang="en"> <section id="CD010089-sec-0001"> <h3 class="title" id="CD010089-sec-0001">Background</h3> <p>Acute otitis media (AOM) is one of the most common infectious diseases in children. It has been reported that 64% of infants have an episode of AOM by the age of six months and 86% by one year. Although most cases of AOM are due to bacterial infection, it is commonly triggered by a viral infection. In most children AOM is self limiting, but it does carry a risk of complications. Since antibiotic treatment increases the risk of antibiotic resistance, influenza vaccines might be an effective way of reducing this risk by preventing the development of AOM. </p> </section> <section id="CD010089-sec-0002"> <h3 class="title" id="CD010089-sec-0002">Objectives</h3> <p>To assess the effectiveness of influenza vaccine in reducing the occurrence of acute otitis media in infants and children. </p> </section> <section id="CD010089-sec-0003"> <h3 class="title" id="CD010089-sec-0003">Search methods</h3> <p>We searched the Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE, Embase, CINAHL, LILACS, Web of Science, the WHO International Clinical Trials Registry Platform, and ClinicalTrials.gov (15 February 2017). We also searched the reference lists of included studies to identify any additional trials. </p> </section> <section id="CD010089-sec-0004"> <h3 class="title" id="CD010089-sec-0004">Selection criteria</h3> <p>Randomised controlled trials comparing influenza vaccine with placebo or no treatment in infants and children aged younger than six years. We included children of either sex and of any ethnicity, with or without a history of recurrent AOM. </p> </section> <section id="CD010089-sec-0005"> <h3 class="title" id="CD010089-sec-0005">Data collection and analysis</h3> <p>Two review authors independently screened studies, assessed trial quality, and extracted data. We performed statistical analyses using the random‐effects and fixed‐effect models and expressed the results as risk ratio (RR), risk difference (RD), and number needed to treat for an additional beneficial outcome (NNTB) for dichotomous outcomes, with 95% confidence intervals (CI). </p> </section> <section id="CD010089-sec-0006"> <h3 class="title" id="CD010089-sec-0006">Main results</h3> <p>We included 11 trials (6 trials in high‐income countries and 5 multicentre trials in high‐, middle‐, and low‐income countries) involving 17,123 children aged 6 months to 6 years. Eight trials recruited participants from a healthcare setting. Ten trials (and all four trials that contributed to the primary outcome) declared funding from vaccine manufacturers. Four trials reported adequate allocation concealment, and 10 trials reported adequate blinding of participants and personnel. Attrition was low for eight trials included in the analysis. </p> <p>The primary outcome showed a small reduction in at least one episode of AOM over at least six months of follow‐up (4 trials, 3134 children; RR 0.84, 95% CI 0.69 to 1.02; RD ‐0.04, 95% CI ‐0.08 to ‐0.00; NNTB 25, 95% CI 12.5 to 100; low‐quality evidence). </p> <p>The subgroup analyses (i.e. number of courses and types of vaccine administered) showed no differences. </p> <p>There was a reduction in the use of antibiotics in vaccinated children (2 trials, 1223 children; RR 0.70, 95% CI 0.59 to 0.83; RD ‐0.11, 95% CI ‐0.16 to ‐0.06; moderate‐quality evidence). </p> <p>We were unable to demonstrate whether there was any difference in the utilisation of health care. The use of influenza vaccine resulted in a significant increase in fever (7 trials, 10,615 children; RR 1.15, 95% CI 1.06 to 1.24; RD 0.02, 95% CI 0.00 to 0.04; low‐quality evidence), rhinorrhoea (6 trials, 10,563 children; RR 1.17, 95% CI 1.07 to 1.29; RD 0.09, 95% CI 0.01 to 0.16; low‐quality evidence), but no difference in pharyngitis. No major adverse events were reported. </p> <p>Differing from the protocol, the original publication of the review included a subgroup analysis of AOM episodes by season, and the secondary outcome ‘types of influenza vaccine’ was changed to a subgroup analysis. For this update, we removed the subgroup analyses for trial setting, season, and utilisation of health care due to the small number of trials involved. We removed <a href="http://Belshe 2000" target="_blank">Belshe 2000</a> from primary and secondary outcomes (courses of vaccine and types of vaccine) because it reported episodes of AOM per person. We did not perform a subgroup analysis by type of adverse event. We have reported each type of adverse event as a separate analysis. </p> </section> <section id="CD010089-sec-0007"> <h3 class="title" id="CD010089-sec-0007">Authors' conclusions</h3> <p>Influenza vaccine results in a small reduction in AOM. The observed reduction in the use of antibiotics needs to be considered in light of current recommended practices aimed at avoiding antibiotic overuse. Safety data from these trials were limited. The benefits may not justify the use of influenza vaccine without taking into account the vaccine efficacy in reducing influenza and safety data. We judged the quality of the evidence to be low to moderate. Additional research is needed. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD010089-abs-0005" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD010089-abs-0005">English</a> </li> <li class="section-language"> <a class="" href="full/de#CD010089-abs-0012">Deutsch</a> </li> <li class="section-language"> <a class="" href="full/es#CD010089-abs-0011">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD010089-abs-0016">فارسی</a> </li> <li class="section-language"> <a class="" href="full/hr#CD010089-abs-0010">Hrvatski</a> </li> <li class="section-language"> <a class="" href="full/ja#CD010089-abs-0009">日本語</a> </li> <li class="section-language"> <a class="" href="full/ko#CD010089-abs-0007">한국어</a> </li> <li class="section-language"> <a class="" href="full/ms#CD010089-abs-0008">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="full/ru#CD010089-abs-0006">Русский</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD010089-abs-0014">简体中文</a> </li> <li class="section-language"> <a class="" href="full/zh_HANT#CD010089-abs-0017">繁體中文</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD010089-abs-0005" lang="en"> <h3>Influenza vaccine for preventing acute otitis media (middle ear infection)</h3> <p><b>Review question</b> </p> <p>We reviewed the effect of influenza vaccine on preventing acute otitis media (AOM) in infants and children. </p> <p><b>Background</b> </p> <p>Acute otitis media is one of the most common infectious diseases in infants and preschool children. Symptoms include ear pain and fever, but it may also cause hearing loss due to eardrum perforation or fluid accumulation in the middle ear. Acute otitis media is usually bacterial in origin and is often treated with antibiotics, which may carry the risk of antibiotic resistance. Even so, AOM is often preceded by viral infection, such as influenza. Preventing viral infections might prevent AOM. We therefore investigated whether influenza vaccines might reduce the occurrence of AOM in infants and children. </p> <p><b>Study characteristics</b> </p> <p>The evidence is current to 15 February 2017. We selected randomised controlled trials comparing influenza vaccine with placebo or no treatment in infants and children aged six months to six years, with or without a history of previous episodes of AOM. We included 11 trials involving 17,123 children. Ten out of 11 trials were funded by vaccine manufacturers. </p> <p><b>Key results</b> </p> <p>We found a 4% reduction in AOM and about an 11% reduction in the number of antibiotic prescriptions. There was no difference in the number of courses or types of vaccine administered between those who were vaccinated and those who were unvaccinated. Influenza vaccine side effects included an increase in fever, runny nose, and drowsiness. It remains uncertain whether the influenza vaccine reduced visits or admissions to healthcare facilities. Data were insufficient to show that this benefit might be balanced against more serious or rarer side effects from the vaccine. </p> <p>Although we observed a reduction in antibiotic usage, this impact is uncertain because the current practice is to avoid overuse of antibiotics. Coupled with other vaccine safety concerns, the use of influenza vaccine to reduce AOM is not yet justified, and additional research is needed. </p> <p><b>Quality of the evidence</b> </p> <p>The overall quality of the evidence was low to moderate.</p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD010089-sec-0109" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD010089-sec-0109"></div> <h3 class="title" id="CD010089-sec-0110">Implications for practice</h3> <section id="CD010089-sec-0110"> <p>Influenza vaccine appears to have a small beneficial effect in reducing acute otitis media (AOM), resulting in a 4% absolute reduction in children who experienced at least one episode of otitis media. Promoting influenza vaccination solely to reduce AOM therefore does not seem justified, but it may be useful to parents when making a decision whether or not to vaccinate their children. Influenza vaccine appears to be effective in reducing antibiotic usage, and its usage for this purpose might be justified. However, in settings with a low incidence of mastoiditis, where 'watchful waiting' is practised as a means of reducing antibiotic over usage, the impact of this finding is uncertain. The findings of this review would need to be considered in the context of the efficacy of the vaccine, which is reported in a separate review (<a href="./references#CD010089-bbs2-0049" title="JeffersonT , DiPietrantonjC , RivettiA , BawazeerGA , Al‐AnsaryLA , FerroniE . Vaccines for preventing influenza in healthy adults. Cochrane Database of Systematic Reviews2014, Issue 3. [DOI: 10.1002/14651858.CD001269.pub5] ">Jefferson 2014</a>). Data in this review on rarer and serious adverse effects of the vaccine are limited, and more safety data would be needed to assess more fully whether influenza vaccine would be a useful intervention to reduce antibiotic usage. Reduction in the occurrence of AOM was not observed in trials that recruited children in healthcare facilities. </p> </section> <h3 class="title" id="CD010089-sec-0111">Implications for research</h3> <section id="CD010089-sec-0111"> <p>If further studies examining the use of influenza vaccine in young infants and preschool children are to be conducted, they should include AOM as an outcome and provide detailed safety data. Data on antibiotic usage for AOM and other respiratory infections, incidence of mastoiditis, local prescribing patterns, and existing local guidelines that might confound antibiotic usage should also be collected. If studies are conducted in settings with a definite seasonal occurrence, the follow‐up period should include the influenza season and be of sufficient duration to ensure that episodes of AOM and recurrent AOM are captured. </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD010089-sec-0043" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD010089-sec-0043"></div> <div class="table" id="CD010089-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Influenza vaccine compared to control for preventing acute otitis media in infants and children</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Influenza vaccine compared to control for preventing acute otitis media in infants and children</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> infants and children<br/> <b>Setting:</b> health care and day care<br/> <b>Intervention:</b> influenza vaccine<br/> <b>Comparison:</b> control </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with control</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with influenza vaccine</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>At least 1 episode of acute otitis media</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.84<br/> (0.69 to 1.02) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>3134<br/> (4 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> LOW<sup>1,2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>The basis for the assumed risk is the mean risk in the control group across the included studies. There was moderate unexplained inconsistency across the studies. We downgraded for inconsistency. The effect estimates were all in the same direction, but there was uncertainty in the confidence of the effect estimate. </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>292 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>245 per 1000<br/> (201 to 298) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Courses of antibiotics</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.70<br/> (0.59 to 0.83) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>1223<br/> (2 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊝<br/> MODERATE<sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Assumed risk calculated from the mean risk across the control groups of the 2 included studies </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>362 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>254 per 1000<br/> (214 to 301) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Fever</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 1.15<br/> (1.06 to 1.24) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>10,615<br/> (7 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> LOW<sup>1,2,4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Assumed risk calculated from the mean risk across the control groups of the 7 included studies </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>174 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>200 per 1000<br/> (184 to 215) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Rhinorrhoea</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 1.17<br/> (1.07 to 1.29) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>10,563<br/> (6 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> LOW<sup>1,2,4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Assumed risk calculated from the mean risk across the control groups of the 6 included studies </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>424 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>496 per 1000<br/> (453 to 546) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Pharyngitis</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 1.00<br/> (0.80 to 1.25) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>4429<br/> (3 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> LOW<sup>1,2,4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Assumed risk calculated from the mean risk across the control groups of the 3 included studies </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>71 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>71 per 1000<br/> (57 to 88) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> confidence interval; <b>RCT:</b> randomised controlled trial; <b>RR:</b> risk ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High quality:</b> We are very confident that the true effect lies close to that of the estimate of the effect.<br/> <b>Moderate quality:</b> We are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/> <b>Low quality:</b> Our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/> <b>Very low quality:</b> We have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of the effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup>Includes trial(s) at high risk of publication bias.<br/> <sup>2</sup>Unexplained heterogeneity between studies.<br/> <sup>3</sup>Data derived from a single study with uncertainty about the effect size due to poor precision.<br/> <sup>4</sup>Includes trial(s) at high risk of attrition bias. </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD010089-sec-0044" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD010089-sec-0044"></div> <section id="CD010089-sec-0045"> <h3 class="title" id="CD010089-sec-0045">Description of the condition</h3> <p>Acute otitis media (AOM) is one of the most common infectious diseases in children. Eighty per cent of children in high‐income countries experienced at least one episode of AOM by the age of three years (<a href="./references#CD010089-bbs2-0065" title="VergisonA , DaganR , ArguedasA , BonhoefferJ , CohenR , DhoogeI , et al. Otitis media and its consequences: beyond the earache. Lancet Infectious Diseases2010;10(3):195‐203. [PUBMED: 20185098] ">Vergison 2010</a>). With the advent of the pneumococcal conjugate vaccine (PCV), two clinical trials showed a reduction of 7%, <a href="./references#CD010089-bbs2-0039" title="FiremanB , BlackSB , ShinefieldHR , LeeJ , LewisE , RayP . Impact of the pneumococcal conjugate vaccine on otitis media. Pediatric Infectious Disease Journal2003;22(1):10‐6. [PUBMED: 12544402] ">Fireman 2003</a>, and 6%, <a href="./references#CD010089-bbs2-0038" title="EskolaJ , KilpiT , PalmuA , JokinenJ , HaapakoskiJ , HervaE , et al. Efficacy of a pneumococcal conjugate vaccine against acute otitis media. New England Journal of Medicine2001;344(6):403‐9. [PUBMED: 11172176] ">Eskola 2001</a>, in otitis media rates. The rate of ambulatory visits for otitis media also declined by between 6% and 20% in children aged less than two years after the introduction of PCV in the United States vaccination programme, with no significant decrease in outpatient visit rates for pneumonia or other acute respiratory infections (<a href="./references#CD010089-bbs2-0042" title="GrijalvaCG , PoehlingKA , NuortiJP , ZhuY , MartinSW , EdwardsKM , et al. National impact of universal childhood immunization with pneumococcal conjugate vaccine on outpatient medical care visits in the United States. Pediatrics2006;118(3):865‐73. [PUBMED: 16950975] ">Grijalva 2006</a>; <a href="./references#CD010089-bbs2-0055" title="MaromT , TanA , WilkinsonGS , PiersonKS , FreemanJL , ChonmaitreeT . Trends in otitis media‐related health care use in the United States, 2001‐2011. JAMA2014;168(1):68‐75. [PUBMED: 24276262] ">Marom 2014</a>; <a href="./references#CD010089-bbs2-0058" title="PoehlingKA , LafleurBJ , SzilagyiPG , EdwardsKM , MitchelE , BarthR , et al. Population‐based impact of pneumococcal conjugate vaccine in young children. Pediatrics2004;114(3):755‐61. [PUBMED: 15342850] ">Poehling 2004</a>). </p> <p>'Otitis media' is a broad term for any middle ear infection or inflammation. It can present as (i) otitis media with effusion (OME): fluid behind an intact tympanic membrane without the symptoms or signs of AOM; (ii) AOM: fluid behind the tympanic membrane with the symptoms or signs of an acute infection; or (iii) chronic suppurative otitis media (CSOM): persistent discharge of pus through a perforated tympanic membrane for more than six weeks (<a href="./references#CD010089-bbs2-0051" title="LeachAJ , MorrisPS . Antibiotics for the prevention of acute and chronic suppurative otitis media in children. Cochrane Database of Systematic Reviews2011, Issue 1. [DOI: 10.1002/14651858.CD004401.pub2] ">Leach 2011</a>). Several risk factors for AOM have been identified, such as siblings with otitis media, bottle‐feeding, attending day‐care centres, allergies to environmental entities, belonging to a low socioeconomic group, exposure to tobacco smoke, and family history of otitis media (<a href="./references#CD010089-bbs2-0037" title="ErdivanliOC , CoskunZO , KazikdasKC , DemirciM . Prevalence of otitis media with effusion among primary school children in Eastern Black Sea, in Turkey and the effect of smoking in the development of otitis media with effusion. Indian Journal of Otolaryngology and Head and Neck Surgery2012;64(1):17‐21. [PUBMED: 23449553] ">Erdivanli 2012</a>; <a href="./references#CD010089-bbs2-0061" title="Siddartha BhatV , BhandarySK , ShenoyV , Rashmi . Otitis media with effusion in relation to socio economic status: a community based study. Indian Journal of Otolaryngology and Head and Neck Surgery2012;64(1):56‐8. [PUBMED: 23449688] ">Siddartha 2012</a>). </p> <p>In the past, AOM was generally considered to be viral, but with optimal bacteriological techniques and a good diagnosis it has been shown that over 87% of AOM cases are bacterial in origin (<a href="./references#CD010089-bbs2-0033" title="BlockSL , HarrisonCJ , HedrickJA , TylerRD , SmithRA , KeeganE , et al. Penicillin‐resistant Streptococcus pneumoniae in acute otitis media: risk factors, susceptibility patterns and antimicrobial management. Pediatric Infectious Disease Journal1995;14(9):751‐9. [PUBMED: 8559623] ">Block 1995</a>; <a href="./references#CD010089-bbs2-0043" title="HeikkinenT , ChonmaitreeT . Importance of respiratory viruses in acute otitis media. Clinical Microbiology Reviews2003;16(2):230‐41. [PUBMED: 12692096] ">Heikkinen 2003</a>), but commonly triggered by a viral infection. In a 14‐year cohort study among children attending day care, viral pathogens, especially respiratory syncytial virus, influenza virus, and adenovirus, conferred a greater risk of developing AOM (<a href="./references#CD010089-bbs2-0045" title="HendersonFW , CollierAM , SanyalMA , WatkinsJM , FaircloughDL , ClydeWAJr , et al. A longitudinal study of respiratory viruses and bacteria in the etiology of acute otitis media with effusion. New England Journal of Medicine1982;306(23):1377‐83. [PUBMED: 6281639] ">Henderson 1982</a>; <a href="./references#CD010089-bbs2-0047" title="JacobsMR , DaganR , AppelbaumPC , BurchDJ . Prevalence of antimicrobial‐resistant pathogens in middle ear fluid: multinational study of 917 children with acute otitis media. Antimicrobial Agents and Chemotherapy1998;42(3):589‐95. [PUBMED: 9517937] ">Jacobs 1998</a>). Respiratory viruses were isolated in 42% of middle ear fluid specimens from children with AOM (<a href="./references#CD010089-bbs2-0057" title="MonobeH , IshibashiT , NomuraY , ShinogamiM , YanoJ . Role of respiratory viruses in children with acute otitis media. International Journal of Pediatric Otorhinolaryngology2003;67(7):801‐6. ">Monobe 2003</a>), and influenza viruses accounted for up to 28.4% of viral detections (<a href="./references#CD010089-bbs2-0066" title="YanoH , OkitsuN , HoriT , WatanabeO , KisuT , HatagishiE , et al. Detection of respiratory viruses in nasopharyngeal secretions and middle ear fluid from children with acute otitis media. Acta Oto‐Laryngologica2009;129(1):19‐24. ">Yano 2009</a>). </p> <p>A Cochrane Review showed that antibiotics reduced tympanic membrane perforations and contralateral AOM episodes. However, adverse events such as vomiting, diarrhoea, and rash were more common in children who received antibiotics (<a href="./references#CD010089-bbs2-0063" title="VenekampRP , SandersSL , GlasziouPP , DelMarCB , RoversMM . Antibiotics for acute otitis media in children. Cochrane Database of Systematic Reviews2015, Issue 6. [DOI: 10.1002/14651858.CD000219.pub4] ">Venekamp 2015</a>). A separate Cochrane Review showed that administration of short‐course antibiotics (less than seven days) increased the likelihood of relapse and recurrence (<a href="./references#CD010089-bbs2-0050" title="KozyrskyjAL , KlassenTP , MoffattM , HarveyK . Short‐course antibiotics for acute otitis media. Cochrane Database of Systematic Reviews2010, Issue 9. [DOI: 10.1002/14651858.CD001095.pub2] ">Kozyrskyj 2010</a>). The findings of these reviews have led to guidelines recommending limiting or delaying the use of antibiotics, and a policy of 'watchful waiting' has been recommended for some children (<a href="./references#CD010089-bbs2-0054" title="LieberthalAS , CarrollAE , ChonmaitreeT , GaniatsTG , HobermanA , JacksonMA , et al. The diagnosis and management of acute otitis media. Pediatrics2013;131(3):e964‐99. [PUBMED: 23439909] ">Lieberthal 2013</a>). Antibiotics given for six weeks or longer reduced the risk of future episodes of AOM by 50%, with no significant reported side effects such as allergic reactions and diarrhoea (<a href="./references#CD010089-bbs2-0051" title="LeachAJ , MorrisPS . Antibiotics for the prevention of acute and chronic suppurative otitis media in children. Cochrane Database of Systematic Reviews2011, Issue 1. [DOI: 10.1002/14651858.CD004401.pub2] ">Leach 2011</a>). Antibiotics for OME given continuously for four weeks and three months have shown beneficial effects (<a href="./references#CD010089-bbs2-0064" title="VenekampRP , BurtonMJ , vanDongenTM , van derHeijdenGJ , vanZonA , SchilderAG . Antibiotics for otitis media with effusion in children. Cochrane Database of Systematic Reviews2016, Issue 6. [DOI: 10.1002/14651858.CD009163.pub3] ">Venekamp 2016</a>). However, the issue of antibiotic resistance needs to be considered. </p> <p>Acute otitis media is clinically diagnosed based on a history of acute onset, signs and symptoms of middle ear inflammation, and presence of middle ear effusion with either a bulging tympanic membrane, decreased mobility, or an air‐fluid level. Determination of some of the criteria may necessitate the use of pneumatic otoscopy to demonstrate a decrease in tympanic membrane mobility (<a href="./references#CD010089-bbs2-0053" title="LieberthalAS , GaniatsTG , CoxEO , CulpepperL , MahoneyM , MillerD , et al. Diagnosis and management of acute otitis media. Pediatrics2004;113(5):1451‐65. [PUBMED: 15121972] ">Lieberthal 2004</a>). </p> </section> <section id="CD010089-sec-0046"> <h3 class="title" id="CD010089-sec-0046">Description of the intervention</h3> <p>There are two types of influenza vaccine: trivalent inactivated influenza vaccine (TIV) and live attenuated influenza vaccine (LAIV). Trivalent inactivated influenza vaccine is approved for children as young as six months, and LAIV, which is based on cold‐adapted, temperature‐sensitive vaccine viruses, is approved for children aged two years or older. Annual influenza vaccination is recommended for all children aged six months to eight years. If the children have not been previously vaccinated, two doses four weeks apart are recommended. If the child was vaccinated the previous year, the child will receive only one vaccine dose. However, the recommendations regarding the number of doses might change if vaccine antigens change (<a href="./references#CD010089-bbs2-0035" title="Centers for Disease Control and Prevention. Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP). Morbidity and Mortality Weekly Report (MMWR)2011; Vol. 60, issue 33:1128‐32. ">CDC 2011</a>). </p> <p>Cochrane Reviews reported that in preventing influenza among children aged more than two years, live influenza vaccines showed a higher efficacy than inactivated influenza vaccines (82% versus 59%), while in preventing influenza‐like illness, the effectiveness was similar (33% versus 36%). Little evidence is available for children younger than two years (<a href="./references#CD010089-bbs2-0048" title="JeffersonT , RivettiA , DiPietrantonjC , DemicheliV , FerroniE . Vaccines for preventing influenza in healthy children. Cochrane Database of Systematic Reviews2012, Issue 8. [DOI: 10.1002/14651858.CD004879.pub4; PUBMED: 22895945] ">Jefferson 2012</a>). A modest effect of the vaccine on influenza was reported in the general population (<a href="./references#CD010089-bbs2-0049" title="JeffersonT , DiPietrantonjC , RivettiA , BawazeerGA , Al‐AnsaryLA , FerroniE . Vaccines for preventing influenza in healthy adults. Cochrane Database of Systematic Reviews2014, Issue 3. [DOI: 10.1002/14651858.CD001269.pub5] ">Jefferson 2014</a>). </p> <p>A report by the Institute of Medicine looking at 27 adverse events showed that only one study supported a causal relationship between influenza vaccine and anaphylaxis; one study supported a causal relationship for oculo‐respiratory syndrome; and two studies supported rejection of a causal relationship for Bell's palsy and asthma exacerbation or reactive airway disease episodes. The evidence for the remaining 23 adverse events (85%) was insufficient to support or reject a causal link due to weak or absent methodology (<a href="./references#CD010089-bbs2-0062" title="StrattonK , FordA , RuschE , ClaytonEW . Adverse Effects of Vaccines: Evidence and Causality. Institute of Medicine (IOM) of The National Academies Press, 2011. ">Stratton 2011</a>). </p> </section> <section id="CD010089-sec-0047"> <h3 class="title" id="CD010089-sec-0047">How the intervention might work</h3> <p>A Cochrane Review revealed that pneumococcal vaccine had marginally beneficial effects for preventing AOM (<a href="./references#CD010089-bbs2-0040" title="FortanierAC , VenekampRP , BoonackerCW , HakE , SchilderAG , SandersEA , et al. Pneumococcal conjugate vaccines for preventing otitis media. Cochrane Database of Systematic Reviews2014, Issue 4. [DOI: 10.1002/14651858.CD001480.pub4] ">Fortanier 2014</a>). However, since AOM is often preceded by a viral infection, it is possible that influenza vaccines might be effective in preventing the development of AOM. </p> </section> <section id="CD010089-sec-0048"> <h3 class="title" id="CD010089-sec-0048">Why it is important to do this review</h3> <p>The Advisory Committee on Immunization Practices (ACIP) has recommended influenza vaccination for all children aged six months or older in the USA (<a href="./references#CD010089-bbs2-0035" title="Centers for Disease Control and Prevention. Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP). Morbidity and Mortality Weekly Report (MMWR)2011; Vol. 60, issue 33:1128‐32. ">CDC 2011</a>). There are many factors that influence parents' decisions whether or not to vaccinate their child (<a href="./references#CD010089-bbs2-0032" title="BhattP , BlockSL , TobackSL , AmbroseCS . Timing of the availability and administration of influenza vaccine through the vaccines for children program. Pediatric Infectious Disease Journal2011;30(2):100‐6. [PUBMED: 20686436] ">Bhatt 2011</a>). Information on the effect of influenza vaccine on AOM might help parents in this decision. The aim of this review was therefore to report the effect of influenza vaccine on the occurrence of AOM in infants and children. </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD010089-sec-0049" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD010089-sec-0049"></div> <p>To assess the effectiveness of influenza vaccine in reducing the occurrence of acute otitis media (AOM) in infants and children. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD010089-sec-0050" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD010089-sec-0050"></div> <section id="CD010089-sec-0051"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD010089-sec-0052"> <h4 class="title">Types of studies</h4> <p>Randomised controlled trials comparing influenza vaccine with placebo or no treatment. We included blinded and open‐label studies. </p> </section> <section id="CD010089-sec-0053"> <h4 class="title">Types of participants</h4> <p>Infants and children aged younger than six years old of either sex and of any ethnicity, with or without a history of recurrent AOM. </p> </section> <section id="CD010089-sec-0054"> <h4 class="title">Types of interventions</h4> <p>Vaccination with any influenza vaccine, live or inactivated, and whole, split‐virus, or subunit‐type vaccines. Vaccines may be monovalent or polyvalent, single dose or multidose, and administered by any route of administration. </p> <p>Comparison: placebo or no treatment.</p> </section> <section id="CD010089-sec-0055"> <h4 class="title">Types of outcome measures</h4> <p>Acute otitis media must be clinician diagnosed. We excluded studies in which diagnosis of AOM was based on the child or carer report alone. The follow‐up period for primary outcomes was at least six months after vaccination. </p> <section id="CD010089-sec-0056"> <h5 class="title">Primary outcomes</h5> <p> <ol id="CD010089-list-0001"> <li> <p>Number of children having at least one episode of AOM during the follow‐up period.</p> </li> <li> <p>Number of episodes of AOM recorded during the follow‐up period.</p> </li> </ol> </p> </section> <section id="CD010089-sec-0057"> <h5 class="title">Secondary outcomes</h5> <p> <ol id="CD010089-list-0002"> <li> <p>Use of antibiotics to treat AOM and its complications.</p> </li> <li> <p>Causative organism associated with AOM.</p> </li> <li> <p>Utilisation of healthcare and related resources.</p> </li> <li> <p>Number of culture‐confirmed influenza cases.</p> </li> <li> <p>Adverse events (e.g. febrile illness).</p> </li> </ol> </p> </section> </section> </section> <section id="CD010089-sec-0058"> <h3 class="title">Search methods for identification of studies</h3> <section id="CD010089-sec-0059"> <h4 class="title">Electronic searches</h4> <p>We searched:</p> <p> <ul id="CD010089-list-0003"> <li> <p>the Cochrane Central Register of Controlled Trials, which includes the Cochrane Acute Respiratory Infections Group's Specialised Register (CENTRAL; 2017, Issue 1) in the Cochrane Library (searched 15 February 2017); </p> </li> <li> <p>MEDLINE Ovid (1946 to 15 February 2017);</p> </li> <li> <p>Embase.com (1947 to 15 February 2017);</p> </li> <li> <p>CINAHL (Cumulative Index to Nursing and Allied Health Literature) (1981 to 15 February 2017); </p> </li> <li> <p>LILACS (Latin American and Caribbean Health Sciences Literature) (1982 to 15 February 2017); </p> </li> <li> <p>Web of Science (1955 to 15 February 2017).</p> </li> </ul> </p> <p>We used the search strategy in <a href="./appendices#CD010089-sec-0115">Appendix 1</a> to search MEDLINE and CENTRAL. We combined the MEDLINE search strategy with the Cochrane Highly Sensitive Search Strategy for identifying randomised trials in MEDLINE: sensitivity‐ and precision‐maximising version (2008 revision); Ovid format (<a href="./references#CD010089-bbs2-0052" title="LefebvreC , ManheimerE , GlanvilleJ . Chapter 6: Searching for studies. In: Higgins JP, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Lefebvre 2011</a>). We adapted the search strategy for Embase (<a href="./appendices#CD010089-sec-0116">Appendix 2</a>), CINAHL (<a href="./appendices#CD010089-sec-0117">Appendix 3</a>), LILACS (<a href="./appendices#CD010089-sec-0118">Appendix 4</a>), and Web of Science (<a href="./appendices#CD010089-sec-0119">Appendix 5</a>). We did not impose any language or publication restrictions. </p> <p>We searched for completed and ongoing trials in two trial registries:</p> <p> <ul id="CD010089-list-0004"> <li> <p>World Health Organization (WHO) International Clinical Trials Registry Platform (ICTRP) (<a href="http://www.who.int/ictrp/en/" target="_blank">www.who.int/ictrp/en/</a>; searched 15 February 2017). </p> </li> <li> <p>US National Institutes of Health Ongoing Trials Register ClinicalTrials.gov (<a href="http://www.clinicaltrials.gov" target="_blank">www.clinicaltrials.gov</a>; searched 15 February 2017). </p> </li> </ul> </p> </section> <section id="CD010089-sec-0060"> <h4 class="title">Searching other resources</h4> <p>We checked the reference lists of all related studies for further references in order to find unpublished trials or trials not identified by the electronic searches. We contacted pharmaceutical companies that market influenza vaccine to identify other related unpublished trials and ongoing trials. </p> </section> </section> <section id="CD010089-sec-0061"> <h3 class="title" id="CD010089-sec-0061">Data collection and analysis</h3> <section id="CD010089-sec-0062"> <h4 class="title">Selection of studies</h4> <p>Two review authors (MNN, MYA) independently scanned the titles and abstracts identified by the searches, obtaining the full‐text articles for records that appeared to meet the eligibility criteria or for which information was insufficient to assess eligibility. We independently assessed the eligibility of the trials and documented the reasons for exclusion. Any disagreements were resolved between the review authors by discussion. We contacted the trial authors for clarification where required. We translated papers in languages other than English with the help of the Cochrane Acute Respiratory Infections Group. </p> </section> <section id="CD010089-sec-0063"> <h4 class="title">Data extraction and management</h4> <p>We extracted the following from each of the selected studies:</p> <p> <ul id="CD010089-list-0005"> <li> <p>study setting;</p> </li> <li> <p>participant characteristics (age, sex, ethnicity);</p> </li> <li> <p>methodology (number of participants randomised and analysed, duration of follow‐up);</p> </li> <li> <p>type of vaccine used;</p> </li> <li> <p>method for diagnosing AOM;</p> </li> <li> <p>occurrence of AOM and middle ear effusion;</p> </li> <li> <p>antibiotics used to treat AOM and its complications;</p> </li> <li> <p>causative organism associated with AOM;</p> </li> <li> <p>utilisation of healthcare and related resources;</p> </li> <li> <p>number of culture‐confirmed influenza cases; and</p> </li> <li> <p>occurrence of adverse events related to influenza vaccine (e.g. febrile illnesses).</p> </li> </ul> </p> <p>We resolved any disagreements by discussion.</p> </section> <section id="CD010089-sec-0064"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>We assessed the risk of bias based on random sequence generation, allocation concealment, blinding of participants and personnel, blinding of outcome assessors, completeness of outcome data, selectivity of outcome reporting, and other bias, as described in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD010089-bbs2-0046" title="HigginsJP , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Higgins 2011</a>). </p> </section> <section id="CD010089-sec-0065"> <h4 class="title">Measures of treatment effect</h4> <p>We measured the trials with categorical outcomes using risk ratios (RR) and 95% confidence intervals (CI) and calculated risk differences (RD) and 95% CI. We calculated the number needed to treat for an additional beneficial outcome (NNTB) along with a 95% CI for the first primary outcome. Had we encountered numerical outcomes, we intended to analyse these using mean differences (MD) and 95% CI. </p> </section> <section id="CD010089-sec-0066"> <h4 class="title">Unit of analysis issues</h4> <p>We checked included trials for unit of analysis errors and did not encounter any. Had we encountered any cluster‐randomised controlled trials, we intended to adjust the results from trials showing unit of analysis errors based on the mean cluster size and intracluster correlation coefficient (<a href="./references#CD010089-bbs2-0046" title="HigginsJP , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Higgins 2011</a>). </p> </section> <section id="CD010089-sec-0067"> <h4 class="title">Dealing with missing data</h4> <p>We contacted the original trial authors to request missing or inadequately reported data (<a href="./references#CD010089-bbs2-0015" title="BergenR , BlackS , ShinefieldH , LewisE , RayP , HansenJ , et al. Safety of cold‐adapted live attenuated influenza vaccine in a large cohort of children and adolescents. Pediatric Infectious Disease Journal2004;23(2):138‐44. [PUBMED: 14872180] ">Bergen 2004</a>; <a href="./references#CD010089-bbs2-0006" title="KosalaraksaP , JeanfreauR , FrenetteL , DrameM , MadariagaM , InnisBL , et al. AS03B‐adjuvanted H5N1 influenza vaccine in children 6 months through 17 years of age: a phase 2/3 randomized, placebo‐controlled, observer‐blinded trial. Journal of Infectious Diseases2015;211(5):801‐10. [PUBMED: 25293368] ">Kosalaraksa 2015</a>). We performed analyses on the available data in the event that missing data were not available. </p> </section> <section id="CD010089-sec-0068"> <h4 class="title">Assessment of heterogeneity</h4> <p>We assessed the presence of heterogeneity in two steps. First, we assessed obvious heterogeneity at face value by comparing populations, settings, interventions, and outcomes. Second, we assessed statistical heterogeneity by means of the I² statistic (<a href="http://127.0.0.1:33435/media_201204/search/article.tes?href=clsysrev/CD0004/CD004880.xml%26view=article#CD004880-bbs2-0003" target="_blank">Higgins 2011</a>). </p> </section> <section id="CD010089-sec-0069"> <h4 class="title">Assessment of reporting biases</h4> <p>If there were sufficient studies, we intended to use funnel plots to assess the possibility of reporting biases or small‐study biases, or both. </p> </section> <section id="CD010089-sec-0070"> <h4 class="title">Data synthesis</h4> <p>We examined heterogeneity using both fixed‐effect and random‐effects models, depending on the degree of significant clinical or statistical heterogeneity, in Review Manager 5 software (<a href="./references#CD010089-bbs2-0060" title="Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager 5 (RevMan 5). Version 5.3. Copenhagen: Nordic Cochrane Centre, The Cochrane Collaboration, 2014. ">RevMan 2014</a>). Our results are reported with the fixed‐effect model unless it is stated that we have used the random‐effects model. Thresholds for the interpretation of the I² statistic can be misleading, since the importance of inconsistency depends on several factors. We used the guide to interpret heterogeneity as outlined in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="http://127.0.0.1:33435/media_201204/search/article.tes?href=clsysrev/CD0004/CD004880.xml%26view=article#CD004880-bbs2-0003" target="_blank">Higgins 2011</a>): 0% to 40% might not be important; 30% to 60% may represent moderate heterogeneity; 50% to 90% may represent substantial heterogeneity; and 75% to 100% would be considerable heterogeneity. </p> <section id="CD010089-sec-0071"> <h5 class="title">GRADE and 'Summary of findings' table</h5> <p>We created a 'Summary of findings' table using the following outcomes: at least one episode of AOM; courses of antibiotics; fever; rhinorrhoea; and pharyngitis. </p> <p>We used the five GRADE considerations (study limitations, consistency of effect, imprecision, indirectness, and publication bias) to assess the quality of a body of evidence as it relates to the studies that contribute data to the meta‐analyses for the prespecified outcomes (<a href="./references#CD010089-bbs2-0031" title="AtkinsD , BestD , BrissPA , EcclesM , Falck‐YtterY , FlottorpS , et al. GRADE Working Group. Grading quality of evidence and strength of recommendations. BMJ2004;328(7454):1490. ">Atkins 2004</a>). We used methods and recommendations described in Section 8.5 and Chapter 12 of the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD010089-bbs2-0046" title="HigginsJP , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Higgins 2011</a>), employing GRADEpro GDT software (<a href="./references#CD010089-bbs2-0041" title="GRADE Working Group, McMaster University. GRADEpro GDT. Version (accessed 21 November 2015). Hamilton, ON: GRADE Working Group, McMaster University, 2014. ">GRADEpro 2014</a>). We justified all decisions to down‐ or upgrade the quality of studies using footnotes, and made comments to aid the reader's understanding of the review where necessary. </p> </section> </section> <section id="CD010089-sec-0072"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>We planned the following subgroup analyses:</p> <p> <ol id="CD010089-list-0006"> <li> <p>age of children, e.g. above and below two years old;</p> </li> <li> <p>first episode and recurrence of AOM;</p> </li> <li> <p>day‐care and non‐day‐care children;</p> </li> <li> <p>type and route of vaccine administration.</p> </li> </ol> </p> <p>We were unable to carry out all of the subgroup analyses in the categories outlined in the protocol due to insufficient data. However, we conducted subgroup analyses on number of children having at least one episode of AOM by course and type of vaccine. </p> <p>In the original publication of this review we included a subgroup analysis on number of children having at least one episode of AOM by setting and season. We also included subgroup analysis by utilisation of health care, that is hospital admission and patient visits to primary care and the emergency department, because this might differ between different healthcare settings. For example, in some settings, users might be more likely to be hospitalised for relatively minor adverse effects. We specified the subgroup analyses in order to explore this as a possible reason for heterogeneity. </p> <p>We did not perform a subgroup analysis by type of adverse event, but have reported each type of adverse event in the included studies as a separate analysis. </p> <p>We explored the potential sources of heterogeneity. When important heterogeneity was present, we use a random‐effects model (<a href="./references#CD010089-bbs2-0036" title="DerSimonianR , LairdN . Meta‐analysis in clinical trials. Controlled Clinical Trials1986;7:177‐88. ">DerSimonian 1986</a>). </p> </section> <section id="CD010089-sec-0073"> <h4 class="title">Sensitivity analysis</h4> <p>We performed a sensitivity analysis to investigate the impact of risk of bias for sequence generation and allocation concealment of included studies. </p> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD010089-sec-0074" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD010089-sec-0074"></div> <section id="CD010089-sec-0075"> <h3 class="title">Description of studies</h3> <p>See: <a href="./references#CD010089-sec-0133" title="">Characteristics of included studies</a>, <a href="./references#CD010089-sec-0134" title="">Characteristics of excluded studies</a>, and Characteristics of studies awaiting classification tables. </p> <section id="CD010089-sec-0076"> <h4 class="title">Results of the search</h4> <p>In the original publication of this review, we retrieved 319 records from the search of the electronic databases and 12 records from other sources (<a href="#CD010089-fig-0001">Figure 1</a>). We screened a total of 331 records. We reviewed full copies of 28 studies, of which 14 articles possibly met the review inclusion criteria and 14 were not eligible for inclusion. Three of those not eligible for inclusion were systematic reviews and meta‐analyses that were related to our research question (<a href="./references#CD010089-bbs2-0034" title="BlockSL , HeikkinenT , TobackSL , ZhengW , AmbroseCS . The efficacy of live attenuated influenza vaccine against influenza‐associated acute otitis media in children. Pediatric Infectious Disease Journal2011;30(3):203‐7. [PUBMED: 20935591] ">Block 2011</a>; <a href="./references#CD010089-bbs2-0044" title="HeikkinenT , BlockSL , TobackSL , WuX , AmbroseCS . Effectiveness of intranasal live attenuated influenza vaccine against all‐cause acute otitis media in children. Pediatric Infectious Disease Journal2013;32:669‐74. ">Heikkinen 2013</a>; <a href="./references#CD010089-bbs2-0059" title="PrutskyGJ , DomecqJP , ElraiyahT , ProkopLJ , MuradMH . Assessing the evidence: live attenuated influenza vaccine in children younger than 2 years. A systematic review. Pediatric Infectious Disease Journal2014;33:e106‐15. ">Prutsky 2014</a>). We categorised one trial as awaiting classification, as it included children aged one to eight years (<a href="./references#CD010089-bbs2-0015" title="BergenR , BlackS , ShinefieldH , LewisE , RayP , HansenJ , et al. Safety of cold‐adapted live attenuated influenza vaccine in a large cohort of children and adolescents. Pediatric Infectious Disease Journal2004;23(2):138‐44. [PUBMED: 14872180] ">Bergen 2004</a>); we contacted the trial authors for further information on the age group of study participants. Two trials were not eligible as they were quasi‐randomised (<a href="./references#CD010089-bbs2-0017" title="CuhaciCB , BeyazovaU , KemalogluYK , OzkanS , GunduzB , OzdekA . Effectiveness of pandemic influenza A/H1N1 vaccine for prevention of otitis media in children. European Journal of Pediatrics2012;171:1667‐71. ">Cuhaci 2012</a>; <a href="./references#CD010089-bbs2-0022" title="HeikkinenT , RuuskanenO , WarisM , ZieglerT , ArolaM , HalonenP . Influenza vaccination in the prevention of acute otitis media in children. American Journal of Diseases of Children1991;145(4):445‐8. [PUBMED: 1849344] ">Heikkinen 1991</a>). We therefore included 10 trials and excluded 12 trials from the initial review, while one trial awaited classification. </p> <div class="figure" id="CD010089-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Study flow diagram." data-id="CD010089-fig-0001" src="/cdsr/doi/10.1002/14651858.CD010089.pub3/media/CDSR/CD010089/image_n/nCD010089-AFig-FIG01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> </div> <p>In this 2017 update, we excluded a study previously awaiting classification because it included children aged one to eight years, and we were not able to ascertain the number or proportion of children below six years of age (<a href="./references#CD010089-bbs2-0015" title="BergenR , BlackS , ShinefieldH , LewisE , RayP , HansenJ , et al. Safety of cold‐adapted live attenuated influenza vaccine in a large cohort of children and adolescents. Pediatric Infectious Disease Journal2004;23(2):138‐44. [PUBMED: 14872180] ">Bergen 2004</a>). We retrieved 32 additional records from the search of the electronic databases and four records from other sources. We screened a total of 33 records. We reviewed the full texts of seven studies, identifying one trial as meeting the review inclusion criteria (<a href="./references#CD010089-bbs2-0006" title="KosalaraksaP , JeanfreauR , FrenetteL , DrameM , MadariagaM , InnisBL , et al. AS03B‐adjuvanted H5N1 influenza vaccine in children 6 months through 17 years of age: a phase 2/3 randomized, placebo‐controlled, observer‐blinded trial. Journal of Infectious Diseases2015;211(5):801‐10. [PUBMED: 25293368] ">Kosalaraksa 2015</a>), and six as not eligible for inclusion. We have therefore included a total of 11 trials and excluded 19 trials in this review update. </p> </section> <section id="CD010089-sec-0077"> <h4 class="title">Included studies</h4> <p>We included 10 trials (N = 16,707) in the initial review (<a href="./references#CD010089-bbs2-0001" title="BelsheRB , GruberWC . Prevention of otitis media in children with live attenuated influenza vaccine given intranasally. Pediatric Infectious Disease Journal2000;19(Suppl 5):66‐71. ">Belshe 2000</a>; <a href="./references#CD010089-bbs2-0002" title="Bracco NetoH , FarhatCK , TregnaghiMW , MadhiSA , RazmpourA , PalladinoG , et al. Efficacy and safety of 1 and 2 doses of live attenuated influenza vaccine in vaccine‐naive children. Pediatric Infectious Disease Journal2009;28(5):365‐71. [PUBMED: 19395948] ">Bracco 2009</a>; <a href="./references#CD010089-bbs2-0003" title="ClementsDA , LangdonL , BlandC , WalterE . Influenza A vaccine decreases the incidence of otitis media in 6‐ to 30‐month‐old children in day care. Archives of Pediatrics &amp; Adolescent Medicine1995;149(10):1113‐7. [PUBMED: 7550814] ">Clements 1995</a>; <a href="./references#CD010089-bbs2-0004" title="GruberWC , BelsheRB , KingJC , TreanorJJ , PiedraPA , WrightPF , et al. Evaluation of live attenuated influenza vaccines in children 6‐18 months of age: safety, immunogenicity and efficacy. Journal of Infectious Diseases1996;173(6):1313‐9. [PUBMED: 8648202] ">Gruber 1996</a>; <a href="./references#CD010089-bbs2-0005" title="HobermanA , GreenbergDP , ParadiseJL , RocketteHE , LaveJR , KearneyDH , et al. Effectiveness of inactivated influenza vaccine in preventing acute otitis media in young children: a randomised controlled trial. JAMA2003;290(12):1608‐16. [PUBMED: 14506120] ">Hoberman 2003</a>; <a href="./references#CD010089-bbs2-0007" title="LumLC , Borja‐TaboraCF , BreimanRF , VesikariT , SablanBP , ChayOM , et al. Influenza vaccine concurrently administered with a combination measles, mumps, and rubella vaccine to young children. Vaccine2010;28(6):1566‐74. [PUBMED: 20003918] ">Lum 2010</a>; <a href="./references#CD010089-bbs2-0008" title="MarchisioP , CavagnaR , MaspesB , GironiS , EspositoS , LambertiniL , et al. Efficacy of intranasal virosomal influenza vaccine in the prevention of recurrent acute otitis media in children. Clinical Infectious Diseases2002;35(2):168‐74. [PUBMED: 12087523] ">Marchisio 2002</a>; <a href="./references#CD010089-bbs2-0009" title="SwierkoszEM , NewmanFK , AndersonEL , NugentSL , MillsGB , BelsheRB . Multidose, live attenuated, cold‐recombinant, trivalent influenza vaccine in infants and young children. Journal of Infectious Diseases1994;169(5):1121‐4. [PUBMED: 8169405] ">Swierkosz 1994</a>; <a href="./references#CD010089-bbs2-0010" title="TamJS , CapedingMR , LumLC , ChotpitayasunondhT , JiangZ , HuangLM , et al. Efficacy and safety of a live attenuated, cold‐adapted influenza vaccine, trivalent against culture‐confirmed influenza in young children in Asia. Pediatric Infectious Disease Journal2007;26(7):619‐28. [PUBMED: 17596805] ">Tam 2007</a>; <a href="./references#CD010089-bbs2-0011" title="VesikariT , FlemingDM , AristeguiJF , VertruyenA , AshkenaziS , RappaportR , et al. Safety, efficacy and effectiveness of cold‐adapted influenza vaccine‐trivalent against community‐acquired, culture‐confirmed influenza in young children attending day care. Pediatrics2006;118(6):2298‐312. [PUBMED: 17142512] ">Vesikari 2006</a>), and added one further trial (N = 416) in this update (<a href="./references#CD010089-bbs2-0006" title="KosalaraksaP , JeanfreauR , FrenetteL , DrameM , MadariagaM , InnisBL , et al. AS03B‐adjuvanted H5N1 influenza vaccine in children 6 months through 17 years of age: a phase 2/3 randomized, placebo‐controlled, observer‐blinded trial. Journal of Infectious Diseases2015;211(5):801‐10. [PUBMED: 25293368] ">Kosalaraksa 2015</a>), resulting in a total of 11 included studies involving 17,123 children. Ten out of the 11 included studies (and all five that contributed to the primary outcome) declared funding from vaccine manufacturers (<a href="./references#CD010089-bbs2-0001" title="BelsheRB , GruberWC . Prevention of otitis media in children with live attenuated influenza vaccine given intranasally. Pediatric Infectious Disease Journal2000;19(Suppl 5):66‐71. ">Belshe 2000</a>; <a href="./references#CD010089-bbs2-0002" title="Bracco NetoH , FarhatCK , TregnaghiMW , MadhiSA , RazmpourA , PalladinoG , et al. Efficacy and safety of 1 and 2 doses of live attenuated influenza vaccine in vaccine‐naive children. Pediatric Infectious Disease Journal2009;28(5):365‐71. [PUBMED: 19395948] ">Bracco 2009</a>; <a href="./references#CD010089-bbs2-0003" title="ClementsDA , LangdonL , BlandC , WalterE . Influenza A vaccine decreases the incidence of otitis media in 6‐ to 30‐month‐old children in day care. Archives of Pediatrics &amp; Adolescent Medicine1995;149(10):1113‐7. [PUBMED: 7550814] ">Clements 1995</a>; <a href="./references#CD010089-bbs2-0004" title="GruberWC , BelsheRB , KingJC , TreanorJJ , PiedraPA , WrightPF , et al. Evaluation of live attenuated influenza vaccines in children 6‐18 months of age: safety, immunogenicity and efficacy. Journal of Infectious Diseases1996;173(6):1313‐9. [PUBMED: 8648202] ">Gruber 1996</a>; <a href="./references#CD010089-bbs2-0005" title="HobermanA , GreenbergDP , ParadiseJL , RocketteHE , LaveJR , KearneyDH , et al. Effectiveness of inactivated influenza vaccine in preventing acute otitis media in young children: a randomised controlled trial. JAMA2003;290(12):1608‐16. [PUBMED: 14506120] ">Hoberman 2003</a>; <a href="./references#CD010089-bbs2-0006" title="KosalaraksaP , JeanfreauR , FrenetteL , DrameM , MadariagaM , InnisBL , et al. AS03B‐adjuvanted H5N1 influenza vaccine in children 6 months through 17 years of age: a phase 2/3 randomized, placebo‐controlled, observer‐blinded trial. Journal of Infectious Diseases2015;211(5):801‐10. [PUBMED: 25293368] ">Kosalaraksa 2015</a>; <a href="./references#CD010089-bbs2-0007" title="LumLC , Borja‐TaboraCF , BreimanRF , VesikariT , SablanBP , ChayOM , et al. Influenza vaccine concurrently administered with a combination measles, mumps, and rubella vaccine to young children. Vaccine2010;28(6):1566‐74. [PUBMED: 20003918] ">Lum 2010</a>; <a href="./references#CD010089-bbs2-0008" title="MarchisioP , CavagnaR , MaspesB , GironiS , EspositoS , LambertiniL , et al. Efficacy of intranasal virosomal influenza vaccine in the prevention of recurrent acute otitis media in children. Clinical Infectious Diseases2002;35(2):168‐74. [PUBMED: 12087523] ">Marchisio 2002</a>; <a href="./references#CD010089-bbs2-0010" title="TamJS , CapedingMR , LumLC , ChotpitayasunondhT , JiangZ , HuangLM , et al. Efficacy and safety of a live attenuated, cold‐adapted influenza vaccine, trivalent against culture‐confirmed influenza in young children in Asia. Pediatric Infectious Disease Journal2007;26(7):619‐28. [PUBMED: 17596805] ">Tam 2007</a>; <a href="./references#CD010089-bbs2-0011" title="VesikariT , FlemingDM , AristeguiJF , VertruyenA , AshkenaziS , RappaportR , et al. Safety, efficacy and effectiveness of cold‐adapted influenza vaccine‐trivalent against community‐acquired, culture‐confirmed influenza in young children attending day care. Pediatrics2006;118(6):2298‐312. [PUBMED: 17142512] ">Vesikari 2006</a>). </p> <section id="CD010089-sec-0078"> <h5 class="title">Participants</h5> <p>Six of the 11 trials were conducted in high‐income countries (<a href="./references#CD010089-bbs2-0003" title="ClementsDA , LangdonL , BlandC , WalterE . Influenza A vaccine decreases the incidence of otitis media in 6‐ to 30‐month‐old children in day care. Archives of Pediatrics &amp; Adolescent Medicine1995;149(10):1113‐7. [PUBMED: 7550814] ">Clements 1995</a>; <a href="./references#CD010089-bbs2-0004" title="GruberWC , BelsheRB , KingJC , TreanorJJ , PiedraPA , WrightPF , et al. Evaluation of live attenuated influenza vaccines in children 6‐18 months of age: safety, immunogenicity and efficacy. Journal of Infectious Diseases1996;173(6):1313‐9. [PUBMED: 8648202] ">Gruber 1996</a>; <a href="./references#CD010089-bbs2-0005" title="HobermanA , GreenbergDP , ParadiseJL , RocketteHE , LaveJR , KearneyDH , et al. Effectiveness of inactivated influenza vaccine in preventing acute otitis media in young children: a randomised controlled trial. JAMA2003;290(12):1608‐16. [PUBMED: 14506120] ">Hoberman 2003</a>; <a href="./references#CD010089-bbs2-0008" title="MarchisioP , CavagnaR , MaspesB , GironiS , EspositoS , LambertiniL , et al. Efficacy of intranasal virosomal influenza vaccine in the prevention of recurrent acute otitis media in children. Clinical Infectious Diseases2002;35(2):168‐74. [PUBMED: 12087523] ">Marchisio 2002</a>; <a href="./references#CD010089-bbs2-0009" title="SwierkoszEM , NewmanFK , AndersonEL , NugentSL , MillsGB , BelsheRB . Multidose, live attenuated, cold‐recombinant, trivalent influenza vaccine in infants and young children. Journal of Infectious Diseases1994;169(5):1121‐4. [PUBMED: 8169405] ">Swierkosz 1994</a>; <a href="./references#CD010089-bbs2-0011" title="VesikariT , FlemingDM , AristeguiJF , VertruyenA , AshkenaziS , RappaportR , et al. Safety, efficacy and effectiveness of cold‐adapted influenza vaccine‐trivalent against community‐acquired, culture‐confirmed influenza in young children attending day care. Pediatrics2006;118(6):2298‐312. [PUBMED: 17142512] ">Vesikari 2006</a>) and five were multicentre trials in high‐, middle‐, and low‐income countries (<a href="./references#CD010089-bbs2-0001" title="BelsheRB , GruberWC . Prevention of otitis media in children with live attenuated influenza vaccine given intranasally. Pediatric Infectious Disease Journal2000;19(Suppl 5):66‐71. ">Belshe 2000</a>; <a href="./references#CD010089-bbs2-0002" title="Bracco NetoH , FarhatCK , TregnaghiMW , MadhiSA , RazmpourA , PalladinoG , et al. Efficacy and safety of 1 and 2 doses of live attenuated influenza vaccine in vaccine‐naive children. Pediatric Infectious Disease Journal2009;28(5):365‐71. [PUBMED: 19395948] ">Bracco 2009</a>; <a href="./references#CD010089-bbs2-0006" title="KosalaraksaP , JeanfreauR , FrenetteL , DrameM , MadariagaM , InnisBL , et al. AS03B‐adjuvanted H5N1 influenza vaccine in children 6 months through 17 years of age: a phase 2/3 randomized, placebo‐controlled, observer‐blinded trial. Journal of Infectious Diseases2015;211(5):801‐10. [PUBMED: 25293368] ">Kosalaraksa 2015</a>; <a href="./references#CD010089-bbs2-0007" title="LumLC , Borja‐TaboraCF , BreimanRF , VesikariT , SablanBP , ChayOM , et al. Influenza vaccine concurrently administered with a combination measles, mumps, and rubella vaccine to young children. Vaccine2010;28(6):1566‐74. [PUBMED: 20003918] ">Lum 2010</a>; <a href="./references#CD010089-bbs2-0010" title="TamJS , CapedingMR , LumLC , ChotpitayasunondhT , JiangZ , HuangLM , et al. Efficacy and safety of a live attenuated, cold‐adapted influenza vaccine, trivalent against culture‐confirmed influenza in young children in Asia. Pediatric Infectious Disease Journal2007;26(7):619‐28. [PUBMED: 17596805] ">Tam 2007</a>). Eight of the 11 trials recruited participants from healthcare settings (<a href="./references#CD010089-bbs2-0001" title="BelsheRB , GruberWC . Prevention of otitis media in children with live attenuated influenza vaccine given intranasally. Pediatric Infectious Disease Journal2000;19(Suppl 5):66‐71. ">Belshe 2000</a>; <a href="./references#CD010089-bbs2-0002" title="Bracco NetoH , FarhatCK , TregnaghiMW , MadhiSA , RazmpourA , PalladinoG , et al. Efficacy and safety of 1 and 2 doses of live attenuated influenza vaccine in vaccine‐naive children. Pediatric Infectious Disease Journal2009;28(5):365‐71. [PUBMED: 19395948] ">Bracco 2009</a>; <a href="./references#CD010089-bbs2-0004" title="GruberWC , BelsheRB , KingJC , TreanorJJ , PiedraPA , WrightPF , et al. Evaluation of live attenuated influenza vaccines in children 6‐18 months of age: safety, immunogenicity and efficacy. Journal of Infectious Diseases1996;173(6):1313‐9. [PUBMED: 8648202] ">Gruber 1996</a>; <a href="./references#CD010089-bbs2-0005" title="HobermanA , GreenbergDP , ParadiseJL , RocketteHE , LaveJR , KearneyDH , et al. Effectiveness of inactivated influenza vaccine in preventing acute otitis media in young children: a randomised controlled trial. JAMA2003;290(12):1608‐16. [PUBMED: 14506120] ">Hoberman 2003</a>; <a href="./references#CD010089-bbs2-0007" title="LumLC , Borja‐TaboraCF , BreimanRF , VesikariT , SablanBP , ChayOM , et al. Influenza vaccine concurrently administered with a combination measles, mumps, and rubella vaccine to young children. Vaccine2010;28(6):1566‐74. [PUBMED: 20003918] ">Lum 2010</a>; <a href="./references#CD010089-bbs2-0008" title="MarchisioP , CavagnaR , MaspesB , GironiS , EspositoS , LambertiniL , et al. Efficacy of intranasal virosomal influenza vaccine in the prevention of recurrent acute otitis media in children. Clinical Infectious Diseases2002;35(2):168‐74. [PUBMED: 12087523] ">Marchisio 2002</a>; <a href="./references#CD010089-bbs2-0010" title="TamJS , CapedingMR , LumLC , ChotpitayasunondhT , JiangZ , HuangLM , et al. Efficacy and safety of a live attenuated, cold‐adapted influenza vaccine, trivalent against culture‐confirmed influenza in young children in Asia. Pediatric Infectious Disease Journal2007;26(7):619‐28. [PUBMED: 17596805] ">Tam 2007</a>; <a href="./references#CD010089-bbs2-0011" title="VesikariT , FlemingDM , AristeguiJF , VertruyenA , AshkenaziS , RappaportR , et al. Safety, efficacy and effectiveness of cold‐adapted influenza vaccine‐trivalent against community‐acquired, culture‐confirmed influenza in young children attending day care. Pediatrics2006;118(6):2298‐312. [PUBMED: 17142512] ">Vesikari 2006</a>), and one trial recruited participants from day‐care centres (<a href="./references#CD010089-bbs2-0003" title="ClementsDA , LangdonL , BlandC , WalterE . Influenza A vaccine decreases the incidence of otitis media in 6‐ to 30‐month‐old children in day care. Archives of Pediatrics &amp; Adolescent Medicine1995;149(10):1113‐7. [PUBMED: 7550814] ">Clements 1995</a>). Two trials did not mention the setting from which the participants were recruited (<a href="./references#CD010089-bbs2-0006" title="KosalaraksaP , JeanfreauR , FrenetteL , DrameM , MadariagaM , InnisBL , et al. AS03B‐adjuvanted H5N1 influenza vaccine in children 6 months through 17 years of age: a phase 2/3 randomized, placebo‐controlled, observer‐blinded trial. Journal of Infectious Diseases2015;211(5):801‐10. [PUBMED: 25293368] ">Kosalaraksa 2015</a>; <a href="./references#CD010089-bbs2-0009" title="SwierkoszEM , NewmanFK , AndersonEL , NugentSL , MillsGB , BelsheRB . Multidose, live attenuated, cold‐recombinant, trivalent influenza vaccine in infants and young children. Journal of Infectious Diseases1994;169(5):1121‐4. [PUBMED: 8169405] ">Swierkosz 1994</a>). Nine trials reported exclusion of participants due to an acute illness, immunosuppression or receiving medications known to suppress the immune system, or with craniofacial abnormality (<a href="./references#CD010089-bbs2-0001" title="BelsheRB , GruberWC . Prevention of otitis media in children with live attenuated influenza vaccine given intranasally. Pediatric Infectious Disease Journal2000;19(Suppl 5):66‐71. ">Belshe 2000</a>; <a href="./references#CD010089-bbs2-0002" title="Bracco NetoH , FarhatCK , TregnaghiMW , MadhiSA , RazmpourA , PalladinoG , et al. Efficacy and safety of 1 and 2 doses of live attenuated influenza vaccine in vaccine‐naive children. Pediatric Infectious Disease Journal2009;28(5):365‐71. [PUBMED: 19395948] ">Bracco 2009</a>; <a href="./references#CD010089-bbs2-0003" title="ClementsDA , LangdonL , BlandC , WalterE . Influenza A vaccine decreases the incidence of otitis media in 6‐ to 30‐month‐old children in day care. Archives of Pediatrics &amp; Adolescent Medicine1995;149(10):1113‐7. [PUBMED: 7550814] ">Clements 1995</a>; <a href="./references#CD010089-bbs2-0005" title="HobermanA , GreenbergDP , ParadiseJL , RocketteHE , LaveJR , KearneyDH , et al. Effectiveness of inactivated influenza vaccine in preventing acute otitis media in young children: a randomised controlled trial. JAMA2003;290(12):1608‐16. [PUBMED: 14506120] ">Hoberman 2003</a>; <a href="./references#CD010089-bbs2-0006" title="KosalaraksaP , JeanfreauR , FrenetteL , DrameM , MadariagaM , InnisBL , et al. AS03B‐adjuvanted H5N1 influenza vaccine in children 6 months through 17 years of age: a phase 2/3 randomized, placebo‐controlled, observer‐blinded trial. Journal of Infectious Diseases2015;211(5):801‐10. [PUBMED: 25293368] ">Kosalaraksa 2015</a>; <a href="./references#CD010089-bbs2-0007" title="LumLC , Borja‐TaboraCF , BreimanRF , VesikariT , SablanBP , ChayOM , et al. Influenza vaccine concurrently administered with a combination measles, mumps, and rubella vaccine to young children. Vaccine2010;28(6):1566‐74. [PUBMED: 20003918] ">Lum 2010</a>; <a href="./references#CD010089-bbs2-0008" title="MarchisioP , CavagnaR , MaspesB , GironiS , EspositoS , LambertiniL , et al. Efficacy of intranasal virosomal influenza vaccine in the prevention of recurrent acute otitis media in children. Clinical Infectious Diseases2002;35(2):168‐74. [PUBMED: 12087523] ">Marchisio 2002</a>; <a href="./references#CD010089-bbs2-0010" title="TamJS , CapedingMR , LumLC , ChotpitayasunondhT , JiangZ , HuangLM , et al. Efficacy and safety of a live attenuated, cold‐adapted influenza vaccine, trivalent against culture‐confirmed influenza in young children in Asia. Pediatric Infectious Disease Journal2007;26(7):619‐28. [PUBMED: 17596805] ">Tam 2007</a>; <a href="./references#CD010089-bbs2-0011" title="VesikariT , FlemingDM , AristeguiJF , VertruyenA , AshkenaziS , RappaportR , et al. Safety, efficacy and effectiveness of cold‐adapted influenza vaccine‐trivalent against community‐acquired, culture‐confirmed influenza in young children attending day care. Pediatrics2006;118(6):2298‐312. [PUBMED: 17142512] ">Vesikari 2006</a>). Seven trials involving 8154 children mentioned the sex of the children, and these were equally distributed throughout the seven trials and across the intervention and comparison groups (<a href="./references#CD010089-bbs2-0003" title="ClementsDA , LangdonL , BlandC , WalterE . Influenza A vaccine decreases the incidence of otitis media in 6‐ to 30‐month‐old children in day care. Archives of Pediatrics &amp; Adolescent Medicine1995;149(10):1113‐7. [PUBMED: 7550814] ">Clements 1995</a>; <a href="./references#CD010089-bbs2-0005" title="HobermanA , GreenbergDP , ParadiseJL , RocketteHE , LaveJR , KearneyDH , et al. Effectiveness of inactivated influenza vaccine in preventing acute otitis media in young children: a randomised controlled trial. JAMA2003;290(12):1608‐16. [PUBMED: 14506120] ">Hoberman 2003</a>; <a href="./references#CD010089-bbs2-0006" title="KosalaraksaP , JeanfreauR , FrenetteL , DrameM , MadariagaM , InnisBL , et al. AS03B‐adjuvanted H5N1 influenza vaccine in children 6 months through 17 years of age: a phase 2/3 randomized, placebo‐controlled, observer‐blinded trial. Journal of Infectious Diseases2015;211(5):801‐10. [PUBMED: 25293368] ">Kosalaraksa 2015</a>; <a href="./references#CD010089-bbs2-0007" title="LumLC , Borja‐TaboraCF , BreimanRF , VesikariT , SablanBP , ChayOM , et al. Influenza vaccine concurrently administered with a combination measles, mumps, and rubella vaccine to young children. Vaccine2010;28(6):1566‐74. [PUBMED: 20003918] ">Lum 2010</a>; <a href="./references#CD010089-bbs2-0008" title="MarchisioP , CavagnaR , MaspesB , GironiS , EspositoS , LambertiniL , et al. Efficacy of intranasal virosomal influenza vaccine in the prevention of recurrent acute otitis media in children. Clinical Infectious Diseases2002;35(2):168‐74. [PUBMED: 12087523] ">Marchisio 2002</a>; <a href="./references#CD010089-bbs2-0010" title="TamJS , CapedingMR , LumLC , ChotpitayasunondhT , JiangZ , HuangLM , et al. Efficacy and safety of a live attenuated, cold‐adapted influenza vaccine, trivalent against culture‐confirmed influenza in young children in Asia. Pediatric Infectious Disease Journal2007;26(7):619‐28. [PUBMED: 17596805] ">Tam 2007</a>; <a href="./references#CD010089-bbs2-0011" title="VesikariT , FlemingDM , AristeguiJF , VertruyenA , AshkenaziS , RappaportR , et al. Safety, efficacy and effectiveness of cold‐adapted influenza vaccine‐trivalent against community‐acquired, culture‐confirmed influenza in young children attending day care. Pediatrics2006;118(6):2298‐312. [PUBMED: 17142512] ">Vesikari 2006</a>). For one trial, the denominator (number of children who had the outcome measured) was unclear, so we used the number randomised as the denominator based on the intention‐to‐treat principle (<a href="./references#CD010089-bbs2-0003" title="ClementsDA , LangdonL , BlandC , WalterE . Influenza A vaccine decreases the incidence of otitis media in 6‐ to 30‐month‐old children in day care. Archives of Pediatrics &amp; Adolescent Medicine1995;149(10):1113‐7. [PUBMED: 7550814] ">Clements 1995</a>). </p> </section> <section id="CD010089-sec-0079"> <h5 class="title">Intervention</h5> <p>Participants in the trials were randomised into intervention and control groups. The intervention was a trivalent vaccine in six trials (<a href="./references#CD010089-bbs2-0001" title="BelsheRB , GruberWC . Prevention of otitis media in children with live attenuated influenza vaccine given intranasally. Pediatric Infectious Disease Journal2000;19(Suppl 5):66‐71. ">Belshe 2000</a>; <a href="./references#CD010089-bbs2-0003" title="ClementsDA , LangdonL , BlandC , WalterE . Influenza A vaccine decreases the incidence of otitis media in 6‐ to 30‐month‐old children in day care. Archives of Pediatrics &amp; Adolescent Medicine1995;149(10):1113‐7. [PUBMED: 7550814] ">Clements 1995</a>; <a href="./references#CD010089-bbs2-0005" title="HobermanA , GreenbergDP , ParadiseJL , RocketteHE , LaveJR , KearneyDH , et al. Effectiveness of inactivated influenza vaccine in preventing acute otitis media in young children: a randomised controlled trial. JAMA2003;290(12):1608‐16. [PUBMED: 14506120] ">Hoberman 2003</a>; <a href="./references#CD010089-bbs2-0009" title="SwierkoszEM , NewmanFK , AndersonEL , NugentSL , MillsGB , BelsheRB . Multidose, live attenuated, cold‐recombinant, trivalent influenza vaccine in infants and young children. Journal of Infectious Diseases1994;169(5):1121‐4. [PUBMED: 8169405] ">Swierkosz 1994</a>; <a href="./references#CD010089-bbs2-0010" title="TamJS , CapedingMR , LumLC , ChotpitayasunondhT , JiangZ , HuangLM , et al. Efficacy and safety of a live attenuated, cold‐adapted influenza vaccine, trivalent against culture‐confirmed influenza in young children in Asia. Pediatric Infectious Disease Journal2007;26(7):619‐28. [PUBMED: 17596805] ">Tam 2007</a>; <a href="./references#CD010089-bbs2-0011" title="VesikariT , FlemingDM , AristeguiJF , VertruyenA , AshkenaziS , RappaportR , et al. Safety, efficacy and effectiveness of cold‐adapted influenza vaccine‐trivalent against community‐acquired, culture‐confirmed influenza in young children attending day care. Pediatrics2006;118(6):2298‐312. [PUBMED: 17142512] ">Vesikari 2006</a>), reassortant in two trials (<a href="./references#CD010089-bbs2-0002" title="Bracco NetoH , FarhatCK , TregnaghiMW , MadhiSA , RazmpourA , PalladinoG , et al. Efficacy and safety of 1 and 2 doses of live attenuated influenza vaccine in vaccine‐naive children. Pediatric Infectious Disease Journal2009;28(5):365‐71. [PUBMED: 19395948] ">Bracco 2009</a>; <a href="./references#CD010089-bbs2-0007" title="LumLC , Borja‐TaboraCF , BreimanRF , VesikariT , SablanBP , ChayOM , et al. Influenza vaccine concurrently administered with a combination measles, mumps, and rubella vaccine to young children. Vaccine2010;28(6):1566‐74. [PUBMED: 20003918] ">Lum 2010</a>), and a combination of monovalent and bivalent in one trial (<a href="./references#CD010089-bbs2-0004" title="GruberWC , BelsheRB , KingJC , TreanorJJ , PiedraPA , WrightPF , et al. Evaluation of live attenuated influenza vaccines in children 6‐18 months of age: safety, immunogenicity and efficacy. Journal of Infectious Diseases1996;173(6):1313‐9. [PUBMED: 8648202] ">Gruber 1996</a>). Live attenuated vaccine was administered in seven trials (<a href="./references#CD010089-bbs2-0001" title="BelsheRB , GruberWC . Prevention of otitis media in children with live attenuated influenza vaccine given intranasally. Pediatric Infectious Disease Journal2000;19(Suppl 5):66‐71. ">Belshe 2000</a>; <a href="./references#CD010089-bbs2-0002" title="Bracco NetoH , FarhatCK , TregnaghiMW , MadhiSA , RazmpourA , PalladinoG , et al. Efficacy and safety of 1 and 2 doses of live attenuated influenza vaccine in vaccine‐naive children. Pediatric Infectious Disease Journal2009;28(5):365‐71. [PUBMED: 19395948] ">Bracco 2009</a>; <a href="./references#CD010089-bbs2-0004" title="GruberWC , BelsheRB , KingJC , TreanorJJ , PiedraPA , WrightPF , et al. Evaluation of live attenuated influenza vaccines in children 6‐18 months of age: safety, immunogenicity and efficacy. Journal of Infectious Diseases1996;173(6):1313‐9. [PUBMED: 8648202] ">Gruber 1996</a>; <a href="./references#CD010089-bbs2-0007" title="LumLC , Borja‐TaboraCF , BreimanRF , VesikariT , SablanBP , ChayOM , et al. Influenza vaccine concurrently administered with a combination measles, mumps, and rubella vaccine to young children. Vaccine2010;28(6):1566‐74. [PUBMED: 20003918] ">Lum 2010</a>; <a href="./references#CD010089-bbs2-0009" title="SwierkoszEM , NewmanFK , AndersonEL , NugentSL , MillsGB , BelsheRB . Multidose, live attenuated, cold‐recombinant, trivalent influenza vaccine in infants and young children. Journal of Infectious Diseases1994;169(5):1121‐4. [PUBMED: 8169405] ">Swierkosz 1994</a>; <a href="./references#CD010089-bbs2-0010" title="TamJS , CapedingMR , LumLC , ChotpitayasunondhT , JiangZ , HuangLM , et al. Efficacy and safety of a live attenuated, cold‐adapted influenza vaccine, trivalent against culture‐confirmed influenza in young children in Asia. Pediatric Infectious Disease Journal2007;26(7):619‐28. [PUBMED: 17596805] ">Tam 2007</a>; <a href="./references#CD010089-bbs2-0011" title="VesikariT , FlemingDM , AristeguiJF , VertruyenA , AshkenaziS , RappaportR , et al. Safety, efficacy and effectiveness of cold‐adapted influenza vaccine‐trivalent against community‐acquired, culture‐confirmed influenza in young children attending day care. Pediatrics2006;118(6):2298‐312. [PUBMED: 17142512] ">Vesikari 2006</a>), virosomal subunit in one trial (<a href="./references#CD010089-bbs2-0008" title="MarchisioP , CavagnaR , MaspesB , GironiS , EspositoS , LambertiniL , et al. Efficacy of intranasal virosomal influenza vaccine in the prevention of recurrent acute otitis media in children. Clinical Infectious Diseases2002;35(2):168‐74. [PUBMED: 12087523] ">Marchisio 2002</a>), subvirion in two trials (<a href="./references#CD010089-bbs2-0003" title="ClementsDA , LangdonL , BlandC , WalterE . Influenza A vaccine decreases the incidence of otitis media in 6‐ to 30‐month‐old children in day care. Archives of Pediatrics &amp; Adolescent Medicine1995;149(10):1113‐7. [PUBMED: 7550814] ">Clements 1995</a>; <a href="./references#CD010089-bbs2-0005" title="HobermanA , GreenbergDP , ParadiseJL , RocketteHE , LaveJR , KearneyDH , et al. Effectiveness of inactivated influenza vaccine in preventing acute otitis media in young children: a randomised controlled trial. JAMA2003;290(12):1608‐16. [PUBMED: 14506120] ">Hoberman 2003</a>), and split virion in one trial (<a href="./references#CD010089-bbs2-0006" title="KosalaraksaP , JeanfreauR , FrenetteL , DrameM , MadariagaM , InnisBL , et al. AS03B‐adjuvanted H5N1 influenza vaccine in children 6 months through 17 years of age: a phase 2/3 randomized, placebo‐controlled, observer‐blinded trial. Journal of Infectious Diseases2015;211(5):801‐10. [PUBMED: 25293368] ">Kosalaraksa 2015</a>). The vaccines were administered intranasally in seven trials (<a href="./references#CD010089-bbs2-0001" title="BelsheRB , GruberWC . Prevention of otitis media in children with live attenuated influenza vaccine given intranasally. Pediatric Infectious Disease Journal2000;19(Suppl 5):66‐71. ">Belshe 2000</a>; <a href="./references#CD010089-bbs2-0002" title="Bracco NetoH , FarhatCK , TregnaghiMW , MadhiSA , RazmpourA , PalladinoG , et al. Efficacy and safety of 1 and 2 doses of live attenuated influenza vaccine in vaccine‐naive children. Pediatric Infectious Disease Journal2009;28(5):365‐71. [PUBMED: 19395948] ">Bracco 2009</a>; <a href="./references#CD010089-bbs2-0004" title="GruberWC , BelsheRB , KingJC , TreanorJJ , PiedraPA , WrightPF , et al. Evaluation of live attenuated influenza vaccines in children 6‐18 months of age: safety, immunogenicity and efficacy. Journal of Infectious Diseases1996;173(6):1313‐9. [PUBMED: 8648202] ">Gruber 1996</a>; <a href="./references#CD010089-bbs2-0008" title="MarchisioP , CavagnaR , MaspesB , GironiS , EspositoS , LambertiniL , et al. Efficacy of intranasal virosomal influenza vaccine in the prevention of recurrent acute otitis media in children. Clinical Infectious Diseases2002;35(2):168‐74. [PUBMED: 12087523] ">Marchisio 2002</a>; <a href="./references#CD010089-bbs2-0009" title="SwierkoszEM , NewmanFK , AndersonEL , NugentSL , MillsGB , BelsheRB . Multidose, live attenuated, cold‐recombinant, trivalent influenza vaccine in infants and young children. Journal of Infectious Diseases1994;169(5):1121‐4. [PUBMED: 8169405] ">Swierkosz 1994</a>; <a href="./references#CD010089-bbs2-0010" title="TamJS , CapedingMR , LumLC , ChotpitayasunondhT , JiangZ , HuangLM , et al. Efficacy and safety of a live attenuated, cold‐adapted influenza vaccine, trivalent against culture‐confirmed influenza in young children in Asia. Pediatric Infectious Disease Journal2007;26(7):619‐28. [PUBMED: 17596805] ">Tam 2007</a>; <a href="./references#CD010089-bbs2-0011" title="VesikariT , FlemingDM , AristeguiJF , VertruyenA , AshkenaziS , RappaportR , et al. Safety, efficacy and effectiveness of cold‐adapted influenza vaccine‐trivalent against community‐acquired, culture‐confirmed influenza in young children attending day care. Pediatrics2006;118(6):2298‐312. [PUBMED: 17142512] ">Vesikari 2006</a>), intramuscularly in two trials (<a href="./references#CD010089-bbs2-0005" title="HobermanA , GreenbergDP , ParadiseJL , RocketteHE , LaveJR , KearneyDH , et al. Effectiveness of inactivated influenza vaccine in preventing acute otitis media in young children: a randomised controlled trial. JAMA2003;290(12):1608‐16. [PUBMED: 14506120] ">Hoberman 2003</a>; <a href="./references#CD010089-bbs2-0006" title="KosalaraksaP , JeanfreauR , FrenetteL , DrameM , MadariagaM , InnisBL , et al. AS03B‐adjuvanted H5N1 influenza vaccine in children 6 months through 17 years of age: a phase 2/3 randomized, placebo‐controlled, observer‐blinded trial. Journal of Infectious Diseases2015;211(5):801‐10. [PUBMED: 25293368] ">Kosalaraksa 2015</a>), and subcutaneously in one trial (<a href="./references#CD010089-bbs2-0007" title="LumLC , Borja‐TaboraCF , BreimanRF , VesikariT , SablanBP , ChayOM , et al. Influenza vaccine concurrently administered with a combination measles, mumps, and rubella vaccine to young children. Vaccine2010;28(6):1566‐74. [PUBMED: 20003918] ">Lum 2010</a>). Five trials gave a single course of one to three doses (<a href="./references#CD010089-bbs2-0003" title="ClementsDA , LangdonL , BlandC , WalterE . Influenza A vaccine decreases the incidence of otitis media in 6‐ to 30‐month‐old children in day care. Archives of Pediatrics &amp; Adolescent Medicine1995;149(10):1113‐7. [PUBMED: 7550814] ">Clements 1995</a>; <a href="./references#CD010089-bbs2-0004" title="GruberWC , BelsheRB , KingJC , TreanorJJ , PiedraPA , WrightPF , et al. Evaluation of live attenuated influenza vaccines in children 6‐18 months of age: safety, immunogenicity and efficacy. Journal of Infectious Diseases1996;173(6):1313‐9. [PUBMED: 8648202] ">Gruber 1996</a>; <a href="./references#CD010089-bbs2-0007" title="LumLC , Borja‐TaboraCF , BreimanRF , VesikariT , SablanBP , ChayOM , et al. Influenza vaccine concurrently administered with a combination measles, mumps, and rubella vaccine to young children. Vaccine2010;28(6):1566‐74. [PUBMED: 20003918] ">Lum 2010</a>; <a href="./references#CD010089-bbs2-0008" title="MarchisioP , CavagnaR , MaspesB , GironiS , EspositoS , LambertiniL , et al. Efficacy of intranasal virosomal influenza vaccine in the prevention of recurrent acute otitis media in children. Clinical Infectious Diseases2002;35(2):168‐74. [PUBMED: 12087523] ">Marchisio 2002</a>; <a href="./references#CD010089-bbs2-0009" title="SwierkoszEM , NewmanFK , AndersonEL , NugentSL , MillsGB , BelsheRB . Multidose, live attenuated, cold‐recombinant, trivalent influenza vaccine in infants and young children. Journal of Infectious Diseases1994;169(5):1121‐4. [PUBMED: 8169405] ">Swierkosz 1994</a>), and six trials gave two courses, where the first course was either one or two doses and the second course was a single dose given six months to one year later (<a href="./references#CD010089-bbs2-0001" title="BelsheRB , GruberWC . Prevention of otitis media in children with live attenuated influenza vaccine given intranasally. Pediatric Infectious Disease Journal2000;19(Suppl 5):66‐71. ">Belshe 2000</a>; <a href="./references#CD010089-bbs2-0002" title="Bracco NetoH , FarhatCK , TregnaghiMW , MadhiSA , RazmpourA , PalladinoG , et al. Efficacy and safety of 1 and 2 doses of live attenuated influenza vaccine in vaccine‐naive children. Pediatric Infectious Disease Journal2009;28(5):365‐71. [PUBMED: 19395948] ">Bracco 2009</a>; <a href="./references#CD010089-bbs2-0005" title="HobermanA , GreenbergDP , ParadiseJL , RocketteHE , LaveJR , KearneyDH , et al. Effectiveness of inactivated influenza vaccine in preventing acute otitis media in young children: a randomised controlled trial. JAMA2003;290(12):1608‐16. [PUBMED: 14506120] ">Hoberman 2003</a>; <a href="./references#CD010089-bbs2-0006" title="KosalaraksaP , JeanfreauR , FrenetteL , DrameM , MadariagaM , InnisBL , et al. AS03B‐adjuvanted H5N1 influenza vaccine in children 6 months through 17 years of age: a phase 2/3 randomized, placebo‐controlled, observer‐blinded trial. Journal of Infectious Diseases2015;211(5):801‐10. [PUBMED: 25293368] ">Kosalaraksa 2015</a>; <a href="./references#CD010089-bbs2-0010" title="TamJS , CapedingMR , LumLC , ChotpitayasunondhT , JiangZ , HuangLM , et al. Efficacy and safety of a live attenuated, cold‐adapted influenza vaccine, trivalent against culture‐confirmed influenza in young children in Asia. Pediatric Infectious Disease Journal2007;26(7):619‐28. [PUBMED: 17596805] ">Tam 2007</a>; <a href="./references#CD010089-bbs2-0011" title="VesikariT , FlemingDM , AristeguiJF , VertruyenA , AshkenaziS , RappaportR , et al. Safety, efficacy and effectiveness of cold‐adapted influenza vaccine‐trivalent against community‐acquired, culture‐confirmed influenza in young children attending day care. Pediatrics2006;118(6):2298‐312. [PUBMED: 17142512] ">Vesikari 2006</a>). For those trials that gave two courses, follow‐up was reported for at least six months after each course was completed. </p> </section> <section id="CD010089-sec-0080"> <h5 class="title">Outcomes</h5> <p>Eight trials reported measuring the number of children with at least one episode of AOM during follow‐up (<a href="./references#CD010089-bbs2-0002" title="Bracco NetoH , FarhatCK , TregnaghiMW , MadhiSA , RazmpourA , PalladinoG , et al. Efficacy and safety of 1 and 2 doses of live attenuated influenza vaccine in vaccine‐naive children. Pediatric Infectious Disease Journal2009;28(5):365‐71. [PUBMED: 19395948] ">Bracco 2009</a>; <a href="./references#CD010089-bbs2-0003" title="ClementsDA , LangdonL , BlandC , WalterE . Influenza A vaccine decreases the incidence of otitis media in 6‐ to 30‐month‐old children in day care. Archives of Pediatrics &amp; Adolescent Medicine1995;149(10):1113‐7. [PUBMED: 7550814] ">Clements 1995</a>; <a href="./references#CD010089-bbs2-0004" title="GruberWC , BelsheRB , KingJC , TreanorJJ , PiedraPA , WrightPF , et al. Evaluation of live attenuated influenza vaccines in children 6‐18 months of age: safety, immunogenicity and efficacy. Journal of Infectious Diseases1996;173(6):1313‐9. [PUBMED: 8648202] ">Gruber 1996</a>; <a href="./references#CD010089-bbs2-0005" title="HobermanA , GreenbergDP , ParadiseJL , RocketteHE , LaveJR , KearneyDH , et al. Effectiveness of inactivated influenza vaccine in preventing acute otitis media in young children: a randomised controlled trial. JAMA2003;290(12):1608‐16. [PUBMED: 14506120] ">Hoberman 2003</a>; <a href="./references#CD010089-bbs2-0007" title="LumLC , Borja‐TaboraCF , BreimanRF , VesikariT , SablanBP , ChayOM , et al. Influenza vaccine concurrently administered with a combination measles, mumps, and rubella vaccine to young children. Vaccine2010;28(6):1566‐74. [PUBMED: 20003918] ">Lum 2010</a>; <a href="./references#CD010089-bbs2-0008" title="MarchisioP , CavagnaR , MaspesB , GironiS , EspositoS , LambertiniL , et al. Efficacy of intranasal virosomal influenza vaccine in the prevention of recurrent acute otitis media in children. Clinical Infectious Diseases2002;35(2):168‐74. [PUBMED: 12087523] ">Marchisio 2002</a>; <a href="./references#CD010089-bbs2-0009" title="SwierkoszEM , NewmanFK , AndersonEL , NugentSL , MillsGB , BelsheRB . Multidose, live attenuated, cold‐recombinant, trivalent influenza vaccine in infants and young children. Journal of Infectious Diseases1994;169(5):1121‐4. [PUBMED: 8169405] ">Swierkosz 1994</a>; <a href="./references#CD010089-bbs2-0011" title="VesikariT , FlemingDM , AristeguiJF , VertruyenA , AshkenaziS , RappaportR , et al. Safety, efficacy and effectiveness of cold‐adapted influenza vaccine‐trivalent against community‐acquired, culture‐confirmed influenza in young children attending day care. Pediatrics2006;118(6):2298‐312. [PUBMED: 17142512] ">Vesikari 2006</a>). However, only three trials met our prespecified duration of follow‐up of at least six months (<a href="./references#CD010089-bbs2-0005" title="HobermanA , GreenbergDP , ParadiseJL , RocketteHE , LaveJR , KearneyDH , et al. Effectiveness of inactivated influenza vaccine in preventing acute otitis media in young children: a randomised controlled trial. JAMA2003;290(12):1608‐16. [PUBMED: 14506120] ">Hoberman 2003</a>; <a href="./references#CD010089-bbs2-0007" title="LumLC , Borja‐TaboraCF , BreimanRF , VesikariT , SablanBP , ChayOM , et al. Influenza vaccine concurrently administered with a combination measles, mumps, and rubella vaccine to young children. Vaccine2010;28(6):1566‐74. [PUBMED: 20003918] ">Lum 2010</a>; <a href="./references#CD010089-bbs2-0011" title="VesikariT , FlemingDM , AristeguiJF , VertruyenA , AshkenaziS , RappaportR , et al. Safety, efficacy and effectiveness of cold‐adapted influenza vaccine‐trivalent against community‐acquired, culture‐confirmed influenza in young children attending day care. Pediatrics2006;118(6):2298‐312. [PUBMED: 17142512] ">Vesikari 2006</a>). We included one additional trial with a five‐month follow‐up period in the review (<a href="./references#CD010089-bbs2-0003" title="ClementsDA , LangdonL , BlandC , WalterE . Influenza A vaccine decreases the incidence of otitis media in 6‐ to 30‐month‐old children in day care. Archives of Pediatrics &amp; Adolescent Medicine1995;149(10):1113‐7. [PUBMED: 7550814] ">Clements 1995</a>). This trial was conducted in a setting that had a distinct respiratory season, and the children were followed up for the respiratory season, which explained the shorter follow‐up. Our primary outcomes were reported. We made a post hoc decision to include this trial despite not quite reaching our inclusion criteria of six months' follow‐up, testing this decision in our sensitivity analysis. The remaining trials all had short follow‐up periods of eight weeks or less, therefore we excluded the primary outcome data and only reported secondary outcomes from these trials. One trial randomised children into one of four regimens: (i) two doses of LAIV; (ii) single‐dose LAIV; (iii) excipient placebo; or (iv) saline placebo with six to 36 months' follow‐up (<a href="./references#CD010089-bbs2-0002" title="Bracco NetoH , FarhatCK , TregnaghiMW , MadhiSA , RazmpourA , PalladinoG , et al. Efficacy and safety of 1 and 2 doses of live attenuated influenza vaccine in vaccine‐naive children. Pediatric Infectious Disease Journal2009;28(5):365‐71. [PUBMED: 19395948] ">Bracco 2009</a>). However, the numbers of children in group (iii) and (iv) were not reported, therefore we could not include this trial in the meta‐analysis. We included four trials in the meta‐analysis for the primary outcomes (<a href="./references#CD010089-bbs2-0003" title="ClementsDA , LangdonL , BlandC , WalterE . Influenza A vaccine decreases the incidence of otitis media in 6‐ to 30‐month‐old children in day care. Archives of Pediatrics &amp; Adolescent Medicine1995;149(10):1113‐7. [PUBMED: 7550814] ">Clements 1995</a>; <a href="./references#CD010089-bbs2-0005" title="HobermanA , GreenbergDP , ParadiseJL , RocketteHE , LaveJR , KearneyDH , et al. Effectiveness of inactivated influenza vaccine in preventing acute otitis media in young children: a randomised controlled trial. JAMA2003;290(12):1608‐16. [PUBMED: 14506120] ">Hoberman 2003</a>; <a href="./references#CD010089-bbs2-0007" title="LumLC , Borja‐TaboraCF , BreimanRF , VesikariT , SablanBP , ChayOM , et al. Influenza vaccine concurrently administered with a combination measles, mumps, and rubella vaccine to young children. Vaccine2010;28(6):1566‐74. [PUBMED: 20003918] ">Lum 2010</a>; <a href="./references#CD010089-bbs2-0011" title="VesikariT , FlemingDM , AristeguiJF , VertruyenA , AshkenaziS , RappaportR , et al. Safety, efficacy and effectiveness of cold‐adapted influenza vaccine‐trivalent against community‐acquired, culture‐confirmed influenza in young children attending day care. Pediatrics2006;118(6):2298‐312. [PUBMED: 17142512] ">Vesikari 2006</a>). One trial involving 1602 children reported the mean episodes per person without a measure of dispersion that could be used to calculate the standard deviation, hence we were unable to analyse this outcome (<a href="./references#CD010089-bbs2-0001" title="BelsheRB , GruberWC . Prevention of otitis media in children with live attenuated influenza vaccine given intranasally. Pediatric Infectious Disease Journal2000;19(Suppl 5):66‐71. ">Belshe 2000</a>). For those trials that gave two courses of vaccine, we reported the first primary outcome for the follow‐up period after the first course (<a href="./references#CD010089-bbs2-0001" title="BelsheRB , GruberWC . Prevention of otitis media in children with live attenuated influenza vaccine given intranasally. Pediatric Infectious Disease Journal2000;19(Suppl 5):66‐71. ">Belshe 2000</a>; <a href="./references#CD010089-bbs2-0005" title="HobermanA , GreenbergDP , ParadiseJL , RocketteHE , LaveJR , KearneyDH , et al. Effectiveness of inactivated influenza vaccine in preventing acute otitis media in young children: a randomised controlled trial. JAMA2003;290(12):1608‐16. [PUBMED: 14506120] ">Hoberman 2003</a>; <a href="./references#CD010089-bbs2-0011" title="VesikariT , FlemingDM , AristeguiJF , VertruyenA , AshkenaziS , RappaportR , et al. Safety, efficacy and effectiveness of cold‐adapted influenza vaccine‐trivalent against community‐acquired, culture‐confirmed influenza in young children attending day care. Pediatrics2006;118(6):2298‐312. [PUBMED: 17142512] ">Vesikari 2006</a>), which we felt allowed for better consistency across the included trials. However, we have also included a subgroup analysis of the first primary outcome by number of courses. </p> <p>Ten trials reported our secondary outcomes (<a href="./references#CD010089-bbs2-0001" title="BelsheRB , GruberWC . Prevention of otitis media in children with live attenuated influenza vaccine given intranasally. Pediatric Infectious Disease Journal2000;19(Suppl 5):66‐71. ">Belshe 2000</a>; <a href="./references#CD010089-bbs2-0002" title="Bracco NetoH , FarhatCK , TregnaghiMW , MadhiSA , RazmpourA , PalladinoG , et al. Efficacy and safety of 1 and 2 doses of live attenuated influenza vaccine in vaccine‐naive children. Pediatric Infectious Disease Journal2009;28(5):365‐71. [PUBMED: 19395948] ">Bracco 2009</a>; <a href="./references#CD010089-bbs2-0004" title="GruberWC , BelsheRB , KingJC , TreanorJJ , PiedraPA , WrightPF , et al. Evaluation of live attenuated influenza vaccines in children 6‐18 months of age: safety, immunogenicity and efficacy. Journal of Infectious Diseases1996;173(6):1313‐9. [PUBMED: 8648202] ">Gruber 1996</a>; <a href="./references#CD010089-bbs2-0005" title="HobermanA , GreenbergDP , ParadiseJL , RocketteHE , LaveJR , KearneyDH , et al. Effectiveness of inactivated influenza vaccine in preventing acute otitis media in young children: a randomised controlled trial. JAMA2003;290(12):1608‐16. [PUBMED: 14506120] ">Hoberman 2003</a>; <a href="./references#CD010089-bbs2-0006" title="KosalaraksaP , JeanfreauR , FrenetteL , DrameM , MadariagaM , InnisBL , et al. AS03B‐adjuvanted H5N1 influenza vaccine in children 6 months through 17 years of age: a phase 2/3 randomized, placebo‐controlled, observer‐blinded trial. Journal of Infectious Diseases2015;211(5):801‐10. [PUBMED: 25293368] ">Kosalaraksa 2015</a>; <a href="./references#CD010089-bbs2-0007" title="LumLC , Borja‐TaboraCF , BreimanRF , VesikariT , SablanBP , ChayOM , et al. Influenza vaccine concurrently administered with a combination measles, mumps, and rubella vaccine to young children. Vaccine2010;28(6):1566‐74. [PUBMED: 20003918] ">Lum 2010</a>; <a href="./references#CD010089-bbs2-0008" title="MarchisioP , CavagnaR , MaspesB , GironiS , EspositoS , LambertiniL , et al. Efficacy of intranasal virosomal influenza vaccine in the prevention of recurrent acute otitis media in children. Clinical Infectious Diseases2002;35(2):168‐74. [PUBMED: 12087523] ">Marchisio 2002</a>; <a href="./references#CD010089-bbs2-0009" title="SwierkoszEM , NewmanFK , AndersonEL , NugentSL , MillsGB , BelsheRB . Multidose, live attenuated, cold‐recombinant, trivalent influenza vaccine in infants and young children. Journal of Infectious Diseases1994;169(5):1121‐4. [PUBMED: 8169405] ">Swierkosz 1994</a>; <a href="./references#CD010089-bbs2-0010" title="TamJS , CapedingMR , LumLC , ChotpitayasunondhT , JiangZ , HuangLM , et al. Efficacy and safety of a live attenuated, cold‐adapted influenza vaccine, trivalent against culture‐confirmed influenza in young children in Asia. Pediatric Infectious Disease Journal2007;26(7):619‐28. [PUBMED: 17596805] ">Tam 2007</a>; <a href="./references#CD010089-bbs2-0011" title="VesikariT , FlemingDM , AristeguiJF , VertruyenA , AshkenaziS , RappaportR , et al. Safety, efficacy and effectiveness of cold‐adapted influenza vaccine‐trivalent against community‐acquired, culture‐confirmed influenza in young children attending day care. Pediatrics2006;118(6):2298‐312. [PUBMED: 17142512] ">Vesikari 2006</a>). One trial randomised children in a 3:2 ratio to receive two doses of vaccine or placebo in year one, and re‐randomised children in year two in a 1:1 ratio to receive a single dose of vaccine or placebo without consideration of their group assignment in the first year (<a href="./references#CD010089-bbs2-0010" title="TamJS , CapedingMR , LumLC , ChotpitayasunondhT , JiangZ , HuangLM , et al. Efficacy and safety of a live attenuated, cold‐adapted influenza vaccine, trivalent against culture‐confirmed influenza in young children in Asia. Pediatric Infectious Disease Journal2007;26(7):619‐28. [PUBMED: 17596805] ">Tam 2007</a>). The findings were therefore obtained cumulatively from both years. </p> </section> </section> <section id="CD010089-sec-0081"> <h4 class="title">Excluded studies</h4> <p>We excluded 19 trials. Ten trials did not report any of our outcomes of interest (<a href="./references#CD010089-bbs2-0013" title="BelsheRB , MendelmanPM , TreanorJ , KingJ , GruberWC , PiedraP , et al. The efficacy of live attenuated, cold‐adapted, trivalent, intranasal influenza virus vaccine in children. New England Journal of Medicine1998;338(20):1405‐12. [PUBMED: 9580647] ">Belshe 1998</a>; <a href="./references#CD010089-bbs2-0014" title="BelsheRB , EdwardsKM , VesikariT , BlackSV , WalkerRE , HultquistM , et al. Live attenuated versus inactivated influenza vaccine in infants and young children. New England Journal of Medicine2007;356(7):685‐96. [PUBMED: 17301299] ">Belshe 2007</a>; <a href="./references#CD010089-bbs2-0018" title="EspositoS , MarchisioP , CavagnaR , GironiS , BosisS , LambertiniL , et al. Effectiveness of influenza vaccination of children with recurrent respiratory tract infections in reducing respiratory‐related morbidity within the households. Vaccine2003;21(23):3162‐8. ">Esposito 2003</a>; <a href="./references#CD010089-bbs2-0019" title="ForrestBD , PrideMW , DunningAJ , CapedingMR , ChotpitayasunondhT , TamJS , et al. Correlation of cellular immune responses with protection against culture‐confirmed influenza virus in young children. Clinical and Vaccine Immunology2008;15(7):1042‐53. [PUBMED: 18448618] ">Forrest 2008</a>; <a href="./references#CD010089-bbs2-0020" title="GruberWC , DardenPM , StillJG , LohrJ , ReedG , WrightPF . Evaluation of bivalent live attenuated influenza A vaccines in children 2 months to 3 years of age: safety, immunogenicity and dose‐response. Vaccine1997;15(12‐13):1379‐84. [PUBMED: 9302748] ">Gruber 1997</a>; <a href="./references#CD010089-bbs2-0026" title="LonginiIM , HalloranME , NizamA , WolffM , MendelmanPM , FastPE , et al. Estimation of the efficacy of live, attenuated influenza vaccine from a two‐year, multi‐center vaccine trial: implications for influenza epidemic control. Vaccine2000;18(18):1902‐9. [PUBMED: 10699339] ">Longini 2000</a>; <a href="./references#CD010089-bbs2-0027" title="MaedaT , ShintaniY , NakanoK , TerashimaK , YamadaY . Failure of inactivated influenza A vaccine to protect healthy children aged 6‐24 months. Pediatrics International2004;46(2):122‐5. [PUBMED: 15056235] ">Maeda 2004</a>; <a href="./references#CD010089-bbs2-0028" title="PrincipiN , EspositoS , MarchisioP , GaspariniR , CrovariP . Socioeconomic impact of influenza on healthy children and their families. Pediatric Infectious Disease Journal2003;22(Suppl 10):207‐10. [PUBMED: 14551476] ">Principi 2003</a>; <a href="./references#CD010089-bbs2-0029" title="ThorsV , ChristensenH , Morales‐AzaB , VipondI , MuirP , FinnA . The effects of live attenuated influenza vaccine on nasopharyngeal bacteria in healthy 2 to 4 year olds: a randomized controlled trial. American Journal of Respiratory and Critical Care Medicine2016;193(12):1401‐9. [PUBMED: 26742001] ">Thors 2016</a>; <a href="./references#CD010089-bbs2-0030" title="VesikariT , KnufM , WutzlerP , KarvonenA , Kieninger‐BaumD , SchmittHJ , et al. Oil‐in‐water emulsion adjuvant with influenza vaccine in young children. New England Journal of Medicine2011;365(15):1406‐16. [PUBMED: 21995388] ">Vesikari 2011</a>). Three trials compared different types of influenza vaccine (<a href="./references#CD010089-bbs2-0016" title="BradyRC , HuW , HouchinVG , EderFS , JacksonKC , HartelGF , et al. Randomized trial to compare the safety and immunogenicity of CSL Limited's 2009 trivalent inactivated influenza vaccine to an established vaccine in United States children. Vaccine2014;32(52):7141‐7. [PUBMED: 25454878] ">Brady 2014</a>; <a href="./references#CD010089-bbs2-0024" title="LangleyJM , WangL , AggarwalN , BuesoA , ChandrasekaranV , CousinL , et al. Immunogenicity and reactogenicity of an inactivated quadrivalent influenza vaccine administered intramuscularly to children 6 to 35 months of age in 2012‐2013: a randomized, double‐blind, controlled, multicenter, multicountry, clinical trial. Journal of the Pediatric Infectious Diseases Society2015;4(3):242‐51. [PUBMED: 26336604] ">Langley 2015</a>; <a href="./references#CD010089-bbs2-0025" title="LoebM , RussellML , ManningV , FonsecaK , EarnDJ , HorsmanG , et al. Live attenuated versus inactivated influenza vaccine in Hutterite children: a cluster randomized blinded trial. Annals of Internal Medicine2016;165(9):617‐24. [PUBMED: 27538259] ">Loeb 2016</a>), and five trials had no control group (<a href="./references#CD010089-bbs2-0012" title="AshkenaziS , VertruyenA , AristeguiJ , EspositoS , McKeithDD , KlemolaT , et al. Superior relative efficacy of live attenuated influenza vaccine compared with inactivated influenza vaccine in young children with recurrent respiratory tract infections. Pediatric Infectious Disease Journal2006;25(10):870‐9. [PUBMED: 17006279] ">Ashkenazi 2006</a>; <a href="./references#CD010089-bbs2-0016" title="BradyRC , HuW , HouchinVG , EderFS , JacksonKC , HartelGF , et al. Randomized trial to compare the safety and immunogenicity of CSL Limited's 2009 trivalent inactivated influenza vaccine to an established vaccine in United States children. Vaccine2014;32(52):7141‐7. [PUBMED: 25454878] ">Brady 2014</a>; <a href="./references#CD010089-bbs2-0023" title="HoudouinV , LavisN , MeyzerC , JeziorskiE , MerlinE , PinquierD , et al. Safety of the Northern Hemisphere 2014/2015 formulation of the inactivated split‐virion intramuscular trivalent influenza vaccine. Vaccine Reports2016; Vol. 6:1‐7. [DOI: 10.1016/j.vacrep.2016.07.001] ">Houdouin 2016</a>; <a href="./references#CD010089-bbs2-0024" title="LangleyJM , WangL , AggarwalN , BuesoA , ChandrasekaranV , CousinL , et al. Immunogenicity and reactogenicity of an inactivated quadrivalent influenza vaccine administered intramuscularly to children 6 to 35 months of age in 2012‐2013: a randomized, double‐blind, controlled, multicenter, multicountry, clinical trial. Journal of the Pediatric Infectious Diseases Society2015;4(3):242‐51. [PUBMED: 26336604] ">Langley 2015</a>; <a href="./references#CD010089-bbs2-0025" title="LoebM , RussellML , ManningV , FonsecaK , EarnDJ , HorsmanG , et al. Live attenuated versus inactivated influenza vaccine in Hutterite children: a cluster randomized blinded trial. Annals of Internal Medicine2016;165(9):617‐24. [PUBMED: 27538259] ">Loeb 2016</a>). Two trials applied quasi‐randomisation (<a href="./references#CD010089-bbs2-0017" title="CuhaciCB , BeyazovaU , KemalogluYK , OzkanS , GunduzB , OzdekA . Effectiveness of pandemic influenza A/H1N1 vaccine for prevention of otitis media in children. European Journal of Pediatrics2012;171:1667‐71. ">Cuhaci 2012</a>; <a href="./references#CD010089-bbs2-0022" title="HeikkinenT , RuuskanenO , WarisM , ZieglerT , ArolaM , HalonenP . Influenza vaccination in the prevention of acute otitis media in children. American Journal of Diseases of Children1991;145(4):445‐8. [PUBMED: 1849344] ">Heikkinen 1991</a>), and one trial compared a single dose with two doses of influenza vaccine (<a href="./references#CD010089-bbs2-0021" title="HanSB , RhimJW , ShinHJ , LeeSY , KimHH , KimJH , et al. Immunogenicity and safety assessment of a trivalent, inactivated split influenza vaccine in Korean children: double‐blind, randomized, active‐controlled multicenter phase III clinical trial. Human Vaccines &amp; Immunotherapeutics2015;11(5):1094‐102. [PUBMED: 25875868] ">Han 2015</a>). We excluded one trial because the data for the number or proportion of children aged less than six years were not available (<a href="./references#CD010089-bbs2-0015" title="BergenR , BlackS , ShinefieldH , LewisE , RayP , HansenJ , et al. Safety of cold‐adapted live attenuated influenza vaccine in a large cohort of children and adolescents. Pediatric Infectious Disease Journal2004;23(2):138‐44. [PUBMED: 14872180] ">Bergen 2004</a>). The details of these trials are provided in the <a href="./references#CD010089-sec-0134" title="">Characteristics of excluded studies</a> table. </p> </section> </section> <section id="CD010089-sec-0082"> <h3 class="title">Risk of bias in included studies</h3> <p>The assessment of risk of bias is shown in <a href="#CD010089-fig-0002">Figure 2</a> and <a href="#CD010089-fig-0003">Figure 3</a>. <a href="#CD010089-fig-0002">Figure 2</a> shows the proportion of studies assessed as low, high, or unclear risk of bias for each 'Risk of bias' indicator. <a href="#CD010089-fig-0003">Figure 3</a> shows the 'Risk of bias' indicators for individual studies. See the <a href="./references#CD010089-sec-0133" title="">Characteristics of included studies</a> table. </p> <div class="figure" id="CD010089-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="'Risk of bias' graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD010089-fig-0002" src="/cdsr/doi/10.1002/14651858.CD010089.pub3/media/CDSR/CD010089/image_n/nCD010089-AFig-FIG02.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>'Risk of bias' graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> </div> <div class="figure" id="CD010089-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="'Risk of bias' summary: review authors' judgements about each risk of bias item for each included study." data-id="CD010089-fig-0003" src="/cdsr/doi/10.1002/14651858.CD010089.pub3/media/CDSR/CD010089/image_n/nCD010089-AFig-FIG03.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>'Risk of bias' summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> </div> <section id="CD010089-sec-0083"> <h4 class="title">Allocation</h4> <p>Seven trials (including one trial of 2821 children not in the meta‐analysis, <a href="./references#CD010089-bbs2-0002" title="Bracco NetoH , FarhatCK , TregnaghiMW , MadhiSA , RazmpourA , PalladinoG , et al. Efficacy and safety of 1 and 2 doses of live attenuated influenza vaccine in vaccine‐naive children. Pediatric Infectious Disease Journal2009;28(5):365‐71. [PUBMED: 19395948] ">Bracco 2009</a>) described the method of randomisation used. Two trials randomised the children according to a preprinted allocation list (<a href="./references#CD010089-bbs2-0002" title="Bracco NetoH , FarhatCK , TregnaghiMW , MadhiSA , RazmpourA , PalladinoG , et al. Efficacy and safety of 1 and 2 doses of live attenuated influenza vaccine in vaccine‐naive children. Pediatric Infectious Disease Journal2009;28(5):365‐71. [PUBMED: 19395948] ">Bracco 2009</a>; <a href="./references#CD010089-bbs2-0011" title="VesikariT , FlemingDM , AristeguiJF , VertruyenA , AshkenaziS , RappaportR , et al. Safety, efficacy and effectiveness of cold‐adapted influenza vaccine‐trivalent against community‐acquired, culture‐confirmed influenza in young children attending day care. Pediatrics2006;118(6):2298‐312. [PUBMED: 17142512] ">Vesikari 2006</a>); three trials used computer‐generated randomisation (<a href="./references#CD010089-bbs2-0005" title="HobermanA , GreenbergDP , ParadiseJL , RocketteHE , LaveJR , KearneyDH , et al. Effectiveness of inactivated influenza vaccine in preventing acute otitis media in young children: a randomised controlled trial. JAMA2003;290(12):1608‐16. [PUBMED: 14506120] ">Hoberman 2003</a>; <a href="./references#CD010089-bbs2-0007" title="LumLC , Borja‐TaboraCF , BreimanRF , VesikariT , SablanBP , ChayOM , et al. Influenza vaccine concurrently administered with a combination measles, mumps, and rubella vaccine to young children. Vaccine2010;28(6):1566‐74. [PUBMED: 20003918] ">Lum 2010</a>; <a href="./references#CD010089-bbs2-0010" title="TamJS , CapedingMR , LumLC , ChotpitayasunondhT , JiangZ , HuangLM , et al. Efficacy and safety of a live attenuated, cold‐adapted influenza vaccine, trivalent against culture‐confirmed influenza in young children in Asia. Pediatric Infectious Disease Journal2007;26(7):619‐28. [PUBMED: 17596805] ">Tam 2007</a>); and one trial used an internet‐based system (<a href="./references#CD010089-bbs2-0006" title="KosalaraksaP , JeanfreauR , FrenetteL , DrameM , MadariagaM , InnisBL , et al. AS03B‐adjuvanted H5N1 influenza vaccine in children 6 months through 17 years of age: a phase 2/3 randomized, placebo‐controlled, observer‐blinded trial. Journal of Infectious Diseases2015;211(5):801‐10. [PUBMED: 25293368] ">Kosalaraksa 2015</a>). <a href="./references#CD010089-bbs2-0009" title="SwierkoszEM , NewmanFK , AndersonEL , NugentSL , MillsGB , BelsheRB . Multidose, live attenuated, cold‐recombinant, trivalent influenza vaccine in infants and young children. Journal of Infectious Diseases1994;169(5):1121‐4. [PUBMED: 8169405] ">Swierkosz 1994</a> applied a simple randomisation with a ratio of one placebo to every two or three children who received the intervention. The remaining four trials did not report the method of randomisation, thus we assessed random sequence generation as unclear risk of bias (<a href="./references#CD010089-bbs2-0001" title="BelsheRB , GruberWC . Prevention of otitis media in children with live attenuated influenza vaccine given intranasally. Pediatric Infectious Disease Journal2000;19(Suppl 5):66‐71. ">Belshe 2000</a>; <a href="./references#CD010089-bbs2-0003" title="ClementsDA , LangdonL , BlandC , WalterE . Influenza A vaccine decreases the incidence of otitis media in 6‐ to 30‐month‐old children in day care. Archives of Pediatrics &amp; Adolescent Medicine1995;149(10):1113‐7. [PUBMED: 7550814] ">Clements 1995</a>; <a href="./references#CD010089-bbs2-0004" title="GruberWC , BelsheRB , KingJC , TreanorJJ , PiedraPA , WrightPF , et al. Evaluation of live attenuated influenza vaccines in children 6‐18 months of age: safety, immunogenicity and efficacy. Journal of Infectious Diseases1996;173(6):1313‐9. [PUBMED: 8648202] ">Gruber 1996</a>; <a href="./references#CD010089-bbs2-0008" title="MarchisioP , CavagnaR , MaspesB , GironiS , EspositoS , LambertiniL , et al. Efficacy of intranasal virosomal influenza vaccine in the prevention of recurrent acute otitis media in children. Clinical Infectious Diseases2002;35(2):168‐74. [PUBMED: 12087523] ">Marchisio 2002</a>). We assessed allocation concealment as unclear in seven trials (<a href="./references#CD010089-bbs2-0001" title="BelsheRB , GruberWC . Prevention of otitis media in children with live attenuated influenza vaccine given intranasally. Pediatric Infectious Disease Journal2000;19(Suppl 5):66‐71. ">Belshe 2000</a>; <a href="./references#CD010089-bbs2-0003" title="ClementsDA , LangdonL , BlandC , WalterE . Influenza A vaccine decreases the incidence of otitis media in 6‐ to 30‐month‐old children in day care. Archives of Pediatrics &amp; Adolescent Medicine1995;149(10):1113‐7. [PUBMED: 7550814] ">Clements 1995</a>; <a href="./references#CD010089-bbs2-0004" title="GruberWC , BelsheRB , KingJC , TreanorJJ , PiedraPA , WrightPF , et al. Evaluation of live attenuated influenza vaccines in children 6‐18 months of age: safety, immunogenicity and efficacy. Journal of Infectious Diseases1996;173(6):1313‐9. [PUBMED: 8648202] ">Gruber 1996</a>; <a href="./references#CD010089-bbs2-0005" title="HobermanA , GreenbergDP , ParadiseJL , RocketteHE , LaveJR , KearneyDH , et al. Effectiveness of inactivated influenza vaccine in preventing acute otitis media in young children: a randomised controlled trial. JAMA2003;290(12):1608‐16. [PUBMED: 14506120] ">Hoberman 2003</a>; <a href="./references#CD010089-bbs2-0006" title="KosalaraksaP , JeanfreauR , FrenetteL , DrameM , MadariagaM , InnisBL , et al. AS03B‐adjuvanted H5N1 influenza vaccine in children 6 months through 17 years of age: a phase 2/3 randomized, placebo‐controlled, observer‐blinded trial. Journal of Infectious Diseases2015;211(5):801‐10. [PUBMED: 25293368] ">Kosalaraksa 2015</a>; <a href="./references#CD010089-bbs2-0008" title="MarchisioP , CavagnaR , MaspesB , GironiS , EspositoS , LambertiniL , et al. Efficacy of intranasal virosomal influenza vaccine in the prevention of recurrent acute otitis media in children. Clinical Infectious Diseases2002;35(2):168‐74. [PUBMED: 12087523] ">Marchisio 2002</a>; <a href="./references#CD010089-bbs2-0009" title="SwierkoszEM , NewmanFK , AndersonEL , NugentSL , MillsGB , BelsheRB . Multidose, live attenuated, cold‐recombinant, trivalent influenza vaccine in infants and young children. Journal of Infectious Diseases1994;169(5):1121‐4. [PUBMED: 8169405] ">Swierkosz 1994</a>). </p> </section> <section id="CD010089-sec-0084"> <h4 class="title">Blinding</h4> <p>Nine trials used a placebo control (<a href="./references#CD010089-bbs2-0001" title="BelsheRB , GruberWC . Prevention of otitis media in children with live attenuated influenza vaccine given intranasally. Pediatric Infectious Disease Journal2000;19(Suppl 5):66‐71. ">Belshe 2000</a>; <a href="./references#CD010089-bbs2-0002" title="Bracco NetoH , FarhatCK , TregnaghiMW , MadhiSA , RazmpourA , PalladinoG , et al. Efficacy and safety of 1 and 2 doses of live attenuated influenza vaccine in vaccine‐naive children. Pediatric Infectious Disease Journal2009;28(5):365‐71. [PUBMED: 19395948] ">Bracco 2009</a>; <a href="./references#CD010089-bbs2-0004" title="GruberWC , BelsheRB , KingJC , TreanorJJ , PiedraPA , WrightPF , et al. Evaluation of live attenuated influenza vaccines in children 6‐18 months of age: safety, immunogenicity and efficacy. Journal of Infectious Diseases1996;173(6):1313‐9. [PUBMED: 8648202] ">Gruber 1996</a>; <a href="./references#CD010089-bbs2-0005" title="HobermanA , GreenbergDP , ParadiseJL , RocketteHE , LaveJR , KearneyDH , et al. Effectiveness of inactivated influenza vaccine in preventing acute otitis media in young children: a randomised controlled trial. JAMA2003;290(12):1608‐16. [PUBMED: 14506120] ">Hoberman 2003</a>; <a href="./references#CD010089-bbs2-0006" title="KosalaraksaP , JeanfreauR , FrenetteL , DrameM , MadariagaM , InnisBL , et al. AS03B‐adjuvanted H5N1 influenza vaccine in children 6 months through 17 years of age: a phase 2/3 randomized, placebo‐controlled, observer‐blinded trial. Journal of Infectious Diseases2015;211(5):801‐10. [PUBMED: 25293368] ">Kosalaraksa 2015</a>; <a href="./references#CD010089-bbs2-0007" title="LumLC , Borja‐TaboraCF , BreimanRF , VesikariT , SablanBP , ChayOM , et al. Influenza vaccine concurrently administered with a combination measles, mumps, and rubella vaccine to young children. Vaccine2010;28(6):1566‐74. [PUBMED: 20003918] ">Lum 2010</a>; <a href="./references#CD010089-bbs2-0009" title="SwierkoszEM , NewmanFK , AndersonEL , NugentSL , MillsGB , BelsheRB . Multidose, live attenuated, cold‐recombinant, trivalent influenza vaccine in infants and young children. Journal of Infectious Diseases1994;169(5):1121‐4. [PUBMED: 8169405] ">Swierkosz 1994</a>; <a href="./references#CD010089-bbs2-0010" title="TamJS , CapedingMR , LumLC , ChotpitayasunondhT , JiangZ , HuangLM , et al. Efficacy and safety of a live attenuated, cold‐adapted influenza vaccine, trivalent against culture‐confirmed influenza in young children in Asia. Pediatric Infectious Disease Journal2007;26(7):619‐28. [PUBMED: 17596805] ">Tam 2007</a>; <a href="./references#CD010089-bbs2-0011" title="VesikariT , FlemingDM , AristeguiJF , VertruyenA , AshkenaziS , RappaportR , et al. Safety, efficacy and effectiveness of cold‐adapted influenza vaccine‐trivalent against community‐acquired, culture‐confirmed influenza in young children attending day care. Pediatrics2006;118(6):2298‐312. [PUBMED: 17142512] ">Vesikari 2006</a>), and one trial gave no treatment to the control group (<a href="./references#CD010089-bbs2-0008" title="MarchisioP , CavagnaR , MaspesB , GironiS , EspositoS , LambertiniL , et al. Efficacy of intranasal virosomal influenza vaccine in the prevention of recurrent acute otitis media in children. Clinical Infectious Diseases2002;35(2):168‐74. [PUBMED: 12087523] ">Marchisio 2002</a>). In the latter trial, the parents were asked not to inform the outcome assessors of the group assignment, and only the investigators were blinded to group assignment (<a href="./references#CD010089-bbs2-0008" title="MarchisioP , CavagnaR , MaspesB , GironiS , EspositoS , LambertiniL , et al. Efficacy of intranasal virosomal influenza vaccine in the prevention of recurrent acute otitis media in children. Clinical Infectious Diseases2002;35(2):168‐74. [PUBMED: 12087523] ">Marchisio 2002</a>). The control group in one trial received hepatitis B immunisation, and blinding was not described in this trial (<a href="./references#CD010089-bbs2-0003" title="ClementsDA , LangdonL , BlandC , WalterE . Influenza A vaccine decreases the incidence of otitis media in 6‐ to 30‐month‐old children in day care. Archives of Pediatrics &amp; Adolescent Medicine1995;149(10):1113‐7. [PUBMED: 7550814] ">Clements 1995</a>). </p> </section> <section id="CD010089-sec-0085"> <h4 class="title">Incomplete outcome data</h4> <p>Five trials measured the primary outcomes and were included in the meta‐analysis. Of these, three trials administered two courses of vaccine, that is at year one (one or two doses) and year two (single dose) (<a href="./references#CD010089-bbs2-0001" title="BelsheRB , GruberWC . Prevention of otitis media in children with live attenuated influenza vaccine given intranasally. Pediatric Infectious Disease Journal2000;19(Suppl 5):66‐71. ">Belshe 2000</a>; <a href="./references#CD010089-bbs2-0005" title="HobermanA , GreenbergDP , ParadiseJL , RocketteHE , LaveJR , KearneyDH , et al. Effectiveness of inactivated influenza vaccine in preventing acute otitis media in young children: a randomised controlled trial. JAMA2003;290(12):1608‐16. [PUBMED: 14506120] ">Hoberman 2003</a>; <a href="./references#CD010089-bbs2-0011" title="VesikariT , FlemingDM , AristeguiJF , VertruyenA , AshkenaziS , RappaportR , et al. Safety, efficacy and effectiveness of cold‐adapted influenza vaccine‐trivalent against community‐acquired, culture‐confirmed influenza in young children attending day care. Pediatrics2006;118(6):2298‐312. [PUBMED: 17142512] ">Vesikari 2006</a>), and two trials administered one course of vaccine (one or two doses) (<a href="./references#CD010089-bbs2-0003" title="ClementsDA , LangdonL , BlandC , WalterE . Influenza A vaccine decreases the incidence of otitis media in 6‐ to 30‐month‐old children in day care. Archives of Pediatrics &amp; Adolescent Medicine1995;149(10):1113‐7. [PUBMED: 7550814] ">Clements 1995</a>; <a href="./references#CD010089-bbs2-0007" title="LumLC , Borja‐TaboraCF , BreimanRF , VesikariT , SablanBP , ChayOM , et al. Influenza vaccine concurrently administered with a combination measles, mumps, and rubella vaccine to young children. Vaccine2010;28(6):1566‐74. [PUBMED: 20003918] ">Lum 2010</a>). Five trials measured the primary outcome at six to eight months (<a href="./references#CD010089-bbs2-0001" title="BelsheRB , GruberWC . Prevention of otitis media in children with live attenuated influenza vaccine given intranasally. Pediatric Infectious Disease Journal2000;19(Suppl 5):66‐71. ">Belshe 2000</a>; <a href="./references#CD010089-bbs2-0003" title="ClementsDA , LangdonL , BlandC , WalterE . Influenza A vaccine decreases the incidence of otitis media in 6‐ to 30‐month‐old children in day care. Archives of Pediatrics &amp; Adolescent Medicine1995;149(10):1113‐7. [PUBMED: 7550814] ">Clements 1995</a>; <a href="./references#CD010089-bbs2-0005" title="HobermanA , GreenbergDP , ParadiseJL , RocketteHE , LaveJR , KearneyDH , et al. Effectiveness of inactivated influenza vaccine in preventing acute otitis media in young children: a randomised controlled trial. JAMA2003;290(12):1608‐16. [PUBMED: 14506120] ">Hoberman 2003</a>; <a href="./references#CD010089-bbs2-0007" title="LumLC , Borja‐TaboraCF , BreimanRF , VesikariT , SablanBP , ChayOM , et al. Influenza vaccine concurrently administered with a combination measles, mumps, and rubella vaccine to young children. Vaccine2010;28(6):1566‐74. [PUBMED: 20003918] ">Lum 2010</a>; <a href="./references#CD010089-bbs2-0011" title="VesikariT , FlemingDM , AristeguiJF , VertruyenA , AshkenaziS , RappaportR , et al. Safety, efficacy and effectiveness of cold‐adapted influenza vaccine‐trivalent against community‐acquired, culture‐confirmed influenza in young children attending day care. Pediatrics2006;118(6):2298‐312. [PUBMED: 17142512] ">Vesikari 2006</a>), and one trial measured outcomes at one year (<a href="./references#CD010089-bbs2-0005" title="HobermanA , GreenbergDP , ParadiseJL , RocketteHE , LaveJR , KearneyDH , et al. Effectiveness of inactivated influenza vaccine in preventing acute otitis media in young children: a randomised controlled trial. JAMA2003;290(12):1608‐16. [PUBMED: 14506120] ">Hoberman 2003</a>). All five trials had less than 20% loss to follow‐up. </p> <p>We did not include <a href="./references#CD010089-bbs2-0002" title="Bracco NetoH , FarhatCK , TregnaghiMW , MadhiSA , RazmpourA , PalladinoG , et al. Efficacy and safety of 1 and 2 doses of live attenuated influenza vaccine in vaccine‐naive children. Pediatric Infectious Disease Journal2009;28(5):365‐71. [PUBMED: 19395948] ">Bracco 2009</a> in the meta‐analysis for the first primary outcome as the follow‐up period was too short. Due to the treatment allocation coding and a labelling error in the second season, 683 of 2054 children were excluded because they received a treatment other than that to which they were randomised. Thus, the year two per‐protocol response rate was 42.6%. However, data on adverse effects for the second season were supplied by the trial authors and could be included in the meta‐analysis of adverse effects. Ten trials measured secondary outcomes, and in all of these the non‐response rate was less than 10% (<a href="./references#CD010089-bbs2-0001" title="BelsheRB , GruberWC . Prevention of otitis media in children with live attenuated influenza vaccine given intranasally. Pediatric Infectious Disease Journal2000;19(Suppl 5):66‐71. ">Belshe 2000</a>; <a href="./references#CD010089-bbs2-0002" title="Bracco NetoH , FarhatCK , TregnaghiMW , MadhiSA , RazmpourA , PalladinoG , et al. Efficacy and safety of 1 and 2 doses of live attenuated influenza vaccine in vaccine‐naive children. Pediatric Infectious Disease Journal2009;28(5):365‐71. [PUBMED: 19395948] ">Bracco 2009</a>; <a href="./references#CD010089-bbs2-0004" title="GruberWC , BelsheRB , KingJC , TreanorJJ , PiedraPA , WrightPF , et al. Evaluation of live attenuated influenza vaccines in children 6‐18 months of age: safety, immunogenicity and efficacy. Journal of Infectious Diseases1996;173(6):1313‐9. [PUBMED: 8648202] ">Gruber 1996</a>; <a href="./references#CD010089-bbs2-0005" title="HobermanA , GreenbergDP , ParadiseJL , RocketteHE , LaveJR , KearneyDH , et al. Effectiveness of inactivated influenza vaccine in preventing acute otitis media in young children: a randomised controlled trial. JAMA2003;290(12):1608‐16. [PUBMED: 14506120] ">Hoberman 2003</a>; <a href="./references#CD010089-bbs2-0006" title="KosalaraksaP , JeanfreauR , FrenetteL , DrameM , MadariagaM , InnisBL , et al. AS03B‐adjuvanted H5N1 influenza vaccine in children 6 months through 17 years of age: a phase 2/3 randomized, placebo‐controlled, observer‐blinded trial. Journal of Infectious Diseases2015;211(5):801‐10. [PUBMED: 25293368] ">Kosalaraksa 2015</a>; <a href="./references#CD010089-bbs2-0007" title="LumLC , Borja‐TaboraCF , BreimanRF , VesikariT , SablanBP , ChayOM , et al. Influenza vaccine concurrently administered with a combination measles, mumps, and rubella vaccine to young children. Vaccine2010;28(6):1566‐74. [PUBMED: 20003918] ">Lum 2010</a>; <a href="./references#CD010089-bbs2-0008" title="MarchisioP , CavagnaR , MaspesB , GironiS , EspositoS , LambertiniL , et al. Efficacy of intranasal virosomal influenza vaccine in the prevention of recurrent acute otitis media in children. Clinical Infectious Diseases2002;35(2):168‐74. [PUBMED: 12087523] ">Marchisio 2002</a>; <a href="./references#CD010089-bbs2-0009" title="SwierkoszEM , NewmanFK , AndersonEL , NugentSL , MillsGB , BelsheRB . Multidose, live attenuated, cold‐recombinant, trivalent influenza vaccine in infants and young children. Journal of Infectious Diseases1994;169(5):1121‐4. [PUBMED: 8169405] ">Swierkosz 1994</a>; <a href="./references#CD010089-bbs2-0010" title="TamJS , CapedingMR , LumLC , ChotpitayasunondhT , JiangZ , HuangLM , et al. Efficacy and safety of a live attenuated, cold‐adapted influenza vaccine, trivalent against culture‐confirmed influenza in young children in Asia. Pediatric Infectious Disease Journal2007;26(7):619‐28. [PUBMED: 17596805] ">Tam 2007</a>; <a href="./references#CD010089-bbs2-0011" title="VesikariT , FlemingDM , AristeguiJF , VertruyenA , AshkenaziS , RappaportR , et al. Safety, efficacy and effectiveness of cold‐adapted influenza vaccine‐trivalent against community‐acquired, culture‐confirmed influenza in young children attending day care. Pediatrics2006;118(6):2298‐312. [PUBMED: 17142512] ">Vesikari 2006</a>). </p> <p>Eight trials performed an intention‐to‐treat analysis in which the children were analysed according to the groups to which they were initially assigned (<a href="./references#CD010089-bbs2-0001" title="BelsheRB , GruberWC . Prevention of otitis media in children with live attenuated influenza vaccine given intranasally. Pediatric Infectious Disease Journal2000;19(Suppl 5):66‐71. ">Belshe 2000</a>; <a href="./references#CD010089-bbs2-0002" title="Bracco NetoH , FarhatCK , TregnaghiMW , MadhiSA , RazmpourA , PalladinoG , et al. Efficacy and safety of 1 and 2 doses of live attenuated influenza vaccine in vaccine‐naive children. Pediatric Infectious Disease Journal2009;28(5):365‐71. [PUBMED: 19395948] ">Bracco 2009</a>; <a href="./references#CD010089-bbs2-0003" title="ClementsDA , LangdonL , BlandC , WalterE . Influenza A vaccine decreases the incidence of otitis media in 6‐ to 30‐month‐old children in day care. Archives of Pediatrics &amp; Adolescent Medicine1995;149(10):1113‐7. [PUBMED: 7550814] ">Clements 1995</a>; <a href="./references#CD010089-bbs2-0005" title="HobermanA , GreenbergDP , ParadiseJL , RocketteHE , LaveJR , KearneyDH , et al. Effectiveness of inactivated influenza vaccine in preventing acute otitis media in young children: a randomised controlled trial. JAMA2003;290(12):1608‐16. [PUBMED: 14506120] ">Hoberman 2003</a>; <a href="./references#CD010089-bbs2-0007" title="LumLC , Borja‐TaboraCF , BreimanRF , VesikariT , SablanBP , ChayOM , et al. Influenza vaccine concurrently administered with a combination measles, mumps, and rubella vaccine to young children. Vaccine2010;28(6):1566‐74. [PUBMED: 20003918] ">Lum 2010</a>; <a href="./references#CD010089-bbs2-0008" title="MarchisioP , CavagnaR , MaspesB , GironiS , EspositoS , LambertiniL , et al. Efficacy of intranasal virosomal influenza vaccine in the prevention of recurrent acute otitis media in children. Clinical Infectious Diseases2002;35(2):168‐74. [PUBMED: 12087523] ">Marchisio 2002</a>; <a href="./references#CD010089-bbs2-0010" title="TamJS , CapedingMR , LumLC , ChotpitayasunondhT , JiangZ , HuangLM , et al. Efficacy and safety of a live attenuated, cold‐adapted influenza vaccine, trivalent against culture‐confirmed influenza in young children in Asia. Pediatric Infectious Disease Journal2007;26(7):619‐28. [PUBMED: 17596805] ">Tam 2007</a>; <a href="./references#CD010089-bbs2-0011" title="VesikariT , FlemingDM , AristeguiJF , VertruyenA , AshkenaziS , RappaportR , et al. Safety, efficacy and effectiveness of cold‐adapted influenza vaccine‐trivalent against community‐acquired, culture‐confirmed influenza in young children attending day care. Pediatrics2006;118(6):2298‐312. [PUBMED: 17142512] ">Vesikari 2006</a>). In <a href="./references#CD010089-bbs2-0004" title="GruberWC , BelsheRB , KingJC , TreanorJJ , PiedraPA , WrightPF , et al. Evaluation of live attenuated influenza vaccines in children 6‐18 months of age: safety, immunogenicity and efficacy. Journal of Infectious Diseases1996;173(6):1313‐9. [PUBMED: 8648202] ">Gruber 1996</a>, 182 children were assigned into vaccine and control groups. However, the analysis of two vaccinated children was not included. In <a href="./references#CD010089-bbs2-0009" title="SwierkoszEM , NewmanFK , AndersonEL , NugentSL , MillsGB , BelsheRB . Multidose, live attenuated, cold‐recombinant, trivalent influenza vaccine in infants and young children. Journal of Infectious Diseases1994;169(5):1121‐4. [PUBMED: 8169405] ">Swierkosz 1994</a>, the analyses were based on 22, 18, and 14 children for day 0, day 60, and day 120, respectively. </p> </section> <section id="CD010089-sec-0086"> <h4 class="title">Selective reporting</h4> <p>All 11 trials reported the outcomes as specified in their methods section (<a href="./references#CD010089-bbs2-0001" title="BelsheRB , GruberWC . Prevention of otitis media in children with live attenuated influenza vaccine given intranasally. Pediatric Infectious Disease Journal2000;19(Suppl 5):66‐71. ">Belshe 2000</a>; <a href="./references#CD010089-bbs2-0002" title="Bracco NetoH , FarhatCK , TregnaghiMW , MadhiSA , RazmpourA , PalladinoG , et al. Efficacy and safety of 1 and 2 doses of live attenuated influenza vaccine in vaccine‐naive children. Pediatric Infectious Disease Journal2009;28(5):365‐71. [PUBMED: 19395948] ">Bracco 2009</a>; <a href="./references#CD010089-bbs2-0003" title="ClementsDA , LangdonL , BlandC , WalterE . Influenza A vaccine decreases the incidence of otitis media in 6‐ to 30‐month‐old children in day care. Archives of Pediatrics &amp; Adolescent Medicine1995;149(10):1113‐7. [PUBMED: 7550814] ">Clements 1995</a>; <a href="./references#CD010089-bbs2-0004" title="GruberWC , BelsheRB , KingJC , TreanorJJ , PiedraPA , WrightPF , et al. Evaluation of live attenuated influenza vaccines in children 6‐18 months of age: safety, immunogenicity and efficacy. Journal of Infectious Diseases1996;173(6):1313‐9. [PUBMED: 8648202] ">Gruber 1996</a>; <a href="./references#CD010089-bbs2-0005" title="HobermanA , GreenbergDP , ParadiseJL , RocketteHE , LaveJR , KearneyDH , et al. Effectiveness of inactivated influenza vaccine in preventing acute otitis media in young children: a randomised controlled trial. JAMA2003;290(12):1608‐16. [PUBMED: 14506120] ">Hoberman 2003</a>; <a href="./references#CD010089-bbs2-0006" title="KosalaraksaP , JeanfreauR , FrenetteL , DrameM , MadariagaM , InnisBL , et al. AS03B‐adjuvanted H5N1 influenza vaccine in children 6 months through 17 years of age: a phase 2/3 randomized, placebo‐controlled, observer‐blinded trial. Journal of Infectious Diseases2015;211(5):801‐10. [PUBMED: 25293368] ">Kosalaraksa 2015</a>; <a href="./references#CD010089-bbs2-0007" title="LumLC , Borja‐TaboraCF , BreimanRF , VesikariT , SablanBP , ChayOM , et al. Influenza vaccine concurrently administered with a combination measles, mumps, and rubella vaccine to young children. Vaccine2010;28(6):1566‐74. [PUBMED: 20003918] ">Lum 2010</a>; <a href="./references#CD010089-bbs2-0008" title="MarchisioP , CavagnaR , MaspesB , GironiS , EspositoS , LambertiniL , et al. Efficacy of intranasal virosomal influenza vaccine in the prevention of recurrent acute otitis media in children. Clinical Infectious Diseases2002;35(2):168‐74. [PUBMED: 12087523] ">Marchisio 2002</a>; <a href="./references#CD010089-bbs2-0009" title="SwierkoszEM , NewmanFK , AndersonEL , NugentSL , MillsGB , BelsheRB . Multidose, live attenuated, cold‐recombinant, trivalent influenza vaccine in infants and young children. Journal of Infectious Diseases1994;169(5):1121‐4. [PUBMED: 8169405] ">Swierkosz 1994</a>; <a href="./references#CD010089-bbs2-0010" title="TamJS , CapedingMR , LumLC , ChotpitayasunondhT , JiangZ , HuangLM , et al. Efficacy and safety of a live attenuated, cold‐adapted influenza vaccine, trivalent against culture‐confirmed influenza in young children in Asia. Pediatric Infectious Disease Journal2007;26(7):619‐28. [PUBMED: 17596805] ">Tam 2007</a>; <a href="./references#CD010089-bbs2-0011" title="VesikariT , FlemingDM , AristeguiJF , VertruyenA , AshkenaziS , RappaportR , et al. Safety, efficacy and effectiveness of cold‐adapted influenza vaccine‐trivalent against community‐acquired, culture‐confirmed influenza in young children attending day care. Pediatrics2006;118(6):2298‐312. [PUBMED: 17142512] ">Vesikari 2006</a>). </p> <p>Only two trials were prospectively registered in the WHO ICTRP and ClinicalTrials.gov (<a href="./references#CD010089-bbs2-0006" title="KosalaraksaP , JeanfreauR , FrenetteL , DrameM , MadariagaM , InnisBL , et al. AS03B‐adjuvanted H5N1 influenza vaccine in children 6 months through 17 years of age: a phase 2/3 randomized, placebo‐controlled, observer‐blinded trial. Journal of Infectious Diseases2015;211(5):801‐10. [PUBMED: 25293368] ">Kosalaraksa 2015</a>; <a href="./references#CD010089-bbs2-0007" title="LumLC , Borja‐TaboraCF , BreimanRF , VesikariT , SablanBP , ChayOM , et al. Influenza vaccine concurrently administered with a combination measles, mumps, and rubella vaccine to young children. Vaccine2010;28(6):1566‐74. [PUBMED: 20003918] ">Lum 2010</a>). The outcomes listed in the registered protocols were the same as those reported. We had no access to protocols for nine trials, but all the expected outcomes were reported (<a href="./references#CD010089-bbs2-0001" title="BelsheRB , GruberWC . Prevention of otitis media in children with live attenuated influenza vaccine given intranasally. Pediatric Infectious Disease Journal2000;19(Suppl 5):66‐71. ">Belshe 2000</a>; <a href="./references#CD010089-bbs2-0003" title="ClementsDA , LangdonL , BlandC , WalterE . Influenza A vaccine decreases the incidence of otitis media in 6‐ to 30‐month‐old children in day care. Archives of Pediatrics &amp; Adolescent Medicine1995;149(10):1113‐7. [PUBMED: 7550814] ">Clements 1995</a>; <a href="./references#CD010089-bbs2-0004" title="GruberWC , BelsheRB , KingJC , TreanorJJ , PiedraPA , WrightPF , et al. Evaluation of live attenuated influenza vaccines in children 6‐18 months of age: safety, immunogenicity and efficacy. Journal of Infectious Diseases1996;173(6):1313‐9. [PUBMED: 8648202] ">Gruber 1996</a>; <a href="./references#CD010089-bbs2-0005" title="HobermanA , GreenbergDP , ParadiseJL , RocketteHE , LaveJR , KearneyDH , et al. Effectiveness of inactivated influenza vaccine in preventing acute otitis media in young children: a randomised controlled trial. JAMA2003;290(12):1608‐16. [PUBMED: 14506120] ">Hoberman 2003</a>; <a href="./references#CD010089-bbs2-0007" title="LumLC , Borja‐TaboraCF , BreimanRF , VesikariT , SablanBP , ChayOM , et al. Influenza vaccine concurrently administered with a combination measles, mumps, and rubella vaccine to young children. Vaccine2010;28(6):1566‐74. [PUBMED: 20003918] ">Lum 2010</a>; <a href="./references#CD010089-bbs2-0008" title="MarchisioP , CavagnaR , MaspesB , GironiS , EspositoS , LambertiniL , et al. Efficacy of intranasal virosomal influenza vaccine in the prevention of recurrent acute otitis media in children. Clinical Infectious Diseases2002;35(2):168‐74. [PUBMED: 12087523] ">Marchisio 2002</a>; <a href="./references#CD010089-bbs2-0009" title="SwierkoszEM , NewmanFK , AndersonEL , NugentSL , MillsGB , BelsheRB . Multidose, live attenuated, cold‐recombinant, trivalent influenza vaccine in infants and young children. Journal of Infectious Diseases1994;169(5):1121‐4. [PUBMED: 8169405] ">Swierkosz 1994</a>; <a href="./references#CD010089-bbs2-0010" title="TamJS , CapedingMR , LumLC , ChotpitayasunondhT , JiangZ , HuangLM , et al. Efficacy and safety of a live attenuated, cold‐adapted influenza vaccine, trivalent against culture‐confirmed influenza in young children in Asia. Pediatric Infectious Disease Journal2007;26(7):619‐28. [PUBMED: 17596805] ">Tam 2007</a>; <a href="./references#CD010089-bbs2-0011" title="VesikariT , FlemingDM , AristeguiJF , VertruyenA , AshkenaziS , RappaportR , et al. Safety, efficacy and effectiveness of cold‐adapted influenza vaccine‐trivalent against community‐acquired, culture‐confirmed influenza in young children attending day care. Pediatrics2006;118(6):2298‐312. [PUBMED: 17142512] ">Vesikari 2006</a>). </p> </section> <section id="CD010089-sec-0087"> <h4 class="title">Other potential sources of bias</h4> <p>We detected no other potential sources of bias.</p> </section> </section> <section id="CD010089-sec-0088"> <h3 class="title" id="CD010089-sec-0088">Effects of interventions</h3> <p>See: <a href="./full#CD010089-tbl-0001"><b>Summary of findings for the main comparison</b> Influenza vaccine compared to control for preventing acute otitis media in infants and children</a> </p> <section id="CD010089-sec-0089"> <h4 class="title">Primary outcomes</h4> <section id="CD010089-sec-0090"> <h5 class="title">1. Number of children having at least one episode of acute otitis media during the follow‐up period </h5> <p>Our prespecified outcome was number of children having at least one episode of AOM. Four trials reported at least one episode of AOM during a follow‐up period of at least six months after one course of vaccine (<a href="./references#CD010089-bbs2-0003" title="ClementsDA , LangdonL , BlandC , WalterE . Influenza A vaccine decreases the incidence of otitis media in 6‐ to 30‐month‐old children in day care. Archives of Pediatrics &amp; Adolescent Medicine1995;149(10):1113‐7. [PUBMED: 7550814] ">Clements 1995</a>; <a href="./references#CD010089-bbs2-0005" title="HobermanA , GreenbergDP , ParadiseJL , RocketteHE , LaveJR , KearneyDH , et al. Effectiveness of inactivated influenza vaccine in preventing acute otitis media in young children: a randomised controlled trial. JAMA2003;290(12):1608‐16. [PUBMED: 14506120] ">Hoberman 2003</a>; <a href="./references#CD010089-bbs2-0007" title="LumLC , Borja‐TaboraCF , BreimanRF , VesikariT , SablanBP , ChayOM , et al. Influenza vaccine concurrently administered with a combination measles, mumps, and rubella vaccine to young children. Vaccine2010;28(6):1566‐74. [PUBMED: 20003918] ">Lum 2010</a>; <a href="./references#CD010089-bbs2-0011" title="VesikariT , FlemingDM , AristeguiJF , VertruyenA , AshkenaziS , RappaportR , et al. Safety, efficacy and effectiveness of cold‐adapted influenza vaccine‐trivalent against community‐acquired, culture‐confirmed influenza in young children attending day care. Pediatrics2006;118(6):2298‐312. [PUBMED: 17142512] ">Vesikari 2006</a>) (<a href="./references#CD010089-fig-0004" title="">Analysis 1.1</a>; risk ratio (RR) 0.84, 95% confidence interval (CI) 0.69 to 1.02; risk difference (RD) ‐0.04, 95% CI ‐0.08 to 0.00 random‐effects; I² = 56%, number needed to treat for an additional beneficial outcome (NNTB) 25, 95% CI 12.5 to 100; 4 trials; 3134 children; low‐quality evidence). </p> <section id="CD010089-sec-0091"> <h6 class="title">Acute otitis media by courses of vaccine</h6> <p>Four trials reported at least one episode of AOM during a follow‐up period of at least six months after the first course of vaccine, and these were included in our primary analysis as above (<a href="./references#CD010089-fig-0004" title="">Analysis 1.1</a>) (<a href="./references#CD010089-bbs2-0003" title="ClementsDA , LangdonL , BlandC , WalterE . Influenza A vaccine decreases the incidence of otitis media in 6‐ to 30‐month‐old children in day care. Archives of Pediatrics &amp; Adolescent Medicine1995;149(10):1113‐7. [PUBMED: 7550814] ">Clements 1995</a>; <a href="./references#CD010089-bbs2-0005" title="HobermanA , GreenbergDP , ParadiseJL , RocketteHE , LaveJR , KearneyDH , et al. Effectiveness of inactivated influenza vaccine in preventing acute otitis media in young children: a randomised controlled trial. JAMA2003;290(12):1608‐16. [PUBMED: 14506120] ">Hoberman 2003</a>; <a href="./references#CD010089-bbs2-0007" title="LumLC , Borja‐TaboraCF , BreimanRF , VesikariT , SablanBP , ChayOM , et al. Influenza vaccine concurrently administered with a combination measles, mumps, and rubella vaccine to young children. Vaccine2010;28(6):1566‐74. [PUBMED: 20003918] ">Lum 2010</a>; <a href="./references#CD010089-bbs2-0011" title="VesikariT , FlemingDM , AristeguiJF , VertruyenA , AshkenaziS , RappaportR , et al. Safety, efficacy and effectiveness of cold‐adapted influenza vaccine‐trivalent against community‐acquired, culture‐confirmed influenza in young children attending day care. Pediatrics2006;118(6):2298‐312. [PUBMED: 17142512] ">Vesikari 2006</a>). There was no difference in this outcome by the number of doses (one or two doses in the first course) of vaccine. For those trials that included two courses of vaccine, two trials involving 1447 children showed no difference between the influenza vaccine and control group in AOM during the follow‐up period after the second course (<a href="./references#CD010089-fig-0005" title="">Analysis 1.2</a>) (<a href="./references#CD010089-bbs2-0005" title="HobermanA , GreenbergDP , ParadiseJL , RocketteHE , LaveJR , KearneyDH , et al. Effectiveness of inactivated influenza vaccine in preventing acute otitis media in young children: a randomised controlled trial. JAMA2003;290(12):1608‐16. [PUBMED: 14506120] ">Hoberman 2003</a>; <a href="./references#CD010089-bbs2-0011" title="VesikariT , FlemingDM , AristeguiJF , VertruyenA , AshkenaziS , RappaportR , et al. Safety, efficacy and effectiveness of cold‐adapted influenza vaccine‐trivalent against community‐acquired, culture‐confirmed influenza in young children attending day care. Pediatrics2006;118(6):2298‐312. [PUBMED: 17142512] ">Vesikari 2006</a>). </p> </section> <section id="CD010089-sec-0092"> <h6 class="title">Acute otitis media by trial setting</h6> <p>Recruitment for three trials took place in the healthcare setting (<a href="./references#CD010089-bbs2-0005" title="HobermanA , GreenbergDP , ParadiseJL , RocketteHE , LaveJR , KearneyDH , et al. Effectiveness of inactivated influenza vaccine in preventing acute otitis media in young children: a randomised controlled trial. JAMA2003;290(12):1608‐16. [PUBMED: 14506120] ">Hoberman 2003</a>; <a href="./references#CD010089-bbs2-0007" title="LumLC , Borja‐TaboraCF , BreimanRF , VesikariT , SablanBP , ChayOM , et al. Influenza vaccine concurrently administered with a combination measles, mumps, and rubella vaccine to young children. Vaccine2010;28(6):1566‐74. [PUBMED: 20003918] ">Lum 2010</a>; <a href="./references#CD010089-bbs2-0011" title="VesikariT , FlemingDM , AristeguiJF , VertruyenA , AshkenaziS , RappaportR , et al. Safety, efficacy and effectiveness of cold‐adapted influenza vaccine‐trivalent against community‐acquired, culture‐confirmed influenza in young children attending day care. Pediatrics2006;118(6):2298‐312. [PUBMED: 17142512] ">Vesikari 2006</a>), and for one trial in a day‐care setting (<a href="./references#CD010089-bbs2-0003" title="ClementsDA , LangdonL , BlandC , WalterE . Influenza A vaccine decreases the incidence of otitis media in 6‐ to 30‐month‐old children in day care. Archives of Pediatrics &amp; Adolescent Medicine1995;149(10):1113‐7. [PUBMED: 7550814] ">Clements 1995</a>). Due to the small number of studies in this subgroup, we did not do a subgroup analysis by trial setting for this update of the review. </p> </section> <section id="CD010089-sec-0093"> <h6 class="title">Acute otitis media by season</h6> <p>Two trials documented this outcome according to season, either the respiratory or the influenza season. The vaccine was administered at the beginning of the season in two trials (<a href="./references#CD010089-bbs2-0003" title="ClementsDA , LangdonL , BlandC , WalterE . Influenza A vaccine decreases the incidence of otitis media in 6‐ to 30‐month‐old children in day care. Archives of Pediatrics &amp; Adolescent Medicine1995;149(10):1113‐7. [PUBMED: 7550814] ">Clements 1995</a>; <a href="./references#CD010089-bbs2-0005" title="HobermanA , GreenbergDP , ParadiseJL , RocketteHE , LaveJR , KearneyDH , et al. Effectiveness of inactivated influenza vaccine in preventing acute otitis media in young children: a randomised controlled trial. JAMA2003;290(12):1608‐16. [PUBMED: 14506120] ">Hoberman 2003</a>). One trial reported AOM during the respiratory season (<a href="./references#CD010089-bbs2-0005" title="HobermanA , GreenbergDP , ParadiseJL , RocketteHE , LaveJR , KearneyDH , et al. Effectiveness of inactivated influenza vaccine in preventing acute otitis media in young children: a randomised controlled trial. JAMA2003;290(12):1608‐16. [PUBMED: 14506120] ">Hoberman 2003</a>). We did not perform a subgroup analysis due to the limited number of studies reporting season. </p> </section> <section id="CD010089-sec-0094"> <h6 class="title">Acute otitis media by type of vaccine</h6> <p>Of the four studies that reported the outcome of at least one episode of AOM during the follow‐up period, only two types of vaccine were used, trivalent cold‐adapted vaccine, in <a href="./references#CD010089-bbs2-0007" title="LumLC , Borja‐TaboraCF , BreimanRF , VesikariT , SablanBP , ChayOM , et al. Influenza vaccine concurrently administered with a combination measles, mumps, and rubella vaccine to young children. Vaccine2010;28(6):1566‐74. [PUBMED: 20003918] ">Lum 2010</a> and <a href="./references#CD010089-bbs2-0011" title="VesikariT , FlemingDM , AristeguiJF , VertruyenA , AshkenaziS , RappaportR , et al. Safety, efficacy and effectiveness of cold‐adapted influenza vaccine‐trivalent against community‐acquired, culture‐confirmed influenza in young children attending day care. Pediatrics2006;118(6):2298‐312. [PUBMED: 17142512] ">Vesikari 2006</a>, and trivalent subvirion vaccines, in <a href="./references#CD010089-bbs2-0003" title="ClementsDA , LangdonL , BlandC , WalterE . Influenza A vaccine decreases the incidence of otitis media in 6‐ to 30‐month‐old children in day care. Archives of Pediatrics &amp; Adolescent Medicine1995;149(10):1113‐7. [PUBMED: 7550814] ">Clements 1995</a> and <a href="./references#CD010089-bbs2-0005" title="HobermanA , GreenbergDP , ParadiseJL , RocketteHE , LaveJR , KearneyDH , et al. Effectiveness of inactivated influenza vaccine in preventing acute otitis media in young children: a randomised controlled trial. JAMA2003;290(12):1608‐16. [PUBMED: 14506120] ">Hoberman 2003</a>. There was substantial heterogeneity in the two subgroups and in the overall result. The two subgroups failed to show a difference in AOM, and there was no significant difference between the subgroups (<a href="./references#CD010089-fig-0006" title="">Analysis 1.3</a>). </p> </section> </section> <section id="CD010089-sec-0095"> <h5 class="title">2. Number of episodes of acute otitis media recorded during the follow‐up period</h5> <p>One trial involving 396 children reported this outcome but without a measure of variance, hence we were unable to analyse this outcome (<a href="./references#CD010089-bbs2-0005" title="HobermanA , GreenbergDP , ParadiseJL , RocketteHE , LaveJR , KearneyDH , et al. Effectiveness of inactivated influenza vaccine in preventing acute otitis media in young children: a randomised controlled trial. JAMA2003;290(12):1608‐16. [PUBMED: 14506120] ">Hoberman 2003</a>). </p> </section> </section> <section id="CD010089-sec-0096"> <h4 class="title">Secondary outcomes</h4> <section id="CD010089-sec-0097"> <h5 class="title">1. Use of antibiotics to treat acute otitis media and its complications</h5> <p>Two trials reported the number of children who received any antibiotics over the follow‐up period (<a href="./references#CD010089-bbs2-0008" title="MarchisioP , CavagnaR , MaspesB , GironiS , EspositoS , LambertiniL , et al. Efficacy of intranasal virosomal influenza vaccine in the prevention of recurrent acute otitis media in children. Clinical Infectious Diseases2002;35(2):168‐74. [PUBMED: 12087523] ">Marchisio 2002</a>; <a href="./references#CD010089-bbs2-0011" title="VesikariT , FlemingDM , AristeguiJF , VertruyenA , AshkenaziS , RappaportR , et al. Safety, efficacy and effectiveness of cold‐adapted influenza vaccine‐trivalent against community‐acquired, culture‐confirmed influenza in young children attending day care. Pediatrics2006;118(6):2298‐312. [PUBMED: 17142512] ">Vesikari 2006</a>). <a href="./references#CD010089-bbs2-0008" title="MarchisioP , CavagnaR , MaspesB , GironiS , EspositoS , LambertiniL , et al. Efficacy of intranasal virosomal influenza vaccine in the prevention of recurrent acute otitis media in children. Clinical Infectious Diseases2002;35(2):168‐74. [PUBMED: 12087523] ">Marchisio 2002</a> (N = 133) reported antibiotics prescribed for AOM, and <a href="./references#CD010089-bbs2-0011" title="VesikariT , FlemingDM , AristeguiJF , VertruyenA , AshkenaziS , RappaportR , et al. Safety, efficacy and effectiveness of cold‐adapted influenza vaccine‐trivalent against community‐acquired, culture‐confirmed influenza in young children attending day care. Pediatrics2006;118(6):2298‐312. [PUBMED: 17142512] ">Vesikari 2006</a> (N = 1090) reported antibiotics prescribed for influenza‐like illness including AOM (<a href="./references#CD010089-fig-0007" title="">Analysis 1.4</a>; 2 trials; 1223 children; RR 0.70, 95% CI 0.59 to 0.83; RD ‐0.11, 95% CI ‐0.16 to ‐0.06; I² = 0%; moderate‐quality evidence). One trial reported the mean courses of antibiotics, but as the data appeared to be skewed, we were unable to perform a meta‐analysis (<a href="./references#CD010089-bbs2-0005" title="HobermanA , GreenbergDP , ParadiseJL , RocketteHE , LaveJR , KearneyDH , et al. Effectiveness of inactivated influenza vaccine in preventing acute otitis media in young children: a randomised controlled trial. JAMA2003;290(12):1608‐16. [PUBMED: 14506120] ">Hoberman 2003</a>). </p> </section> <section id="CD010089-sec-0098"> <h5 class="title">2. Causative organism associated with acute otitis media</h5> <p>None of the studies reported on this outcome.</p> </section> <section id="CD010089-sec-0099"> <h5 class="title">3. Utilisation of healthcare and related resources</h5> <p>Utilisation of healthcare resources refers to any reported self referral by a trial participant to a healthcare provider during the follow‐up period. One trial reported the number of children who were hospitalised during the follow‐up period (<a href="./references#CD010089-bbs2-0005" title="HobermanA , GreenbergDP , ParadiseJL , RocketteHE , LaveJR , KearneyDH , et al. Effectiveness of inactivated influenza vaccine in preventing acute otitis media in young children: a randomised controlled trial. JAMA2003;290(12):1608‐16. [PUBMED: 14506120] ">Hoberman 2003</a>). This trial showed no difference between the influenza vaccine and control groups in rate of hospitalisation. One trial reported the mean visits to primary care, emergency department, or hospital admission, but as the data appeared to be skewed, we were unable to include these data in a meta‐analysis (<a href="./references#CD010089-bbs2-0005" title="HobermanA , GreenbergDP , ParadiseJL , RocketteHE , LaveJR , KearneyDH , et al. Effectiveness of inactivated influenza vaccine in preventing acute otitis media in young children: a randomised controlled trial. JAMA2003;290(12):1608‐16. [PUBMED: 14506120] ">Hoberman 2003</a>). </p> </section> <section id="CD010089-sec-0100"> <h5 class="title">4. Number of culture‐confirmed influenza cases</h5> <p>Three trials reported the number of culture‐confirmed influenza cases (<a href="./references#CD010089-bbs2-0001" title="BelsheRB , GruberWC . Prevention of otitis media in children with live attenuated influenza vaccine given intranasally. Pediatric Infectious Disease Journal2000;19(Suppl 5):66‐71. ">Belshe 2000</a>; <a href="./references#CD010089-bbs2-0007" title="LumLC , Borja‐TaboraCF , BreimanRF , VesikariT , SablanBP , ChayOM , et al. Influenza vaccine concurrently administered with a combination measles, mumps, and rubella vaccine to young children. Vaccine2010;28(6):1566‐74. [PUBMED: 20003918] ">Lum 2010</a>; <a href="./references#CD010089-bbs2-0011" title="VesikariT , FlemingDM , AristeguiJF , VertruyenA , AshkenaziS , RappaportR , et al. Safety, efficacy and effectiveness of cold‐adapted influenza vaccine‐trivalent against community‐acquired, culture‐confirmed influenza in young children attending day care. Pediatrics2006;118(6):2298‐312. [PUBMED: 17142512] ">Vesikari 2006</a>). In the vaccine group, there was a significant reduction in the number of culture‐confirmed influenza cases with considerable heterogeneity (3 trials; 4449 children, random‐effects; RR 0.07, 95% CI 0.02 to 0.17; RD ‐0.02, 95% CI ‐0.04 to ‐0.01; I² = 84%). </p> </section> <section id="CD010089-sec-0101"> <h5 class="title">5. Adverse events</h5> <p>Seven trials reported measuring adverse events. There was a significant increase in the number of children with febrile reaction in the vaccine group (<a href="./references#CD010089-fig-0008" title="">Analysis 1.5</a>; 7 trials; 10,615 children; RR 1.15, 95% CI 1.06 to 1.24; RD 0.02, 95% CI 0.00 to 0.04; I² = 0%; low‐quality evidence) (<a href="./references#CD010089-bbs2-0002" title="Bracco NetoH , FarhatCK , TregnaghiMW , MadhiSA , RazmpourA , PalladinoG , et al. Efficacy and safety of 1 and 2 doses of live attenuated influenza vaccine in vaccine‐naive children. Pediatric Infectious Disease Journal2009;28(5):365‐71. [PUBMED: 19395948] ">Bracco 2009</a>; <a href="./references#CD010089-bbs2-0004" title="GruberWC , BelsheRB , KingJC , TreanorJJ , PiedraPA , WrightPF , et al. Evaluation of live attenuated influenza vaccines in children 6‐18 months of age: safety, immunogenicity and efficacy. Journal of Infectious Diseases1996;173(6):1313‐9. [PUBMED: 8648202] ">Gruber 1996</a>; <a href="./references#CD010089-bbs2-0006" title="KosalaraksaP , JeanfreauR , FrenetteL , DrameM , MadariagaM , InnisBL , et al. AS03B‐adjuvanted H5N1 influenza vaccine in children 6 months through 17 years of age: a phase 2/3 randomized, placebo‐controlled, observer‐blinded trial. Journal of Infectious Diseases2015;211(5):801‐10. [PUBMED: 25293368] ">Kosalaraksa 2015</a>; <a href="./references#CD010089-bbs2-0007" title="LumLC , Borja‐TaboraCF , BreimanRF , VesikariT , SablanBP , ChayOM , et al. Influenza vaccine concurrently administered with a combination measles, mumps, and rubella vaccine to young children. Vaccine2010;28(6):1566‐74. [PUBMED: 20003918] ">Lum 2010</a>; <a href="./references#CD010089-bbs2-0009" title="SwierkoszEM , NewmanFK , AndersonEL , NugentSL , MillsGB , BelsheRB . Multidose, live attenuated, cold‐recombinant, trivalent influenza vaccine in infants and young children. Journal of Infectious Diseases1994;169(5):1121‐4. [PUBMED: 8169405] ">Swierkosz 1994</a>; <a href="./references#CD010089-bbs2-0010" title="TamJS , CapedingMR , LumLC , ChotpitayasunondhT , JiangZ , HuangLM , et al. Efficacy and safety of a live attenuated, cold‐adapted influenza vaccine, trivalent against culture‐confirmed influenza in young children in Asia. Pediatric Infectious Disease Journal2007;26(7):619‐28. [PUBMED: 17596805] ">Tam 2007</a>; <a href="./references#CD010089-bbs2-0011" title="VesikariT , FlemingDM , AristeguiJF , VertruyenA , AshkenaziS , RappaportR , et al. Safety, efficacy and effectiveness of cold‐adapted influenza vaccine‐trivalent against community‐acquired, culture‐confirmed influenza in young children attending day care. Pediatrics2006;118(6):2298‐312. [PUBMED: 17142512] ">Vesikari 2006</a>). </p> <p>Six trials reported a significant increase in the number of children with rhinorrhoea in the vaccine group (<a href="./references#CD010089-fig-0009" title="">Analysis 1.6</a>; 6 trials; 10,563 children; RR 1.17, 95% CI 1.07 to 1.29; RD 0.09, 95% CI 0.01 to 0.16; I² = 63%; low‐quality evidence) (<a href="./references#CD010089-bbs2-0002" title="Bracco NetoH , FarhatCK , TregnaghiMW , MadhiSA , RazmpourA , PalladinoG , et al. Efficacy and safety of 1 and 2 doses of live attenuated influenza vaccine in vaccine‐naive children. Pediatric Infectious Disease Journal2009;28(5):365‐71. [PUBMED: 19395948] ">Bracco 2009</a>; <a href="./references#CD010089-bbs2-0004" title="GruberWC , BelsheRB , KingJC , TreanorJJ , PiedraPA , WrightPF , et al. Evaluation of live attenuated influenza vaccines in children 6‐18 months of age: safety, immunogenicity and efficacy. Journal of Infectious Diseases1996;173(6):1313‐9. [PUBMED: 8648202] ">Gruber 1996</a>; <a href="./references#CD010089-bbs2-0007" title="LumLC , Borja‐TaboraCF , BreimanRF , VesikariT , SablanBP , ChayOM , et al. Influenza vaccine concurrently administered with a combination measles, mumps, and rubella vaccine to young children. Vaccine2010;28(6):1566‐74. [PUBMED: 20003918] ">Lum 2010</a>; <a href="./references#CD010089-bbs2-0009" title="SwierkoszEM , NewmanFK , AndersonEL , NugentSL , MillsGB , BelsheRB . Multidose, live attenuated, cold‐recombinant, trivalent influenza vaccine in infants and young children. Journal of Infectious Diseases1994;169(5):1121‐4. [PUBMED: 8169405] ">Swierkosz 1994</a>; <a href="./references#CD010089-bbs2-0010" title="TamJS , CapedingMR , LumLC , ChotpitayasunondhT , JiangZ , HuangLM , et al. Efficacy and safety of a live attenuated, cold‐adapted influenza vaccine, trivalent against culture‐confirmed influenza in young children in Asia. Pediatric Infectious Disease Journal2007;26(7):619‐28. [PUBMED: 17596805] ">Tam 2007</a>; <a href="./references#CD010089-bbs2-0011" title="VesikariT , FlemingDM , AristeguiJF , VertruyenA , AshkenaziS , RappaportR , et al. Safety, efficacy and effectiveness of cold‐adapted influenza vaccine‐trivalent against community‐acquired, culture‐confirmed influenza in young children attending day care. Pediatrics2006;118(6):2298‐312. [PUBMED: 17142512] ">Vesikari 2006</a>). </p> <p>Three trials reported pharyngitis (<a href="./references#CD010089-bbs2-0002" title="Bracco NetoH , FarhatCK , TregnaghiMW , MadhiSA , RazmpourA , PalladinoG , et al. Efficacy and safety of 1 and 2 doses of live attenuated influenza vaccine in vaccine‐naive children. Pediatric Infectious Disease Journal2009;28(5):365‐71. [PUBMED: 19395948] ">Bracco 2009</a>; <a href="./references#CD010089-bbs2-0007" title="LumLC , Borja‐TaboraCF , BreimanRF , VesikariT , SablanBP , ChayOM , et al. Influenza vaccine concurrently administered with a combination measles, mumps, and rubella vaccine to young children. Vaccine2010;28(6):1566‐74. [PUBMED: 20003918] ">Lum 2010</a>; <a href="./references#CD010089-bbs2-0011" title="VesikariT , FlemingDM , AristeguiJF , VertruyenA , AshkenaziS , RappaportR , et al. Safety, efficacy and effectiveness of cold‐adapted influenza vaccine‐trivalent against community‐acquired, culture‐confirmed influenza in young children attending day care. Pediatrics2006;118(6):2298‐312. [PUBMED: 17142512] ">Vesikari 2006</a>). There was no difference between the vaccine and control groups (<a href="./references#CD010089-fig-0010" title="">Analysis 1.7</a>). </p> <p>Additional adverse events were reported in this update. One trial reported the number of children with drowsiness, irritability/fussiness, and loss of appetite (<a href="./references#CD010089-bbs2-0006" title="KosalaraksaP , JeanfreauR , FrenetteL , DrameM , MadariagaM , InnisBL , et al. AS03B‐adjuvanted H5N1 influenza vaccine in children 6 months through 17 years of age: a phase 2/3 randomized, placebo‐controlled, observer‐blinded trial. Journal of Infectious Diseases2015;211(5):801‐10. [PUBMED: 25293368] ">Kosalaraksa 2015</a>). This trial showed a significant difference between influenza vaccine and control groups in rate of drowsiness (1 trial; 416 children; RR 1.45, 95% CI 1.01 to 2.06; RD 0.11, 95% CI 0.01 to 0.20; P = 0.04). This trial showed no difference in rates of irritability/fussiness (1 trial; 416 children; RR 1.33, 95% CI 1.00 to 1.77; RD 1.11, 95% CI 0.01 to 0.21) and loss of appetite (1 trial; 416 children; RR 1.13, 95% CI 0.78 to 1.64; RD 0.03, 95% CI ‐0.06 to 0.12) between the influenza vaccine and control groups. </p> </section> </section> <section id="CD010089-sec-0102"> <h4 class="title">Sensitivity analysis</h4> <p>For all outcomes, there was no substantial change in the effect sizes and CI after removing the trials with unclear risk of bias for allocation concealment and random sequence generation. The inclusion of a trial with a five‐month follow‐up period (<a href="./references#CD010089-bbs2-0003" title="ClementsDA , LangdonL , BlandC , WalterE . Influenza A vaccine decreases the incidence of otitis media in 6‐ to 30‐month‐old children in day care. Archives of Pediatrics &amp; Adolescent Medicine1995;149(10):1113‐7. [PUBMED: 7550814] ">Clements 1995</a>), shorter than our predefined follow‐up of at least six months, did not substantially affect our results. </p> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD010089-sec-0103" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD010089-sec-0103"></div> <section id="CD010089-sec-0104"> <h3 class="title" id="CD010089-sec-0104">Summary of main results</h3> <p>This review was designed to include all randomised controlled trials (RCTs) addressing the effectiveness of influenza vaccine in reducing the occurrence of acute otitis media (AOM) in infants and children. The 11 identified trials formed a heterogeneous group addressing several comparisons and a variety of outcomes, resulting in few trials contributing to each of our predefined outcomes. </p> <p>There was a 4% absolute reduction in episodes of AOM among vaccinated children during the follow‐up period. The subgroup analyses (i.e. number of courses or types of vaccine administered) showed no difference. There was a clinically important 11% absolute reduction in children receiving an antibiotic for AOM or its complications. We were unable to demonstrate whether there was any difference in utilisation of health care between the vaccine and control groups for the one included trial. Reporting of adverse events was limited to minor side effects, which included episodes of fever, rhinorrhoea, and drowsiness, and these were increased with the vaccine. We were unable to pool the results for all adverse events because some children may have experienced more than one adverse event. </p> </section> <section id="CD010089-sec-0105"> <h3 class="title" id="CD010089-sec-0105">Overall completeness and applicability of evidence</h3> <p>We performed a comprehensive and extensive literature review to assess the effectiveness of influenza vaccine in reducing the occurrence of AOM in infants and children. We included 11 trials, but the findings of this review may not be applicable to children aged less than six months or more than six years, as they were excluded from the included trials. Nevertheless, the age ranges in the included studies do represent the age range of children at risk of AOM (<a href="./references#CD010089-bbs2-0056" title="Acute otitis media. MeReC Bulletin2006;17(3):9‐11. ">MeReC 2006</a>). We could not include five of the 11 trials in the meta‐analysis because the follow‐up period was too short. One trial was not included due to a very high rate of attrition, and 13,989 children were not included in the primary outcome. This limits the applicability of the findings of this review. None of the 11 included trials examined the causative organism associated with AOM. Our review evaluated monovalent, bivalent, or trivalent influenza vaccine as single, two, or three doses given between seven to 60 days apart, but was not able to show whether the number of doses made a difference in the occurrence of AOM. Although the immunogenicity of the vaccine for one, two, and three doses has been studied (<a href="./references#CD010089-bbs2-0009" title="SwierkoszEM , NewmanFK , AndersonEL , NugentSL , MillsGB , BelsheRB . Multidose, live attenuated, cold‐recombinant, trivalent influenza vaccine in infants and young children. Journal of Infectious Diseases1994;169(5):1121‐4. [PUBMED: 8169405] ">Swierkosz 1994</a>), we are unaware of any direct comparisons of different doses that looked at clinically important outcomes. From the reported incidence of adverse events, we were able to detect common side effects, that is febrile reactions to vaccination, rhinorrhoea, pharyngitis, and drowsiness. The information on adverse events came from seven trials involving about 10,000 children, but there was a lack of information on more rare and serious adverse events. However, in a Cochrane Review examining the efficacy and safety of influenza vaccine in healthy children, there were reports of additional rare or serious adverse events over and above those reported in the trials included in our review (<a href="./references#CD010089-bbs2-0048" title="JeffersonT , RivettiA , DiPietrantonjC , DemicheliV , FerroniE . Vaccines for preventing influenza in healthy children. Cochrane Database of Systematic Reviews2012, Issue 8. [DOI: 10.1002/14651858.CD004879.pub4; PUBMED: 22895945] ">Jefferson 2012</a>). These included lower respiratory infections, septicaemia, and death. However, none of the trial investigators judged these rare events to be due to the vaccine. </p> </section> <section id="CD010089-sec-0106"> <h3 class="title" id="CD010089-sec-0106">Quality of the evidence</h3> <p>Overall, we judged the quality of evidence to be low to moderate, but judged evidence for adverse events to be of low quality. Generally, there was a low or unclear risk of bias for most trials in most domains. There was no access to protocols in nine trials. However, we judged selective reporting bias to be low because all the expected outcomes had been reported. Only two trials were prospectively registered on a trial registration database. Four studies had unclear risk of bias for method of randomisation and allocation concealment, of which two, described as double‐blind, placebo‐controlled studies, contributed to the first primary outcome. Removing these studies on sensitivity analysis did not substantially change the effect estimate or the confidence, so we have not downgraded for this. </p> <p>Risk of attrition bias was present in two trials. Both of these studies only contributed to the adverse effects outcomes, therefore we have downgraded these outcomes for risk of bias. Attrition bias was unclear in one trial due to unexplained reasons for loss to follow‐up (<a href="#CD010089-fig-0003">Figure 3</a>). Loss to follow‐up was less than 20% in six trials, and nine trials carried out intention‐to‐treat analysis. Ten trials declared funding from vaccine manufacturers, and there is a potential for financial competing interest. We have therefore downgraded all outcomes over concerns about potential publication bias. For most of our meta‐analyses, we encountered little or moderate heterogeneity. We have shown the results of the random‐effects meta‐analysis where there was moderate heterogeneity. Where we have done random‐effects meta‐analysis, there was no shift in the effect estimate, and although the 95% confidence interval was wider in all instances, the outcome remained significant. Some outcomes showed substantial heterogeneity; where this occurred we have indicated this and not shown the pooled estimate. We downgraded our first primary outcome due to concerns about this. For all studies contributing to this outcome, the effect estimate favoured influenza vaccine, but heterogeneity (I² = 62%) reduces our certainty about the size of reduction for this outcome. Using the GRADE approach, we therefore assessed the overall level of evidence contributing to this review as low to moderate quality (<a href="./full#CD010089-tbl-0001">summary of findings Table for the main comparison</a>). </p> <p>There was a wide variation among the included studies in the frequency of adverse events reported, suggesting differences in definitions used and difficulty in identifying and reporting adverse events. We have therefore downgraded these adverse events for heterogeneity. </p> </section> <section id="CD010089-sec-0107"> <h3 class="title" id="CD010089-sec-0107">Potential biases in the review process</h3> <p>We attempted to reduce publication bias by checking the reference lists of all related studies for further references and searching multiple databases without language restriction. However, we cannot be certain that we have located all the trials in this area. Although there were 11 included trials, we were not able to construct a funnel plot for detecting bias or heterogeneity due to insufficient studies contributing to each outcome. Not all included trials reported all outcomes. One included trial did not meet our inclusion criteria in terms of the duration of follow‐up (<a href="./references#CD010089-bbs2-0003" title="ClementsDA , LangdonL , BlandC , WalterE . Influenza A vaccine decreases the incidence of otitis media in 6‐ to 30‐month‐old children in day care. Archives of Pediatrics &amp; Adolescent Medicine1995;149(10):1113‐7. [PUBMED: 7550814] ">Clements 1995</a>). This trial had a maximum follow‐up period of five months. This was also the only trial carried out in day‐care centres. However, there was no significant difference between this trial and the four trials that recruited children from healthcare settings, although the study with a five‐month follow‐up period actually reported a higher incidence of AOM. In spite of the fact that the included studies all showed the same direction of effect, we encountered moderate heterogeneity in our first primary outcome. We were unable to demonstrate whether the heterogeneity could be explained by subgroup analysis. However, there were differences in the measurement of AOM. Diagnosis of AOM is subjective, and although attempts were made in all the included studies to make this more objective, the definitions used varied across the studies. Since only two of the included studies were prospectively registered, we cannot be certain that we missed studies that measured AOM but did not report it. </p> <p>A possible bias in this review is that we excluded one study due to uncertainty of the age of the participants (<a href="./references#CD010089-bbs2-0015" title="BergenR , BlackS , ShinefieldH , LewisE , RayP , HansenJ , et al. Safety of cold‐adapted live attenuated influenza vaccine in a large cohort of children and adolescents. Pediatric Infectious Disease Journal2004;23(2):138‐44. [PUBMED: 14872180] ">Bergen 2004</a>). However, the results of this study were consistent with the findings of our review, reporting a significant reduction in otitis media in children one to eight years of age, but reported lower febrile illness in the vaccine group. </p> </section> <section id="CD010089-sec-0108"> <h3 class="title" id="CD010089-sec-0108">Agreements and disagreements with other studies or reviews</h3> <p>Three other systematic reviews have examined the effect of influenza vaccine on otitis media (<a href="./references#CD010089-bbs2-0034" title="BlockSL , HeikkinenT , TobackSL , ZhengW , AmbroseCS . The efficacy of live attenuated influenza vaccine against influenza‐associated acute otitis media in children. Pediatric Infectious Disease Journal2011;30(3):203‐7. [PUBMED: 20935591] ">Block 2011</a>; <a href="./references#CD010089-bbs2-0044" title="HeikkinenT , BlockSL , TobackSL , WuX , AmbroseCS . Effectiveness of intranasal live attenuated influenza vaccine against all‐cause acute otitis media in children. Pediatric Infectious Disease Journal2013;32:669‐74. ">Heikkinen 2013</a>; <a href="./references#CD010089-bbs2-0059" title="PrutskyGJ , DomecqJP , ElraiyahT , ProkopLJ , MuradMH . Assessing the evidence: live attenuated influenza vaccine in children younger than 2 years. A systematic review. Pediatric Infectious Disease Journal2014;33:e106‐15. ">Prutsky 2014</a>). <a href="./references#CD010089-bbs2-0034" title="BlockSL , HeikkinenT , TobackSL , ZhengW , AmbroseCS . The efficacy of live attenuated influenza vaccine against influenza‐associated acute otitis media in children. Pediatric Infectious Disease Journal2011;30(3):203‐7. [PUBMED: 20935591] ">Block 2011</a> evaluated the efficacy of live attenuated influenza vaccine (LAIV), trivalent inactivated influenza vaccine (TIV), and placebo for influenza‐associated AOM from RCTs. This review included six placebo‐controlled trials and two TIV‐controlled trials. Five of the eight trials were included in this review, and the others were excluded for absence of relevant primary or secondary outcomes and the absence of a control group (<a href="./references#CD010089-bbs2-0001" title="BelsheRB , GruberWC . Prevention of otitis media in children with live attenuated influenza vaccine given intranasally. Pediatric Infectious Disease Journal2000;19(Suppl 5):66‐71. ">Belshe 2000</a>; <a href="./references#CD010089-bbs2-0002" title="Bracco NetoH , FarhatCK , TregnaghiMW , MadhiSA , RazmpourA , PalladinoG , et al. Efficacy and safety of 1 and 2 doses of live attenuated influenza vaccine in vaccine‐naive children. Pediatric Infectious Disease Journal2009;28(5):365‐71. [PUBMED: 19395948] ">Bracco 2009</a>; <a href="./references#CD010089-bbs2-0007" title="LumLC , Borja‐TaboraCF , BreimanRF , VesikariT , SablanBP , ChayOM , et al. Influenza vaccine concurrently administered with a combination measles, mumps, and rubella vaccine to young children. Vaccine2010;28(6):1566‐74. [PUBMED: 20003918] ">Lum 2010</a>; <a href="./references#CD010089-bbs2-0010" title="TamJS , CapedingMR , LumLC , ChotpitayasunondhT , JiangZ , HuangLM , et al. Efficacy and safety of a live attenuated, cold‐adapted influenza vaccine, trivalent against culture‐confirmed influenza in young children in Asia. Pediatric Infectious Disease Journal2007;26(7):619‐28. [PUBMED: 17596805] ">Tam 2007</a>; <a href="./references#CD010089-bbs2-0011" title="VesikariT , FlemingDM , AristeguiJF , VertruyenA , AshkenaziS , RappaportR , et al. Safety, efficacy and effectiveness of cold‐adapted influenza vaccine‐trivalent against community‐acquired, culture‐confirmed influenza in young children attending day care. Pediatrics2006;118(6):2298‐312. [PUBMED: 17142512] ">Vesikari 2006</a>). </p> <p><a href="./references#CD010089-bbs2-0044" title="HeikkinenT , BlockSL , TobackSL , WuX , AmbroseCS . Effectiveness of intranasal live attenuated influenza vaccine against all‐cause acute otitis media in children. Pediatric Infectious Disease Journal2013;32:669‐74. ">Heikkinen 2013</a> included the same trials as in <a href="./references#CD010089-bbs2-0034" title="BlockSL , HeikkinenT , TobackSL , ZhengW , AmbroseCS . The efficacy of live attenuated influenza vaccine against influenza‐associated acute otitis media in children. Pediatric Infectious Disease Journal2011;30(3):203‐7. [PUBMED: 20935591] ">Block 2011</a>. <a href="./references#CD010089-bbs2-0059" title="PrutskyGJ , DomecqJP , ElraiyahT , ProkopLJ , MuradMH . Assessing the evidence: live attenuated influenza vaccine in children younger than 2 years. A systematic review. Pediatric Infectious Disease Journal2014;33:e106‐15. ">Prutsky 2014</a> included seven RCTs and two observational studies. Four of the seven RCTs were included in our review, and the remaining three trials were not related to our prespecified primary or secondary outcomes (<a href="./references#CD010089-bbs2-0004" title="GruberWC , BelsheRB , KingJC , TreanorJJ , PiedraPA , WrightPF , et al. Evaluation of live attenuated influenza vaccines in children 6‐18 months of age: safety, immunogenicity and efficacy. Journal of Infectious Diseases1996;173(6):1313‐9. [PUBMED: 8648202] ">Gruber 1996</a>; <a href="./references#CD010089-bbs2-0007" title="LumLC , Borja‐TaboraCF , BreimanRF , VesikariT , SablanBP , ChayOM , et al. Influenza vaccine concurrently administered with a combination measles, mumps, and rubella vaccine to young children. Vaccine2010;28(6):1566‐74. [PUBMED: 20003918] ">Lum 2010</a>; <a href="./references#CD010089-bbs2-0009" title="SwierkoszEM , NewmanFK , AndersonEL , NugentSL , MillsGB , BelsheRB . Multidose, live attenuated, cold‐recombinant, trivalent influenza vaccine in infants and young children. Journal of Infectious Diseases1994;169(5):1121‐4. [PUBMED: 8169405] ">Swierkosz 1994</a>; <a href="./references#CD010089-bbs2-0011" title="VesikariT , FlemingDM , AristeguiJF , VertruyenA , AshkenaziS , RappaportR , et al. Safety, efficacy and effectiveness of cold‐adapted influenza vaccine‐trivalent against community‐acquired, culture‐confirmed influenza in young children attending day care. Pediatrics2006;118(6):2298‐312. [PUBMED: 17142512] ">Vesikari 2006</a>). </p> <p>All three reviews found a reduction in the development of AOM with influenza vaccines, similar to our review. Six of the nine studies in the <a href="./references#CD010089-bbs2-0059" title="PrutskyGJ , DomecqJP , ElraiyahT , ProkopLJ , MuradMH . Assessing the evidence: live attenuated influenza vaccine in children younger than 2 years. A systematic review. Pediatric Infectious Disease Journal2014;33:e106‐15. ">Prutsky 2014</a> review showed an increased risk of developing fever in the vaccine group compared to the placebo group, similar to our findings. We found no other systematic reviews that reported our other prespecified secondary outcomes. </p> <p>The review by <a href="./references#CD010089-bbs2-0048" title="JeffersonT , RivettiA , DiPietrantonjC , DemicheliV , FerroniE . Vaccines for preventing influenza in healthy children. Cochrane Database of Systematic Reviews2012, Issue 8. [DOI: 10.1002/14651858.CD004879.pub4; PUBMED: 22895945] ">Jefferson 2012</a> on vaccines for preventing influenza in healthy children showed that for live attenuated vaccines, there was an 80% overall reduction in influenza (RR 0.20, 95% CI 0.13 to 0.32). The RR for children under the age of six years old was 0.18 (95% CI 0.11 to 0.29), but little evidence was available for children under two years old. </p> <p>We consider this to be consistent with other data. In a Cochrane Review on pneumococcal conjugate vaccines (PCV), the 7‐valent PCV with CRM197 as carrier protein (CRM197‐PCV7) administered during early infancy was associated with a relative risk reduction of all‐cause AOM of ‐5% in high‐risk children (95% CI ‐25% to 12%). Administering PCV7 in healthy infants with a low baseline risk of AOM showed modest beneficial effects, with relative risk reduction of 7% (95% CI 4% to 9%) in three trials (<a href="./references#CD010089-bbs2-0040" title="FortanierAC , VenekampRP , BoonackerCW , HakE , SchilderAG , SandersEA , et al. Pneumococcal conjugate vaccines for preventing otitis media. Cochrane Database of Systematic Reviews2014, Issue 4. [DOI: 10.1002/14651858.CD001480.pub4] ">Fortanier 2014</a>). Pneumococcal vaccine had a small effect on AOM in healthy infants. However, since AOM is preceded by viral infection, a greater reduction in AOM following influenza vaccine is feasible, and the size of the effect we found is consistent with the overall efficacy of the vaccine. Consequently, a reduction in otitis media (RR 0.80) (from 264 to 211 per 1000, i.e. 53 per 1000) (or 5.3%) is compatible with this. </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD010089-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010089.pub3/media/CDSR/CD010089/urn:x-wiley:14651858:media:CD010089:CD010089-AFig-FIG01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010089.pub3/media/CDSR/CD010089/image_t/tCD010089-AFig-FIG01.png" target="_blank"><b></b></a></p> </div><img alt="Study flow diagram." data-id="CD010089-fig-0001" src="/cdsr/doi/10.1002/14651858.CD010089.pub3/media/CDSR/CD010089/image_n/nCD010089-AFig-FIG01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010089.pub3/full#CD010089-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010089.pub3/media/CDSR/CD010089/image_n/nCD010089-AFig-FIG01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010089-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010089.pub3/media/CDSR/CD010089/urn:x-wiley:14651858:media:CD010089:CD010089-AFig-FIG02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010089.pub3/media/CDSR/CD010089/image_t/tCD010089-AFig-FIG02.png" target="_blank"><b></b></a></p> </div><img alt="'Risk of bias' graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD010089-fig-0002" src="/cdsr/doi/10.1002/14651858.CD010089.pub3/media/CDSR/CD010089/image_n/nCD010089-AFig-FIG02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>'Risk of bias' graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010089.pub3/full#CD010089-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010089.pub3/media/CDSR/CD010089/image_n/nCD010089-AFig-FIG02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010089-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010089.pub3/media/CDSR/CD010089/urn:x-wiley:14651858:media:CD010089:CD010089-AFig-FIG03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010089.pub3/media/CDSR/CD010089/image_t/tCD010089-AFig-FIG03.png" target="_blank"><b></b></a></p> </div><img alt="'Risk of bias' summary: review authors' judgements about each risk of bias item for each included study." data-id="CD010089-fig-0003" src="/cdsr/doi/10.1002/14651858.CD010089.pub3/media/CDSR/CD010089/image_n/nCD010089-AFig-FIG03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>'Risk of bias' summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010089.pub3/full#CD010089-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010089.pub3/media/CDSR/CD010089/image_n/nCD010089-AFig-FIG03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010089-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010089.pub3/media/CDSR/CD010089/urn:x-wiley:14651858:media:CD010089:CD010089-CMP-001-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010089.pub3/media/CDSR/CD010089/image_t/tCD010089-CMP-001-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Influenza vaccine versus control, Outcome 1 At least 1 episode of acute otitis media." data-id="CD010089-fig-0004" src="/cdsr/doi/10.1002/14651858.CD010089.pub3/media/CDSR/CD010089/image_n/nCD010089-CMP-001-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1 Influenza vaccine versus control, Outcome 1 At least 1 episode of acute otitis media. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010089.pub3/references#CD010089-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010089.pub3/media/CDSR/CD010089/image_n/nCD010089-CMP-001-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010089-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010089.pub3/media/CDSR/CD010089/urn:x-wiley:14651858:media:CD010089:CD010089-CMP-001-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010089.pub3/media/CDSR/CD010089/image_t/tCD010089-CMP-001-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Influenza vaccine versus control, Outcome 2 Acute otitis media by courses." data-id="CD010089-fig-0005" src="/cdsr/doi/10.1002/14651858.CD010089.pub3/media/CDSR/CD010089/image_n/nCD010089-CMP-001-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1 Influenza vaccine versus control, Outcome 2 Acute otitis media by courses.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010089.pub3/references#CD010089-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010089.pub3/media/CDSR/CD010089/image_n/nCD010089-CMP-001-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010089-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010089.pub3/media/CDSR/CD010089/urn:x-wiley:14651858:media:CD010089:CD010089-CMP-001-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010089.pub3/media/CDSR/CD010089/image_t/tCD010089-CMP-001-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Influenza vaccine versus control, Outcome 3 Acute otitis media by type of vaccine." data-id="CD010089-fig-0006" src="/cdsr/doi/10.1002/14651858.CD010089.pub3/media/CDSR/CD010089/image_n/nCD010089-CMP-001-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.3</div> <div class="figure-caption"> <p>Comparison 1 Influenza vaccine versus control, Outcome 3 Acute otitis media by type of vaccine. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010089.pub3/references#CD010089-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010089.pub3/media/CDSR/CD010089/image_n/nCD010089-CMP-001-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010089-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010089.pub3/media/CDSR/CD010089/urn:x-wiley:14651858:media:CD010089:CD010089-CMP-001-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010089.pub3/media/CDSR/CD010089/image_t/tCD010089-CMP-001-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Influenza vaccine versus control, Outcome 4 Courses of antibiotics." data-id="CD010089-fig-0007" src="/cdsr/doi/10.1002/14651858.CD010089.pub3/media/CDSR/CD010089/image_n/nCD010089-CMP-001-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.4</div> <div class="figure-caption"> <p>Comparison 1 Influenza vaccine versus control, Outcome 4 Courses of antibiotics.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010089.pub3/references#CD010089-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010089.pub3/media/CDSR/CD010089/image_n/nCD010089-CMP-001-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010089-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010089.pub3/media/CDSR/CD010089/urn:x-wiley:14651858:media:CD010089:CD010089-CMP-001-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010089.pub3/media/CDSR/CD010089/image_t/tCD010089-CMP-001-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Influenza vaccine versus control, Outcome 5 Fever." data-id="CD010089-fig-0008" src="/cdsr/doi/10.1002/14651858.CD010089.pub3/media/CDSR/CD010089/image_n/nCD010089-CMP-001-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.5</div> <div class="figure-caption"> <p>Comparison 1 Influenza vaccine versus control, Outcome 5 Fever.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010089.pub3/references#CD010089-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010089.pub3/media/CDSR/CD010089/image_n/nCD010089-CMP-001-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010089-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010089.pub3/media/CDSR/CD010089/urn:x-wiley:14651858:media:CD010089:CD010089-CMP-001-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010089.pub3/media/CDSR/CD010089/image_t/tCD010089-CMP-001-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Influenza vaccine versus control, Outcome 6 Rhinorrhoea." data-id="CD010089-fig-0009" src="/cdsr/doi/10.1002/14651858.CD010089.pub3/media/CDSR/CD010089/image_n/nCD010089-CMP-001-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.6</div> <div class="figure-caption"> <p>Comparison 1 Influenza vaccine versus control, Outcome 6 Rhinorrhoea.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010089.pub3/references#CD010089-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010089.pub3/media/CDSR/CD010089/image_n/nCD010089-CMP-001-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010089-fig-0010"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010089.pub3/media/CDSR/CD010089/urn:x-wiley:14651858:media:CD010089:CD010089-CMP-001-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010089.pub3/media/CDSR/CD010089/image_t/tCD010089-CMP-001-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Influenza vaccine versus control, Outcome 7 Pharyngitis." data-id="CD010089-fig-0010" src="/cdsr/doi/10.1002/14651858.CD010089.pub3/media/CDSR/CD010089/image_n/nCD010089-CMP-001-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.7</div> <div class="figure-caption"> <p>Comparison 1 Influenza vaccine versus control, Outcome 7 Pharyngitis.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010089.pub3/references#CD010089-fig-0010">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010089.pub3/media/CDSR/CD010089/image_n/nCD010089-CMP-001-07.png" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD010089-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Influenza vaccine compared to control for preventing acute otitis media in infants and children</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Influenza vaccine compared to control for preventing acute otitis media in infants and children</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> infants and children<br/> <b>Setting:</b> health care and day care<br/> <b>Intervention:</b> influenza vaccine<br/> <b>Comparison:</b> control </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with control</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with influenza vaccine</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>At least 1 episode of acute otitis media</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.84<br/> (0.69 to 1.02) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>3134<br/> (4 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> LOW<sup>1,2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>The basis for the assumed risk is the mean risk in the control group across the included studies. There was moderate unexplained inconsistency across the studies. We downgraded for inconsistency. The effect estimates were all in the same direction, but there was uncertainty in the confidence of the effect estimate. </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>292 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>245 per 1000<br/> (201 to 298) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Courses of antibiotics</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.70<br/> (0.59 to 0.83) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>1223<br/> (2 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊝<br/> MODERATE<sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Assumed risk calculated from the mean risk across the control groups of the 2 included studies </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>362 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>254 per 1000<br/> (214 to 301) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Fever</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 1.15<br/> (1.06 to 1.24) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>10,615<br/> (7 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> LOW<sup>1,2,4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Assumed risk calculated from the mean risk across the control groups of the 7 included studies </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>174 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>200 per 1000<br/> (184 to 215) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Rhinorrhoea</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 1.17<br/> (1.07 to 1.29) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>10,563<br/> (6 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> LOW<sup>1,2,4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Assumed risk calculated from the mean risk across the control groups of the 6 included studies </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>424 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>496 per 1000<br/> (453 to 546) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Pharyngitis</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 1.00<br/> (0.80 to 1.25) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>4429<br/> (3 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> LOW<sup>1,2,4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Assumed risk calculated from the mean risk across the control groups of the 3 included studies </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>71 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>71 per 1000<br/> (57 to 88) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> confidence interval; <b>RCT:</b> randomised controlled trial; <b>RR:</b> risk ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High quality:</b> We are very confident that the true effect lies close to that of the estimate of the effect.<br/> <b>Moderate quality:</b> We are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/> <b>Low quality:</b> Our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/> <b>Very low quality:</b> We have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of the effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup>Includes trial(s) at high risk of publication bias.<br/> <sup>2</sup>Unexplained heterogeneity between studies.<br/> <sup>3</sup>Data derived from a single study with uncertainty about the effect size due to poor precision.<br/> <sup>4</sup>Includes trial(s) at high risk of attrition bias. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Influenza vaccine compared to control for preventing acute otitis media in infants and children</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010089.pub3/full#CD010089-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD010089-tbl-0002"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Influenza vaccine versus control</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 At least 1 episode of acute otitis media <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3134</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.84 [0.69, 1.02]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Acute otitis media by courses <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 First course (1 or 2 doses)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3134</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.84 [0.69, 1.02]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 Second course (1 dose)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1447</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.12 [0.94, 1.34]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Acute otitis media by type of vaccine <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3134</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.84 [0.69, 1.02]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 Trivalent cold‐adapted influenza vaccine</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2552</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.83 [0.56, 1.21]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2 Trivalent sub virion influenza vaccine</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>582</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.77 [0.48, 1.23]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Courses of antibiotics <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1223</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.70 [0.59, 0.83]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Fever <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>10615</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.15 [1.06, 1.24]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Rhinorrhoea <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>10563</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.17 [1.07, 1.29]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Pharyngitis <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4429</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.00 [0.80, 1.25]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Influenza vaccine versus control</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010089.pub3/references#CD010089-tbl-0002">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD010089.pub3&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="de#CD010089-note-0007">Deutsch</a> </li> <li class="section-language"> <a class="" href="es#CD010089-note-0006">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD010089-note-0009">فارسی</a> </li> <li class="section-language"> <a class="" href="hr#CD010089-note-0005">Hrvatski</a> </li> <li class="section-language"> <a class="" href="ja#CD010089-note-0004">日本語</a> </li> <li class="section-language"> <a class="" href="ko#CD010089-note-0002">한국어</a> </li> <li class="section-language"> <a class="" href="ms#CD010089-note-0003">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="ru#CD010089-note-0001">Русский</a> </li> <li class="section-language"> <a class="" href="zh_HANS#CD010089-note-0008">简体中文</a> </li> <li class="section-language"> <a class="" href="zh_HANT#CD010089-note-0012">繁體中文</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734064000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734064000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772746000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010089\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010089\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010089\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD010089\x2epub3"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010089\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010089\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010089\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010089\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010089\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD010089\x2epub3"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010089\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010089\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010089\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD010089\x2epub3"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010089\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010089\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010089\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD010089\x2epub3"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=sogqpCtr&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD010089.pub3&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD010089.pub3';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD010089.pub3/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD010089.pub3/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD010089.pub3%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740714192531"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD010089.pub3/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740714192535"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD010089.pub3/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918d68b12af4937d',t:'MTc0MDcxNDE5Mi4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 